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The purpose of the current study was to develop a manualized treatment for fibromyalgia 
syndrome (FM) and to examine the efficacy of the treatment in a randomized controlled clinical 
trial.  FM is a chronic musculoskeletal pain disorder characterized by tender points and 
generalized pain.  Depression, chronic fatigue, and sleep disturbance are common.  A 
biopsychosocial model served as a framework for understanding FM by integrating 
psychological, social, and physical factors.  Cognitive-behavioural therapy (CBT), an empirically 
validated treatment for arthritis, has also been used with FM patients in an attempt to improve 
pain control, reduce disability, and increase self-efficacy.  Overall, the attention/placebo 
controlled studies employing CBT as a treatment for FM show that it is not superior to a credible 
attention placebo.  The current study attempted to combine the necessary components of CBT 
with interpersonal therapy to address relational patterns and personality characteristics that can 
affect ability to cope with chronic pain.  One hundred and five women diagnosed with FM by a 
rheumatologist were randomly assigned to the CBT-interpersonal treatment condition or an 
attention-control condition.  There were 8 treatment groups with a mean of 6-7 participants in 
each.  The treatment consisted of weekly 2-hour sessions over 8 consecutive weeks.  Outcome 
measures included: FM impact, pain, health care utilization, depression, coping, and self-
efficacy.  An intention-to-treat analysis was conducted.  Results showed that the impact of FM 
symptoms was reduced following treatment compared to the control group and this was 
statistically and clinically significant, but was not maintained at 3-month follow-up.  Significant 
improvements were also observed in coping strategies, some of which were maintained at 
follow-up.  Importantly, self-efficacy improved significantly following treatment compared to 
the control group.  Self-efficacy beliefs have been related to pain, coping efforts, disability, and 
psychological functioning.  Directions for future research may include a focus on long-term 
maintenance of treatment gains that may be mediated by improvements in self-efficacy.  There is 
strong evidence that changes in self-efficacy are enduring and affect changes in health 
behaviours and health status.   
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Introduction 
Fibromyalgia syndrome is a chronic pain disorder characterized by physical symptoms 
such as tender points and generalized pain (Okifuji & Turk, 1999).  In addition, patients report 
psychological dysfunction and functional limitations including depression, anxiety, chronic 
fatigue, sleep disturbance, stiffness, and headaches (Okifuji & Turk).  Friedberg and Jason 
(2001) have argued that psychological interventions have much to contribute to the treatment of 
fibromyalgia beyond existing medical interventions.  Furthermore, preliminary studies suggest 
that psychological interventions hold much promise for the treatment of fibromyalgia (Rossy et 
al., 1999). 
The current study begins by describing fibromyalgia in terms of the criteria for its 
classification as well as its medical and psychological symptoms.  This is followed by a 
summary of the etiological theories of fibromyalgia.  Next, the literature surrounding 
psychotherapeutic approaches to the treatment of fibromyalgia will be reviewed, with an 
emphasis on the literature related to cognitive-behavioural treatments.  The limitations of 
previous psychotherapeutic interventions will be discussed and a line of research will be 
proposed.  This will include discussion of the manualized treatment and the methodology for the 
combined cognitive-behavioural and interpersonal group treatment for fibromyalgia.  Finally, the 
results of the clinical trial will be discussed and contributions, limitations, and clinical 
implications of the current study are reviewed followed by recommendations for future research.   
Fibromyalgia Syndrome 
Fibromyalgia is a chronic musculoskeletal pain disorder.  It is a rheumatologic condition, 
which means that the muscles and connective tissues can be painful.  In arthritis, also a 
rheumatologic condition, the joints are also affected.  Fibromyalgia, however, is a nonarticular 
condition; therefore the joints are not affected.  Fibromyalgia is not degenerative or deforming 
and has no known excess mortality (Goldenberg, 1987; Okifuji & Turk, 1999).  Long-term 
studies indicate that most fibromyalgia patients will experience chronic pain for more than 5 
years after their diagnosis (Forseth, Forre, & Gran, 1999; Norregaard, Bulow, Prescott, Jacobsen, 
& Danneskiold-Samsoe, 1993; Wigers, 1996).  Fibromyalgia is estimated to affect 3 to 6 million 
individuals in the United States (Okifuji & Turk) and approximately 3 in 100, or 900,000 
individuals in Canada (Arthritis Society, 2008).  The prevalence in the general population is 
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approximately 2% and the female to male ratio is 9:1 when the presence of more than 11 tender 
points is used for the diagnosis (Wolfe et al., 1995). 
Since the early 1900’s the terms fibrositis, fibromyositis, and psychogenic rheumatism 
have been applied to that which is currently called fibromyalgia, a term first suggested by Hench 
in 1976 (Okifuji & Turk, 1999; Wolfe et al., 1990).  The terms primary and secondary 
fibromyalgia have also been used in the diagnostic literature.  Primary fibromyalgia referred to 
the presence of fibromyalgia in the absence of other rheumatic illness, whereas secondary 
fibromyalgia referred to the presence of fibromyalgia and another condition such as rheumatoid 
arthritis.  Wolfe et al., however, suggest that the distinction between primary and secondary 
fibromyalgia should be abolished at the diagnostic level and the term ‘fibromyalgia’ used 
instead.  When a person has another illness the term ‘concomitant’ should be used, or 
fibromyalgia and the other condition are said to be associated.  
The existence of fibromyalgia syndrome and the utility of the diagnosis have been 
challenged by some.  For example, authors argue that the diagnostic label, ‘fibromyalgia 
syndrome,’ drives the illness-disease paradigm, promoting sickness behaviour and somatization 
in people with normal aches and pains (Bohr, 1995; Hadler, 1996).  Goldenberg (1999), 
however, argues that the diagnostic label itself does not promote sickness behaviour unless it is 
used as a substitute for patient information and education.  The diagnosis can be reassuring for 
many people, enabling them to stop worrying that they have a degenerative disease and to begin 
focusing on improving symptoms.   
The American College of Rheumatology (1990) criteria for the classification of 
fibromyalgia are: 1) history of widespread pain for at least 3 months (pain in the left and right 
side of the body, pain above and below the waist, and axial skeletal pain), in combination with, 
2) pain in 11 or more of the 18 specific tender point sites on digital palpation (Wolfe et al., 
1990).  Tender points are examined by palpating with the thumb or the first 2 or 3 fingers at a 
pressure of approximately 4 kg/cm squared or less, or by using a dolorimeter or algometer.  This 
amount of mechanical force can easily be approximated by applying enough manual pressure to 
blanch the thumbnail bed (Ang & Wilke, 1990).  The tender points are located bilaterally at the 
occipital and lower cervical area, trapezius and supraspinatus muscle, second costosternal 
junction, both lateral epicondyles, gluteus muscle, greater trochanteric area, and the medial fat 
pads of the knees (see Appendix A; Wolfe et al., 1990).  Principal symptoms include sleep 
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disturbance, fatigue, and morning stiffness, with at least one of these symptoms present in 75% 
of fibromyalgia patients (Wolfe et al., 1990).  Fibromyalgia symptoms are strongly correlated 
with decreased mechanical pain thresholds.  That is, individuals with fibromyalgia have a low 
pain threshold when pressure is applied.  This is referred to as mechanical hyperalgesia (Wolfe et 
al., 1995).  Staud and Domingo (2001) stated that mechanical hyperalgesia is always detectable 
in fibromyalgia patients, and it seems to represent a very important aspect of the syndrome’s 
underlying pathophysiology.  Other symptoms of fibromyalgia can include anxiety, depression, 
and irritable bowel syndrome (Ahles, Yunus, Riley, Bradley, & Masi, 1984; Burckhardt, Clark, 
& Bennett, 1992; Sivri, Cinda, Dincer, & Sivri, 1996).  High levels of disability, poor quality of 
life, and extensive use of medical care are often reported (Hadhazy, Ezzo, Creamer, & Berman, 
2000; Turk, Okifuji, Starz, & Sinclair, 1996).   
The relation between the physical symptoms, such as pain, and the psychological 
symptoms, such as depression, is complex, leading many authors to argue that a biopsychosocial 
model is the best model with which to conceptualize fibromyalgia and its treatment (Friedberg & 
Jason, 2001; Okifuji & Turk, 1999; Terrell White, Parr Lemkau, & Clasen, 2001; White & 
Nielson, 1995).  A number of etiological theories, however, have been proposed and will be 
reviewed.  
Etiological Theories of Fibromyalgia 
 There are a number of theories postulating the underlying mechanisms of fibromyalgia; 
however, there does not appear to be conclusive evidence for any one particular etiological 
model.  A number of theories are briefly described below, and then the biopsychosocial model 
will be discussed in greater detail.  
Psychogenic Model 
Some authors have proposed a psychogenic model of fibromyalgia, suggesting that 
depression is the primary mechanism underlying the disorder (Alfici, Sigal, & Landau, 1989).  
According to this model, the organic condition does not explain the pain reported by the patient.  
Rather, psychological features such as depression and abnormal illness behaviour are seen to 
play a critical role in the etiology of fibromyalgia (Ercolani et al., 1994).  Since the earliest 
studies, researchers observed that a high percentage of patients with fibromyalgia displayed 
various psychological symptoms (Ellman, Savage, Wittkower, & Rodger, 1945).  For example, 
Hench and Bolland (1946) found that fibromyalgia patients display psychological symptoms 
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including depression and hostility, while Stolze related this to an “inner conflict arising from 
strong unexpressed aggressive feelings” (Ercolani et al.).  Fibromyalgia was viewed as having a 
psychological cause, in the form of unexpressed anger and hostility.  More recent studies suggest 
that the diagnosis of fibromyalgia is, in fact, major depression in 29% to 71% of cases 
(Ferraccioli, Cavalieri, & Salaffi, 1990; Hudson & Pope, 1989).  In the current climate, 
depression may be seen as a more favorable explanation for the etiology of fibromyalgia than 
“inner conflict” and “unexpressed aggression.”  
Other studies, however, report no difference between fibromyalgia patients and controls 
on psychological variables.  For example, Kirmayer, Robbins, and Kapusta (1988) found that 
fibromyalgia patients were not significantly more likely to report depressive symptoms or to 
receive a diagnosis of major depression compared to rheumatoid arthritis patients.  In addition, 
there were no significant differences between the groups in the number of times each patient 
spoke with a physician about nerves or emotional worries in the preceding 12 months.  These 
findings demonstrate that major depression was not a common correlate of fibromyalgia 
syndrome, thus, failing to support the psychogenic model.  
Aaron and Bradley et al. (1996) examined the lifetime prevalence of psychiatric disorders 
in patients with fibromyalgia in tertiary care, in a community sample of people diagnosed with 
fibromyalgia (non-patients), and in healthy controls.  There were a significantly higher number 
of lifetime psychiatric diagnoses in the fibromyalgia patients in tertiary care compared to the 
fibromyalgia non-patients and healthy controls.  However, there was not a significant difference 
in psychiatric diagnoses between fibromyalgia non-patients and healthy controls.  The authors 
concluded that psychiatric disorders are not intrinsically related to fibromyalgia.  Instead, they 
argue that multiple lifetime psychiatric diagnoses may contribute to the decision to seek medical 
care for fibromyalgia in tertiary settings.  
Yunus, Ahles, Aldag, and Masi (1991) demonstrated that fibromyalgia symptoms such as 
tender points, fatigue, and paresthesia are independent of the psychological status of the patient, 
although the degree of pain may be influenced by psychological factors.  In other words, a 
person can be diagnosed as having fibromyalgia based on the clinical symptom presentation.  
Whether or not psychological symptoms are present does not preclude the fact that the clinical 
symptoms of fibromyalgia are real.  Certainly, the notion that psychological factors can affect the 
pain experience is not unfamiliar.  This notion is consistent with the gate control theory of pain 
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proposed by Melzack and Wall (1965).  The fact that psychological factors can alter the pain 
experience does not necessitate that the psychological factors caused the pain.  The gate control 
theory of pain incorporates facts about the nervous system, plausible explanations for clinical 
pain, and stimulates experiments to test the theory.  Melzack and Wall (1965) explain that there 
are powerful influences descending from the brain, which modulate spinal reflexes.  The 
descending influence on inhibitory neurons, in addition to ascending messages to the brain that 
can influence descending controls, complete a loop from the spinal cord to the brain and back to 
the spinal cord (Melzack & Wall, 1965).   
In general, results from empirical studies fail to support the psychogenic model of 
fibromyalgia (Okifuji & Turk, 1999).  Although depression is a frequently found symptom in 
people with fibromyalgia, the model cannot explain the presence of large individual differences 
in the degree of depression and other types of psychological distress among people with 
fibromyalgia.  Also, depression is not specific to fibromyalgia, nor do all people with 
fibromyalgia report elevated levels of depression (Okifuji & Turk). 
Affective Spectrum Disorder Model (ASDM) 
Unlike the psychogenic model, the ASDM of fibromyalgia does not suggest a causal 
relationship between psychological disorders, such as depression, and fibromyalgia.  Instead, the 
ASDM proposes that there is a group of medical and psychiatric disorders that share a common 
pathophysiology.  Hudson and Pope (1989) proposed this model based on the observation that 
major depression was common in fibromyalgia patients and their first-degree relatives.  They 
suggest that the co-occurrence of disorders such as fibromyalgia, irritable bowel syndrome, 
migraine, and major depression is due to a common abnormality.  Positive responses to 
antidepressants in some cases have been proposed as evidence for this model, such that the 
medication is acting on the pathophysiology that is shared by the fibromyalgia and depressive 
symptoms.  Okifuji and Turk (1999) stated that the empirical evidence for the ASDM is 
inconsistent.  For example, greater prevalence of depression is not always observed in 
fibromyalgia compared to other chronic pain conditions.  Also, the effectiveness of 
antidepressant medication on fibromyalgia seems to be overestimated in this model.  
Furthermore, the underlying assumption that if one medication improves multiple symptoms, 
then all of those symptoms share a common pathology is not warranted.  For example, analgesics 
can relieve pain that is caused by many different mechanisms. 
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Cognitive Factors 
Although research has demonstrated that cognitive factors affect one’s ability to adapt to 
his or her symptoms, cognitive factors are generally not considered to be etiological (Turk & 
Rudy, 1986).  A number of chronic pain disorders may be initiated by physical pathology, but 
over time the physical pathology plays a diminished role, while maladaptive cognitions play a 
larger role and may maintain and aggravate symptoms.  One difficulty with this approach is 
determining whether cognitive factors alter the physical symptoms or whether cognitive factors 
alter the ‘perception’ of the symptoms.  
Research in the area of cognition and fibromyalgia is limited compared to other chronic 
pain disorders.  Results, however, indicate that maladaptive thinking is commonly observed in 
people with fibromyalgia, and is associated with functional limitations and affective distress.  
Perceived lack of control and self-efficacy beliefs have been related to increased pain, disability, 
and depressed mood (Buckelew, Murray, Hewett, Johnson, & Huyser, 1995; Turk & Okifuji, 
1997).  It is important to note, though, that not all people with fibromyalgia have maladaptive 
cognitions.  Turk, Okifuji, Starz, and Sinclair (1996) reported that the level and nature of 
maladaptive thoughts vary greatly, with approximately one-third of people with fibromyalgia 
adapting well to their conditions (Burckhardt & Bjelle, 1996; Pastor et al., 1993).  
Hypervigilance Model and Central Modulation Model  
Although the hypervigilance and central modulation models have produced separate lines 
of research, they both define fibromyalgia as a disorder primarily characterized by maladaptive 
information processing.  The models focus on the interaction of neuroendocrine factors and the 
central nervous system.  Although research in this area is increasing, a limited number of studies 
have examined hypotheses stemming from these models, and results thus far have been 
inconsistent and confusing (Okifuji & Turk, 1999).  A number of hypotheses will be presented 
within the areas of neuroendocrine abnormalities, followed by neurologic abnormalities.   
Neuroendocrine Abnormalities 
The autonomic nervous system and the hypothalamic pituitary axis (HPA) are partly 
responsible for physiological pain modulation.  Corticotropin-releasing hormone (CRH) and 
adrenocorticotropin hormone (ACTH) function as part of the HPA.  Stress and pain activate 
neurons that release CRH, and subsequently ACTH is released and painful symptoms are 
decreased (Staud & Domingo, 2001).  Several studies have shown a hyperactivity of the HPA in 
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patients with fibromyalgia (Clauw & Chrousos, 1997; Demitrack & Crofford, 1998; Pillemer, 
Bradley, Crofford, Moldofsky, & Chrousos, 1997).  That is, patients responded with a significant 
increase in ACTH release when stimulated with CRH.  In contrast, patients with chronic fatigue 
syndrome, which shares some features with fibromyalgia, show a hypoactivity of the HPA. 
Because of the comorbidity of fibromyalgia and depression, the effects of major depression on 
neuroendocrine functioning have also been examined.  Crofford, Jacobson, and Young (1999) 
found that in contrast to fibromyalgia patients, depressed individuals show a blunted ACTH 
response to CRH.  Therefore, concomitant psychiatric symptoms do not seem to be responsible 
for the neuroendocrine abnormalities observed in fibromyalgia patients.  Although fibromyalgia, 
chronic fatigue syndrome, and depression have overlapping features, they are distinct syndromes 
with different neuroendocrine abnormalities (Staud & Domingo, 2001).  
 Abnormalities in growth hormone (GH) secretion have been examined in fibromyalgia 
patients.  Prominent GH secretion occurs during stages III and IV of sleep.  These stages of sleep 
are frequently abnormal in fibromyalgia patients; therefore, abnormalities in GH secretion have 
been postulated as a possible etiology for fibromyalgia (Moldofsky, Scarisbrick, England, & 
Smythe, 1975).  Low levels of GH have been reported in some fibromyalgia patients (Bennett, 
1998), whereas elevated levels have been found in patients with chronic fatigue syndrome. 
Replacement of GH was reported to be beneficial only for those fibromyalgia patients deficient 
of GH (Bennett, Clark, & Walczyk, 1998).  Elevated levels of prolactin have also been observed 
in fibromyalgia patients and these elevated levels seem to correlate with symptom severity. 
Sperber et al. (1999) found that 71% of subjects with hyperprolactinemia could also be 
diagnosed with fibromyalgia, in contrast to only 4.5% of normoprolactinemic control subjects.  
 Although a number of neuroendocrine abnormalities are present, it is unclear to what 
extent these neuroendocrine responses are adaptive CNS responses to chronic pain and stress.  
Researchers continue to pursue this line of investigation.  
Neurological Abnormalities 
Abnormal central processing has been proposed as a possible etiology for the increased 
pain sensations experienced by fibromyalgia patients.  Staud and Domingo (2001) examined the 
psychophysical evidence for the possibility that input to central nociceptive pathways is 
abnormally processed in individuals with fibromyalgia.  In particular, they examined temporal 
summation of pain.  Compared to control participants, fibromyalgia patients show differences in 
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response to repetitive thermal stimuli.  Levels of temporal summation from repetitive stimulation 
consistently exceeded those of control participants over a range of stimulus frequencies.  In 
addition, after-sensations lasted longer and were more frequently painful in fibromyalgia 
participants (Staud & Domingo). 
Bennett (2004) stated that there is an impressive body of research that has established that 
pain in fibromyalgia results from abnormal sensory processing within the central nervous 
system, referred to as central sensitization.  Central sensitization acts as an amplifier, resulting in 
sensations that formerly were non-painful becoming painful.  Bennett stated that this is not a 
psychological amplification, but rather a physiological amplification that occurs mainly at the 
level of the spinal cord.  Hyperalgesia and allodynia are important clinical features of central 
sensitization (Staud & Domingo, 2001).  Hyperalgesia and allodynia may be responsible for the 
increased excitability of spinal and supraspinal neurons.  Hours after noxious stimuli are 
presented, there are increases in spontaneous activity, enhanced responsiveness to stimuli, and 
enlarged receptive fields of dorsal horn neurons (Staud & Domingo).  Hyperalgesia is defined as 
“the exaggerated response to noxious stimuli (e.g. painful heat), whereas allodynia describes the 
painful response to a non-noxious stimulus like light touch, mild warmth, or cold.  Both features 
of central sensitization are frequently present in fibromyalgia patients” (Staud & Domingo, p. 
211). 
Substance P levels in the cerebrospinal fluid of fibromyalgia patients have been found to 
be elevated more than two to three times that of normal control subjects (Russell et al., 1994).  
Substance P is a polypeptide that functions as a neurotransmitter and a neuromodulator.  In the 
central nervous system, Substance P has been associated with pain and nociception.  Nociception 
is unconscious activity induced by a harmful stimulus in sense receptors, peripheral nerves, the 
spinal column and the brain (Russell et al.).  Substance P is also activated following tissue injury; 
despite no evidence of tissue injury, fibromyalgia patients have elevated levels of substance P.  
Several studies of fibromyalgia patients report lower cerebrospinal fluid concentration of 
analgesic neurotransmitters compared with normal individuals.  These neurotransmitters provide 
pain inhibitory and facilitatory signals to the dorsal horn, thus decreasing or increasing 
hyperalgesia (Urban & Gebhart, 1999). 
Staud and Domingo (2001) stated that there is convincing evidence that there are distinct 
biological abnormalities present in almost all people with fibromyalgia.  Bennett (2004) provides 
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a review of the research supporting such abnormalities, including: elevated cerebrospinal fluid 
levels of Substance P, dynorphin, and nerve growth factor, enhanced temporal summation, 
enhanced somatosensory potentials, a lower threshold for elicitation of the nociceptive flexion 
reflex, and decreased thalamic activity on functional brain scans.  Bennett (2004) suggests a 
contemporary paradigm for understanding fibromyalgia, which “envisages fibromyalgia as a 
disorder in which the central nervous system amplifies pain sensations (‘central sensitization’) 
due to a complex interplay between genetic predisposition, the cumulative burden of painful 
insults (‘peripheral pain generators’), and a dysregulation of the normal response to stressors 
(‘dys-stress’)” (p. 23).   
Biopsychosocial Model 
Certainly, a number of the above mentioned etiological models for fibromyalgia 
contribute much to the conceptualization of the disorder, particularly the multi-faceted paradigm 
suggested by Bennett (2004).  Some of the models, however, fail to explain important aspects of 
the disorder.  For example, a substantial number of people suffer from persistent pain that is 
unmanaged by available medical and surgical treatments.  In addition, functional disability often 
appears to be in excess of what might be expected on the basis of physical pathology alone 
(Turk, 1996).  These models have been criticized for the failure to account for psychological and 
psychosocial variables in health and disease and for the dynamic interaction of these variables 
with pathophysiological factors (Engel, 1977).  
Indeed, research indicates that psychological and social variables modulate nociception 
and moderate the pain experience and related disability.  Turk and Okifuji (2002) stated that 
“there has been a growing recognition that pain is a complex perceptual experience influenced by 
a wide range of psychosocial factors, including emotions, social and environmental context, 
sociocultural background, the meaning of pain to the person, and beliefs, attitudes, and 
expectations” (p.679).  The biopsychosocial model serves as a framework for understanding 
chronic pain and disability by integrating psychological and social factors with physical factors.  
Numerous authors suggest a biopsychosocial model of fibromyalgia (Friedberg & Jason, 2001; 
Hadhazy et al., 2000; Terrell White et al., 2001; Turk & Okifuji, 2002).  Okifuji and Turk (1999) 
proposed a diathesis-stress model specifically for fibromyalgia, called the dynamic process 
model.  The model is designed to be a heuristic, serving as a guide for a comprehensive 
conceptualization of fibromyalgia that incorporates the authors’ understanding of the current 
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literature.  Turk and Okifuji (2002) stated that the biopsychosocial model presumes some form of 
physical pathology in the muscles, joints, or nerves that generate nociceptive input to the brain. 
Perception involves the interpretation of nociceptive input and identifies the type of pain (i.e., 
sharp, burning, punishing).  Appraisal involves the meaning that is attributed to the pain and 
influences subsequent behaviors.  These appraisals will be influenced by the beliefs each person 
develops over his or her lifetime.  On the basis of these beliefs and the appraisal process, the 
person may choose to ignore the pain and continue working, walking, socializing, and engaging 
in previous levels of activity or may choose to leave work, refrain from all activity, and assume 
the sick role.  In turn, this interpersonal role is shaped by responses from significant others that 
may promote either the healthy and active response or the sick role (Turk & Okifuji, 2002).  
There is significant evidence for the biopsychosocial model of chronic pain.  Among 
psychological factors, the importance of patients’ beliefs has been studied widely.  Beliefs about 
the meaning of symptoms and self-efficacy in pain control play a central role in chronic pain.  
Such beliefs are associated with psychological functioning (Jensen, Romano, Turner, Good, & 
Wald, 1999; Stroud, Thorn, Jensen, & Boothby, 2000), physical functioning (Stroud et al., 2000; 
Turner, Jensen, & Romano, 2000), coping efforts (Anderson, Dowds, Pelletz, Edwards, & 
Peeters-Asdourian, 1995), behavioral responses (Jensen et al., 1999), and response to treatment 
(Tota-Faucette, Gil, Williams, Keefe, & Goli, 1993).  Social factors are also associated with pain 
and distress.  For example, significant others play an important role in influencing pain reports 
and communications of distress and suffering.  Significant others’ reinforcement of pain 
behaviour, solicitousness, criticism, and support, and marital conflict are among the social 
factors that play a role in chronic pain.  These social factors are associated with surgery results 
(Epker & Block, 2001; Graham, 2000; Schade, Semmer, Main, Hora, & Boos, 1999), display of 
pain behaviors (Schwartz, Slater, & Birchler, 1996), physical disability, and nonverbal pain 
behavior (Romano, Turner, Jensen, Friedman, et al., 1995).  
In summary, neuroendocrine dysfunction, maladaptive psychological responses, and 
maladaptive behaviors are associated with fibromyalgia.  The biopsychosocial model integrates 
premorbid, precipitating, and psychological factors with stress responses in an attempt to 
understand the development and maintenance of fibromyalgia.  For example, a stressor may 
trigger physiological and psychological responses in an individual, mediated by biological and 
experiential predispositions.  At this point, the individual may become aware of symptoms but 
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predispositional factors, such as central nervous system reactivity, maladaptive cognitions, 
psychological factors such as depression, or neuroendocrine factors may inhibit the initiation of 
adaptive responses to the symptoms. 
Based on the biopsychosocial model of fibromyalgia and the belief that psychological 
factors can contribute to the maintenance and aggravation of symptoms, psychological 
interventions have been used in the treatment of fibromyalgia.  
Psychotherapeutic Approaches to the Treatment of Fibromyalgia 
Cognitive-Behavioral Approaches  
Given the chronic nature of fibromyalgia, and the fact that the etiology and cure are not 
completely known, people with fibromyalgia may develop the belief that their pain and level of 
disability are uncontrollable.  This belief may result in negative affect, pain, sleep disturbance, 
and reduced attempts to engage in daily activities and to develop effective coping strategies 
(Okifuji & Turk, 1999).  Cognitive-behavioral psychotherapy is a model of therapy based on the 
assumption that a person’s perceptions and evaluations of his or her life events influence his or 
her emotional and behavioral reactions to events (Bradley, 1989).  Perceived lack of control is 
present among fibromyalgia patients, contributing to difficulties with self-esteem, depression, 
pain, functional disability, compliance, and coping.  Targeting these perceptions with cognitive-
behavioral techniques has been suggested as an intervention for fibromyalgia (Bradley, 1989). 
Cognitive-behavioral therapy (CBT) has focused on teaching fibromyalgia patients the skills 
necessary to control pain and disability and to believe that they can employ these skills.  By 
doing so, patients learn to diminish negative cognitions and perceptions surrounding lack of 
control.  
In a meta-analysis of 49 fibromyalgia treatment outcome studies, Rossy et al. (1999) 
suggested that nonpharmacological treatments, specifically CBT and exercise, are more helpful 
in managing self-reported fibromyalgia symptoms (i.e. pain, fatigue, and morning stiffness) than 
pharmacological treatment alone.  However, the positive effect sizes reported in the review are 
associated with studies that compare active treatment to no treatment, such as a wait-list control 
condition, or they are single group uncontrolled studies (Bradley, 2002).  The effects are much 
smaller when active treatment is compared to adequate placebo conditions.  In a review 
conducted by Bradley and Alberts (1999), three studies were found to employ adequate control 
conditions (Buckelew et al., 1998; Nicassio et al. 1997; Vlaeyen et al., 1996).  Importantly, the 
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results of these three controlled studies show that, overall, CBT for fibromyalgia is not superior 
to a credible attention placebo.  However, some positive outcomes were obtained with CBT and 
will be reviewed.  This is a very different conclusion from that associated with the literature on 
CBT for rheumatoid arthritis and osteoarthritis.  In this literature, there are a large number of 
well-controlled trials that have produced very positive results.  Despite the inconsistent results of 
CBT for chronic pain (i.e. arthritis vs. fibromyalgia), CBT does hold promise for the treatment of 
fibromyalgia.  Fibromyalgia, although different from other chronic pain disorders, does share 
many fundamental characteristics.  Therefore, it is likely that certain elements of CBT that have 
been effective for other chronic pain conditions can be effective for patients with fibromyalgia.  
Although the attention/placebo controlled studies of CBT for fibromyalgia have not 
shown overwhelmingly positive results, it is not yet reasonable to discount the potential 
contributions of CBT for fibromyalgia.  In the literature, CBT is widely acknowledged as an 
empirically validated treatment for certain chronic pain conditions, including arthritis.  Since 
fibromyalgia shares many commonalities with other chronic pain conditions, it is likely that a 
fibromyalgia population could realize some of the benefits of CBT, if the necessary adjustments 
are made.  This proposal argues that a potentially necessary adjustment is the addition of 
interpersonal process oriented group therapy.  Interpersonal process group therapy can address 
aspects of living with fibromyalgia that CBT typically does not.  For instance, relational patterns 
can be demonstrated during interactions between group members and the therapist.  These 
patterns can be discussed and processed with respect to their effect on the chronic pain disorder.  
This differs from cognitive-behavioral approaches, although they certainly do address cognitive 
patterns, and adaptive and maladaptive behaviours.  The intricacies of relational patterns and 
personality characteristics that affect interpersonal relationships are more delicate than what a 
psycho-educational cognitive-behavioural group may comfortably address.  The importance of 
addressing interpersonal relationship issues is evident, as reviewed earlier, by the effect 
psychosocial factors have on chronic pain.  For example, marital conflict and a significant 
others’ solicitousness and support are associated with pain and disability.  In addition to 
relational patterns, other important issues may be more appropriately dealt with by an 
interpersonal process approach.  For example, trauma has been associated with pain and 
disability, these experiences are not appropriate to deal with in a psycho-educational setting 
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(Grzesiak, Ury, & Dworkin, 1996).  These issues, however, are important to the experience of 
chronic pain and are associated with fibromyalgia. 
The challenge is to isolate the critical components of CBT that have been effective with 
other chronic pain populations.  In addition, idiosyncratic characteristics associated with 
fibromyalgia must be addressed by another therapeutic orientation.  The unique issues associated 
with fibromyalgia may be effectively addressed using interpersonal psychotherapeutic 
techniques.  Therefore, the aim of the current study is to combine the necessary components of 
both techniques, thereby providing treatment that addresses critical cognitive and behavioural 
factors, as well as emotional and interpersonal factors that affect pain perception, coping 
strategies, and hence, disability (Turk & Okifuji, 2002).   
Fibromyalgia Intervention Studies 
A number of randomized controlled fibromyalgia intervention studies will be reviewed in 
detail, namely, attention/placebo controlled and no treatment (wait-list) controlled trials.  The 
review focuses on studies that employ a cognitive-behavioural approach either alone, or as part 
of a multimodal treatment program.  Table 1 also provides a description of these studies in 
addition to a description of the single group uncontrolled trials.  Characteristics of each study are 
described in Table 1, including the design, intervention, outcome measures, and results.  
A number of these studies specifically identify a component of their multidisciplinary 
treatment programs as cognitive-behavioural in nature, whereas others identify an educational 
component.  Some of the educational components include aspects of CBT, for example, 
cognitive restructuring, coping skills, activity pacing, etc.  Fibromyalgia intervention studies that 
do not employ a CBT component, or an educational component that includes aspects of CBT, are 
not reviewed in the current study.   
Attention/placebo controlled trials by Vlaeyen et al. (1996), Nicassio et al. (1997), 
Buckelew et al. (1998) and Keel, Bodoky, Gerhard, and Muller (1998) will be reviewed in 
greater detail, followed by a review of the wait-list controlled trials.  
Vlaeyen et al. (1996) examined the effectiveness of outpatient educational-cognitive 
group treatment with 125 fibromyalgia patients.  The authors followed suggestions presented by 
Bradley (1989) for randomized controlled clinical trials of cognitive treatment for fibromyalgia. 
For example, Vlaeyen et al. assigned patients to either a treatment condition, an attention-control 
condition, or a wait-list control condition.  An educational program was applied to both the 
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treatment and the attention-control conditions while a cognitive program was applied only to the 
treatment condition.  The educational program provided information about psychosocial factors 
that influence pain, ergonomic principles applied to daily activities, and social security 
legislation.  The information did not focus solely on fibromyalgia, but on chronic pain in general.  
Each session ended with a physical exercise such as swimming or bicycling.  The cognitive 
program was aimed at decreasing distorted pain attributions and at increasing self-efficacy 
expectations.  This group program consisted of 12 sessions of 90 minutes, grouped into 3 phases: 
a reconceptualization phase, a skills acquisition phase, and a generalization phase.  The goal of 
the reconceptualization phase was to modify the pain experience in terms that imply self-control 
and resourcefulness.  In the skills acquisition phase patients practiced imagery techniques and 
relaxation.  During the generalization phase the patients were gradually exposed to tension 
eliciting stimuli and were encouraged to use relaxation skills in the presence of these stimuli.  
The attention-control condition was included in order to control for the nonspecific 
effects of the cognitive treatment while the wait-list control condition controlled for natural 
history effects.  The group discussion included in the attention-control condition involved 
patients reading parts of a book about pain, written for pain patients, and being requested to share 
the information and their own thoughts with the other group members. In addition, participants 
listened to various audiotaped music fragments.  Each session ended with a homework 
assignment, consisting of brief reading assignments and listening to audiotaped musical 
fragments.  The group discussion was conducted by the same psychologist who conducted the 
cognitive treatment, and consisted of the same number of sessions.  Neither the subjects nor the 
rest of the interdisciplinary staff were aware of the difference between the two treatments.   
Vlaeyen et al. (1996) hypothesized that the combination of cognitive treatment with 
group education would be more effective than group education alone on measures of pain coping 
strategies, pain control, tension levels, quality of life, and health care utilization.  The authors 
hypothesized that both interventions would show improvement on knowledge related to the 
information provided in the educational program, whereas the waiting list control condition 
would not show such improvement.  The authors found that participants in the cognitive-
educational intervention condition improved their knowledge about fibromyalgia and pain 
coping compared to the education-discussion intervention condition and the wait-list control 
condition.  Participants in the education-discussion condition reported significantly less fear than 
 15
those in the cognitive-educational condition.  The authors concluded that the addition of a 12-
session cognitive treatment could not be supported by their study since fear reduction in the 
education-discussion condition enhanced pain coping and control, while poor compliance with 
homework in the cognitive-educational condition limited the effectiveness of the cognitive-
educational treatment.  
Nicassio et al. (1997) stated that previous studies provide no conclusive evidence of the 
effectiveness of behavioural or educational approaches in reducing fibromyalgia symptoms and 
disability.  Their research differs from these studies by incorporating a number of 
methodological improvements to compare a comprehensive behavioural intervention for 
fibromyalgia with an education/control condition.  For example, to separate behavioural and 
educational elements that have been mixed in other research, the authors compared the 
behavioural intervention with an educational/control condition in which a range of health-related 
didactic information was presented.  However, they omitted instruction on coping practices to 
manage pain in the control condition.  In addition, this study explored the role of intervening 
variables as mediating improvement in clinical outcomes.  
The behavioural treatment incorporated the following components: 1) education about the 
nature of fibromyalgia and adoption of the gate control theory of pain as a framework for 
understanding the role of cognition and emotions in the experience and expression of pain; 2) 
training in progressive muscle relaxation, deep breathing, and relaxing in the face of stress or an 
increase in pain; 3) behavioural goal setting and activity pacing to increase functioning through 
shaping and establishment of reinforcement contingencies; and 4) involvement of a support 
person who learned the same pain management skills as the subject, and assisted the subject by 
prompting adaptive coping techniques and reinforcing adherence to the protocol.  The first 8 
sessions emphasized skill acquisition and practice, while the last 2 sessions reviewed and 
consolidated pain coping skills and refined strategies for achieving behavioural goals and 
increasing social and physical activity (Nicassio et al., 1997). 
The education/control condition involved 2 major elements: 1) informative lectures 
presented via videotape by a variety of health professionals on topics of general relevance to 
fibromyalgia and other health related issues; and 2) group discussion and support. In the first 
session the co-therapists, a PhD clinical psychologist and a psychology doctoral student, 
presented an introduction to fibromyalgia and provided an explanation of the benefits of 
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information and support in dealing with the syndrome.  The videotapes were presented in 
sessions 2 through 9 and addressed topics such as: diagnostic criteria; similarities and differences 
between fibromyalgia and arthritis; and pain and fatigue.  After each videotaped presentation, 
therapists led a structured group discussion on the relevance of the topic to group members; 
however, at no time during the course of the intervention was specific information imparted on 
coping with pain, problem solving, or the use of cognitive-behavioural strategies.  At the end of 
each session, subjects received written summaries of the educational information presented to 
them. In session 10, educational topics were reviewed, questions were addressed, and 
information on community resources for fibromyalgia was provided.  
The effects of the interventions were assessed on clinical outcomes and intervening 
variables, which served as potential mediators of treatment efficacy at pretreatment, post-
treatment, and 6 month follow-up.  The clinical outcomes included: a number of pain indices, 
including the pain scale of the Fibromyalgia Impact Questionnaire (FIQ) and a composite index; 
self-reported and observed pain behaviour; depression as measured by the CES-D; and disability 
measured by the quality of well-being scale.  Intervening variables were helplessness, pain 
coping measured by the pain management inventory, and social support.  
A total of 36 participants in the behavioural condition and 35 in the education/control 
condition completed all phases of the trial.  All participants were diagnosed with fibromyalgia by 
their rheumatologist or primary care physician.  Participants were excluded if they had 
concomitant rheumatologic conditions such as rheumatoid arthritis, or other serious illnesses 
such as cardiovascular disease or psychiatric disorders such as psychosis.  Participants who used 
antidepressants were required to be stable on their medications for a minimum of 2 months prior 
to the study and to continue on that dosage throughout the clinical trial.  In addition, participants 
were required to have a family member or friend (support person) who would be willing to 
participate in the study over the 10-week treatment period.  After meeting exclusion and 
inclusion criteria, participants were blocked on antidepressant use and assigned to the treatment 
or control condition using a random numbers table.  
Nicassio et al. (1997) found improvement across time on several clinical outcomes and 
mediating variables, but no differential effects between the behavioural and education/control 
conditions over the course of the trial.  Significant reductions in depression, self-reported pain 
behaviour, observed pain behaviour, and myalgia scores occurred.  However, factors such as 
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history, maturation, and testing could potentially have contributed to change in either condition.  
Pain, in contrast, did not decline across the trial.  The reductions in depression and pain 
behaviours in both conditions may be indicative of the potential value of psychosocial treatments 
in treating mood disturbance and functional aspects of the disorder.  Improvement in 
helplessness and the use of passive coping strategies also occurred over the course of the trial, 
and the two conditions did not differ in the degree of change on these variables.  This suggests 
the existence of a common therapeutic process in both conditions.  These improvements 
mediated the change in several clinical outcomes.  Reductions in helplessness predicted 
improvement in pain and depression, whereas decrease in passive coping independently 
predicted change in self-reported pain behaviour.  The finding that these variables were more 
highly correlated with improvement in clinical outcomes in the behavioural condition than in the 
education condition may reflect the association that was made between these factors and clinical 
change to participants in the behavioural condition (Nicassio et al., 1997).  Nicassio et al. 
suggested that future psychosocial interventions for fibromyalgia should explicitly target the 
reduction of helplessness beliefs and maladaptive coping, as these may be instrumental to 
clinical change in fibromyalgia.   
Buckelew et al. (1998) compared the effectiveness of biofeedback/relaxation training, 
exercise, and a combined program for the treatment of fibromyalgia.  Participants were randomly 
assigned to one of 4 conditions: 1) biofeedback / relaxation training, 2) exercise training, 3) a 
combination treatment, or 4) an educational / attention-control program.  Participants were 
assessed on a comprehensive range of outcome measures prior to treatment, immediately after 
the 6-week intervention, and at 3-month, 1-year, and 2-year follow-up.  The 
biofeedback/relaxation training condition involved cognitive and muscular relaxation strategies 
and the application of these strategies to daily living.  The intervention included didactics, self-
monitoring, homework assignments, practice, and electromyogram biofeedback training to 
reduce muscle tension.  The exercise condition involved motion exercises, strengthening, low to 
moderate aerobic exercise, and instruction on proper body mechanics.  The combination 
condition involved participation in both the biofeedback/relaxation and exercise conditions.  The 
educational/attention-control condition was designed to control for attention and time with a 
trainer.  Participants in this condition received educational information regarding the diagnosis 
and treatment of fibromyalgia but no specific problem-solving strategies were taught.  
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A number of outcome measures were assessed, including, a tender point index, visual 
analogue scale for pain rating, arthritis impact measurement scales, depression, and self-efficacy.  
Results demonstrated that all 3 of the treatment conditions resulted in enhanced self-efficacy for 
function.  Self-efficacy refers to the belief that one can competently cope with a challenging 
situation and has the ability to affect behaviour (Bandura, 1977).  For example, people with high 
self-efficacy beliefs tend to persist with coping behaviours until successful. In contrast, 
individuals with low self-efficacy beliefs more quickly discontinue coping efforts because failure 
is anticipated (Buckelew et al., 1998).  There were also significant between-group differences on 
tender point measures.  This difference reflects a modest increase in impairment by the attention-
control condition rather than improvements by the treatment conditions.  There were no 
significant between-group pre- to post-treatment differences on self-report pain, pain behaviour, 
sleep, or psychological distress measures.  Significant within-group effects for all three treatment 
conditions reflected modest improvements on pain and psychological distress measures.  
Participants as a group continued to have significant clinical symptoms of fibromyalgia, despite 
improvement in self-efficacy for managing symptoms.  Only the combination condition 
maintained improvements on the self-efficacy for function measure at 2-year follow-up.  
Buckelew and colleagues’ (1998) study demonstrated that biofeedback/relaxation training 
and structured exercise programs produce short- and long-term benefits for persons with 
fibromyalgia in the areas of self-efficacy, disease severity, and physical activity.  With the 
exception of the self-efficacy scores, the improvements were modest.  Buckelew et al. suggested 
that future studies examine the relative benefits of exercise and psychologically based treatment 
interventions versus antidepressant medications to examine the underlying mechanisms of 
treatment efficacy, and to improve the long-term effectiveness of behavioural treatment 
programs for fibromyalgia.   
Keel et al. (1998) examined the efficacy of an integrated psychological treatment 
program with 32 fibromyalgia patients.  The treatment program consisted of instruction in 
cognitive-behavioural strategies, relaxation, and physical exercise.  The control intervention was 
relaxation training.  They hypothesized that comprehensive cognitive-behavioural training, to 
improve self-efficacy using various pain-control strategies, would lead to more substantial and 
longer-lasting improvements than would relaxation training without the comprehensive 
educational package. 
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The treatment program consisted of 15 weekly group sessions lasting 2 hours.  Each 
session included: information, instruction in self-control strategies, gymnastics, relaxation, and 
group discussion.  The group discussion was structured and focused mainly on the frequency and 
effects of the home exercises.  A psychiatrist, psychologist, and physiotherapist led the sessions. 
The control group was taught relaxation in 15 sessions lasting 45-60 minutes. A 
psychiatrist and a physiotherapist led the sessions.  Patients were asked to practice relaxation at 
home in the same manner as patients in the treatment program. 
Participants were assessed at pre-intervention, post-intervention, and at 3-month follow-
up.  A general symptom checklist was used to assess the clinical features of fibromyalgia, 
including symptoms of pain, nausea, and weakness.  Sleep disturbance, changes in average pain 
intensity, and changes of concurrent treatment (i.e., use of medication) were assessed using daily 
diary entries.  The participants’ own judgment of the treatment program was also assessed by 
asking them to rate the degree to which particular treatment elements were helpful and the 
effectiveness of the entire program.   
Three participants dropped out in the initial phase of treatment, one did not complete 
post-treatment assessment, and one patient’s data was not used due to language barriers.  Data 
from 27 of the 32 participants was analyzed; an intention-to-treat analysis was not conducted 
(please see pages 60-61 for a description of intention-to-treat).  Clinically meaningful 
improvement was defined as at least a 50% improvement from baseline on four of six outcomes 
(medication use, physical therapies, sleep, pain, global assessment, and general symptoms).  
After treatment, clinically meaningful improvement was observed in two participants in the 
treatment condition compared to one control participant.  At follow-up, four participants in the 
treatment condition improved compared to none in the control condition.  However, this 
difference was not statistically significant.  
The authors compared the participants who showed improvement to those who did not 
and found that the successful participants had a significantly shorter duration of pain (6 years vs. 
15 years) and they tended to be more active before treatment.  Keel et al. (1998) stated that the 
intervention was too weak for the majority of participants, and perhaps additional sessions would 
lead to improvement in more participants.  The difference in duration of pain in the successful 
participants led them to conclude that early intervention is important for people with 
fibromyalgia.   
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The next set of studies that will be reviewed employed a no-treatment or wait-list 
controlled design.  
Burckhardt, Mannerkorpi, Hedenberg, and Bjelle (1994) examined the effects of 
education and physical training in women with fibromyalgia.  Participants were randomly 
assigned to one of three groups: a 6-week self-management education program, the education 
program plus physical training, or wait-list control.  The education program consisted of six 
weekly 1 ½ hour classes.  The classes included: information on fibromyalgia, the role of stress in 
the development and maintenance of symptoms, coping strategies, problem solving techniques, 
assertiveness training, relaxation strategies, and the importance of physical conditioning.  Each 
session concluded with an individual contract for behaviour change for the upcoming week.  
Participants in the education plus physical training group received an hour of physical training 
after each education session.  The training included stretching, range of motion exercise, pool 
therapy sessions, and time to develop a physical fitness training program of walking, swimming, 
or cycling.   
The primary outcome was the total score from the FIQ.  Additional outcome measures 
were: the Fibromyalgia Attitudes Index, the Quality of Life Scale (QOLS), the Self-Efficacy 
Scale, and the Beck Depression Inventory.  Physical fitness and tender points were also assessed.  
Of the 99 participants who entered the study, data from 13 were not used in the analysis.  
Therefore, an intention-to-treat analysis was not conducted.  There were no between-group 
differences on the total FIQ score from pre- to post-testing.  In addition, there were no significant 
differences between the two treated groups on any of the outcome variables.  Quality of life and 
self-efficacy (for other symptoms) improved from pre-to post-testing for both treated groups 
compared to the control group.  For other aspects of self-efficacy, including self-efficacy for 
controlling pain, the group that received both education and physical training was significantly 
different from the control group.  Significant within-group changes for the education only group 
included improvement on the fibromyalgia attitudes index, the days feeling bad subscale of the 
FIQ, self-efficacy (for other symptoms), and the myalgic score.  The education plus physical 
training group also improved significantly on the fibromyalgia attitudes index but also on all 
three subscales of the self-efficacy scale.  At follow-up, quality of life and self-efficacy (for pain 
and other) were significantly improved in the education plus physical training group.   
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Burckhardt et al. (1994) concluded that there is some indication that education alone and 
education with exercise benefit patients with fibromyalgia.  They stated that the changes in self-
efficacy were the most notable and are important due to evidence that changes in self-efficacy 
are enduring and affect changes in health behaviours and health status. 
In a 4.5 year prospective study, Wigers, Stiles, and Vogel (1996) compared the effects of 
aerobic exercise, stress management treatment, and treatment-as-usual with 60 fibromyalgia 
patients.  The exercise group received 45 minutes of aerobic exercise 3 times a week for 14 
weeks.  The stress management treatment was cognitive-behavioural in nature and was led by 
two clinical psychologists.  The treatment included applied relaxation and an introduction to 
cognitive therapy in coping with psychological problems.  Sessions were 90 minutes, twice a 
week, for the first 6 weeks and once a week for the remaining 8 weeks.  Participants in the 
treatment-as-usual condition continued treatments that they had been using prior to entering the 
study.  Treatments included aquatic therapy and medication.  
Outcome measures included pain distribution, average intensity of pain, disturbed sleep, 
fatigue, and depression, tender points, exercise capacity, and global subjective improvement.  Of 
the 60 participants enrolled, 44 completed the study.  An intention-to-treat analysis was 
conducted.  At post-treatment, the exercise condition showed significantly reduced pain 
distribution, tender point tenderness, and exercise capacity compared to the treatment-as-usual 
participants.  The participants in the stress management treatment condition showed reduced 
tender point tenderness.  They rated the relaxation skills as the most beneficial component of 
treatment.  At follow-up, the only between-group difference was reduced tenderness in the stress 
management treatment condition compared to the treatment-as-usual condition.  When the 
original data was analyzed instead of the intention-to-treat data, this difference was not 
significant.  Based on the effects of the stress management treatment, the authors concluded that 
a psychological intervention using relaxation and cognitive techniques has beneficial short-term 
effects by reducing pain, tenderness, and depression.  However, this conclusion is based on 
analysis of completers only, not analysis of the intention-to-treat data.  Also, the authors 
concluded that the stress management treatment was successful with respect to long-term 
compliance; 69% of participants were still performing relaxation exercises 4 years later.         
Mason, Goolkasian, and McCain (1998) compared the effects of a month-long 
multimodal treatment program for 11 female fibromyalgia outpatients to a control condition.  
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The control condition consisted of 12 fibromyalgia patients that could not participate in the 
program for insurance reasons.  They completed the same assessment measures on the same 
schedule as the treatment condition but did not receive any intervention.  The treatment program 
included a daily cognitive-behavioral class, focusing on education, relaxation, maladaptive pain 
behaviors, and cognitive distortions.  The cognitions were challenged and the notion of replacing 
them with new mental strategies was discussed.   
Measures obtained immediately after treatment demonstrated that the treatment 
condition’s positive coping skills and sense of control over pain improved significantly, while 
use of negative strategies decreased significantly.  The authors stated that the significant 
reduction in self-reported pain ratings indicated that patients felt greater control over their 
fibromyalgia pain and experienced considerable relief from that pain.  Treated patients also 
reported much less anxiety and depression and had increased ability to accomplish functional 
tasks when compared to the control condition.  However, the 6-month follow-up data 
demonstrated that the treatment gains were not maintained on a long-term basis.  Although the 
treated patients continued to show a significant decrease in symptomatology, there was a trend 
toward pre-treatment levels on all measures except pain tolerance.  This trend may be related to 
lack of practice of either coping skills and/or exercise regimen.  The authors encouraged future 
researchers to emphasize relapse prevention and to encourage patients to continue to participate 
in regular support groups.  They also suggested that follow-up studies evaluate the fibromyalgia 
patient’s pain levels and emotional functioning 1 to 2 years after completion of treatment, and 
include measures of personal adherence to the program components.  
Gowans, deHueck, Voss, and Richardson (1999) examined the effects of an exercise and 
educational program for patients with fibromyalgia.  Participants were randomly assigned to a 6-
week exercise and educational program or to a wait-list control group.  In order to increase 
sample size, the control participants were entered into the intervention program after the initial 6-
week phase and their data was added to the intervention group’s data.  The intervention program 
consisted of two exercise classes in a warm pool and two multidisciplinary educational sessions 
each week.  The group educational sessions were 1-hour long and provided information on 
psychosocial coping strategies, exercise, sleep, relaxation, medication, and nutrition.  The 
sessions included didactic lectures, interactive discussions, and teaching skills, for example, 
relaxation techniques. 
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Participants were assessed at pre- and post-intervention and at follow-up (6 months for 
the original intervention participants and 3 months for the control participants who later received 
treatment).  Outcome measures included the ASES and the FIQ.  Unfortunately, the total FIQ 
score was not analyzed.  Physical function and knowledge of fibromyalgia management were 
also assessed.  Between-group analyses showed that the exercise and educational program 
produced a significant increase in 6-minute walk distances, knowledge of fibromyalgia 
management, and sense of well-being (FIQ).  There was also a significant decrease in morning 
fatigue (FIQ) compared to control participants.  With the addition of the control participants’ 
data (after receiving the intervention), significant improvements were observed in self-efficacy 
for pain and for controlling other symptoms (ASES).  Improvements in well-being, self-efficacy, 
and walk distance were maintained at follow-up.  However, gains in fatigue and knowledge of 
fibromyalgia management were not maintained.      
The authors concluded that short-term exercise and educational programs can produce 
immediate gains in physical function, sense of well-being, and fatigue.  Such programs may also 
produce immediate gains in self-efficacy (for controlling pain and other symptoms).  In addition, 
gains in physical function, well-being, and self-efficacy can be maintained for up to 3 months.  
Gowans et al. (1999) note that these results were achieved with a sample that may be more 
disabled than samples used in other trials.  They reported that their participants were largely 
unemployed, taking multiple medications, and were very deconditioned.    Due to the combined 
exercise and educational intervention, it is not possible to determine whether these gains reflect 
the effect of exercise, education, or both.  Comparing the intervention program to other 
treatments or to an attention/placebo control would assist in clarifying the contributions of 
various treatment modalities.     
Nielson, Walker, and McCain (1992) employed a quasi-experimental design to assess the 
efficacy of a 3-week inpatient CBT program for fibromyalgia.  The participants acted as their 
own wait-list control group prior to receiving treatment.  Strictly speaking, there is a form of 
control group, however, the study is likely best classified as a single group uncontrolled trial 
(Burckhardt, 2006) and it is listed as such in Table 1.  It is important to note, Nielson et al. 
(1992) incorporated a unique element to the design, that is, use of target and non-target variables.  
The intervention also consisted of cognitive restructuring techniques that can be compared to the 
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intervention in the current study.  For these reasons, a review of the Nielson et al. (1992) study 
follows, whereas the remaining single group uncontrolled trials are listed in Table 1.   
 Nielson et al., (1992) employed a quasi-experimental design to assess the efficacy of a 3-
week inpatient cognitive-behavioral treatment program for fibromyalgia.  The primary goal of 
the program was to assist patients in developing an active and resourceful self-management 
approach to coping with their fibromyalgia (Nielson et al., 1992).  Each individual received the 
following interventions: relaxation training, cognitive techniques, aerobic exercise and 
stretching, pacing and enhancement of pain tolerance, family education, and in vivo rehearsal.  
More specifically, the relaxation training involved progressive muscle relaxation, which was 
supplemented with biofeedback for individuals that had difficulty with relaxation.  The cognitive 
techniques involved reconceptualization of pain as something over which the individual could 
exert some control.  Restructuring techniques were also used to challenge negative cognitions 
and promote positive problem solving strategies. 
Participants were assessed at two intervals before beginning the program, approximately 
5 months prior and a second time at admission to the program.  Post-assessment occurred at the 
conclusion of the 3-week program.  Participants were assessed on a number of variables, 
including: experience of pain, impact of pain on life, pain behaviour, depression, and marital 
adjustment.  Nielson et al. (1992) classified variables as ‘target’ or ‘non-target’.  They expected 
the target variables to reflect a response to the treatment, while the non-target variables were not 
expected to change in response to the treatment.  Comparison of the pretest and posttest scores 
indicated that the target variables, such as pain severity, perceived interference with life, sense of 
control over pain, and emotional distress, showed statistically significant improvement.  Nielson 
et al. (1992) also found that there was no statistically significant change in the non-target 
variables, such as perceived support by others, response by significant others to pain, marital 
adjustment, and activity level.  The separation of target and non-target variables in an attempt to 
assess the potential impact of demand characteristics was a valuable component of this study.  
Because of the combined nature of the treatment it is not possible to determine the impact of 
particular components of the treatment program on the outcome measures.  This is significant 
since the program consisted of some interventions that were not cognitive behavioural in nature, 
for example, the exercise component. 
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Nielson and colleagues (1992) used a small sample of 25 participants, thereby reducing 
the power of statistical tests.  The quasi-experimental design used participants as their own 
waiting list controls.  However, a formal control condition was not included; for example, 
attention-placebo control conditions have been recommended (Bradley & Alberts, 1999).  
Medication use, particularly antidepressants, was not controlled for in this study and the authors 
state that it is possible that medication accounted for some of the observed results.  However, 
improvements in psychological outcome measures were not limited to those individuals taking 
antidepressants. The authors also suggested that future research include more sophisticated 
measures of function, for example, the FIQ.  
White and Nielson (1995) conducted the first reported attempt to determine the long-term 
efficacy of a CBT program for the treatment of fibromyalgia.  At a mean of 30 months after 
discharge, they assessed 22 of the 25 participants from the cognitive-behavioral treatment 
program described above (Nielson et al., 1992).  Of the 10 target variables, the following 3 
variables remained significantly different from pre-treatment levels: degree of worry, observed 
pain behavior, and sense of control over illness.  In addition, all 10 target variables changed in 
the direction of improvement, while none of the non-target variables were significantly different 
between pre-treatment and long-term follow-up.  White and Neilson suggested that randomized 
controlled trials be conducted in order to demonstrate the effectiveness of CBT alone and in 
combination with other treatment modalities. 
In summary, a limited number of controlled studies have examined the effects of CBT on 
fibromyalgia.  The available literature is limited statistically, to some extent, by small sample 
sizes. This reduces the power of the statistical tests.  The literature is also limited by the analysis 
of a varied and large number of outcome variables.  Also, few studies have examined relapse 
prevention, long-term follow-up, and measures of long-term compliance.  
Integrative Psychotherapy Approaches 
Before discussing integrative psychodynamic group therapy approaches to the treatment 
of chronic pain, it is helpful to examine a number of psychodynamic factors that are related to 
the chronic pain experience. A number of factors will be briefly reviewed prior to presenting two 
therapeutic approaches: supportive-expressive group therapy and integrative psychodynamic 
group therapy. Additional factors will be reviewed concurrently with the discussion of the 
therapeutic approaches, as they are clearly linked to the rationale of the approach.  
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Psychodynamic Themes and Chronic Pain 
Grzesiak, Ury, and Dworkin (1996) highlight some of the psychodynamic themes that 
they have found useful in their work as psychotherapists with chronic pain patients. Childhood 
development and early experiences with pain and illness can be significant experiences. These 
experiences are not limited to traumatic experiences, but also include the behaviour of significant 
others, especially family members, and their influences on the child. For example, a parent with 
a chronic illness, or a pain condition, can have tremendous influence on the child with respect to 
the child’s understanding of pain and illness and adaptation to these conditions. Both clinical 
observations and research have suggested that social modeling and early identifications with ill 
or disabled family members may play a role in the later development of a chronic pain syndrome 
(Adler, Zlot, Hurny, & Minder, 1989; Craig, 1978; Engel, 1959). Internalized relationships with 
parents and significant others are often not immediately accessible to conscious recall, but 
sometimes the experience and behaviour of a chronic pain patient can be associated with early 
experiences and exposure to the ways in which significant others have coped with pain and 
illness (Grzesiak et al., 1996).  
Anger, helplessness, depression, and loss are central themes that are often relevant when 
working with people with chronic pain.  Grzesiak et al. (1996) stated “the appropriate acceptance 
and management of anger constitute one of the central issues in psychotherapeutic work with 
chronic pain patients”. Whale (1992) described a short-term psychotherapeutic approach to the 
treatment of chronic pain. The author stated that patients had to come to terms with their 
unadmitted and unaccepted anger over various losses in their lives. One source of anger is often 
the sense of helplessness that many patients feel as a result of persisting pain and physical 
limitations. According to Levine, Brooks, Irving, and Fishman (1993), it is the patient’s 
intolerance of the affective experience of helplessness that needs to be addressed in 
psychotherapy.  
The theme of depression may be played out in a number of ways in people with 
fibromyalgia.  Krishnan, France, and Davidson (1988) suggested at least four possible 
relationships between pain and depression: 1) pain as a symptom of depression, 2) depression as 
a complication of chronic pain, 3) pain and depression inextricably linked, and 4) pain and 
depression coexist but may not be related.  Experiences of loss and mourning are often integral 
aspects of depression in chronic pain patients (Grzesiak et al., 1996).  Schoffermann et al. (1993) 
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found that mourning and dealing appropriately with losses were important components of 
adapting to pain or pain relief.  Engel (1959) found that dealing with the loss of loved ones was 
frequently an important psychodynamic consideration in working with people with chronic pain.   
Ercolani et al. (1994) assessed depression and illness behaviour in 327 people with 
fibromyalgia in Italy.  Validated translations of the Center of Epidemiological Studies-
Depression scale (CES-D) and the Illness Behaviour Questionnaire (IBQ) were administered.  
The CES-D was developed by the National Institute of Mental Health, USA, to measure 
depression in the general population.  The IBQ was developed to study abnormal illness 
behaviour and includes the following scales: general hypochondriasis, disease conviction, and 
affective inhibition.  It is a valid instrument to predict general hospital utilization and degree of 
somatization (Ercolani et al.).  The IBQ helps to elicit the psychopathology of patients with 
somatic symptoms, particularly in the form of DSM-III-R somatoform pain disorders.  For 
example, patients who score high on the disease conviction, psychological versus somatic 
focusing, and denial and affective disturbance scales tend to ascribe their personal and social 
difficulties to pain.  In fact, pain is used to cope with difficulties and avoid psychological and 
social conflicts (Ercolani et al.).  
Ercolani et al. (1994) examined whether the combination of depression and abnormal 
illness behaviour in fibromyalgia patients leads to serious difficulties in: doctor-patient 
relationships, the number and kind of treatments requested, and the results of treatment.  The 
authors noted that depression observed in general medical practice differs from that observed in 
psychiatric practice.  The former is associated with a lower frequency of suicide, while feelings 
of helplessness and anxiety are prevalent.  There is also a tendency to accuse other people, 
especially medical staff, as opposed to self-accusation.  Depression in general medical practice is 
also observed in the form of an increased reporting of somatic symptoms.  Ecolani et al. argued 
that patients gain support from health services based on these somatic complaints, allowing them 
to establish “manipulative interpersonal relationships.”  Ecolani et al. described another aspect of 
illness behaviour whereby manipulative conduct of chronic pain patients is described as a 
demand for medical care, denigration of received treatments, protests against ineffectiveness, and 
requests for more suitable treatments.  This behaviour, especially in people with fibromyalgia, 
may in part be based on the frustrations associated with suffering with an illness that does not 
have a known diagnostic test or ‘cure.’  Fibromyalgia patients may have a greater tendency to 
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attempt to gain support, or to protest, since they generally do not feel supported based on the 
difficulties associated with the somewhat controversial nature of the syndrome.  These 
tendencies highlight the contribution that interpersonal psychotherapy can offer to the treatment 
of fibromyalgia.  
Those chronic pain patients who are convinced of the severity of their illness despite 
medical reassurance, and who find it difficult to express emotion, experience more disabling 
pain.  Ercolani et al. (1994) stated that they exhibit “misadaptive behaviour” that is related but 
not proportionate to the disease, but is a function of cognitive and affective disturbance rather 
than physical illness.  The belief that the illness is severe despite medical reassurance is likely 
related to difficulty trusting others, especially when in a vulnerable position. Difficulty with trust 
and with expressing emotion can be addressed by interpersonal psychotherapy approaches. 
An additional theme is that of pain as an affect, which was first addressed by Fenichel 
(1945).  The approach requires the psychotherapist to work with the pain patient to explore and 
interpret personal meanings related to pain and the functions that the emotion of pain may be 
serving for the individual.  “Such psychotherapeutic explorations of the meaning of pain are 
relevant, regardless of the relative roles played by organic and psychosocial factors in accounting 
for the patient’s experience of pain” (p. 160).  Although psychological symptoms are present in a 
proportion of fibromyalgia patients, the question remains, ‘what is the role of psychological 
symptoms in the clinical picture of fibromyalgia?’  In other words, regardless of the causal 
influence that psychological variables may or may not play in fibromyalgia, it is important to 
examine the effect these variables have on patients’ ability to cope and to function 
interpersonally.  
Supportive-Expressive Group Psychotherapy 
Spiegel has developed a model of supportive-expressive group psychotherapy which is an 
integrative model built upon Yalom’s interpersonal process oriented work (M. Leszcz, personal 
communication, 2003; I. Yalom, personal communication, 2003).  Although this model of 
psychotherapy has not, to my knowledge, been applied to a fibromyalgia population, it has been 
applied to chronic illness populations including cancer and lupus.  Lupus and fibromyalgia are 
both rheumatologic conditions and share some similarities; therefore, some of the findings from 
the following study may be helpful in informing interventions for fibromyalgia.  However, it is 
important to consider the differences between the illnesses and not overgeneralize.  
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Edworthy et al. (2003) investigated whether brief supportive-expressive group 
psychotherapy might reduce illness-induced interference with valued activities and interests (i.e., 
illness intrusiveness) among women with systemic lupus erythematosus (SLE).  The 
psychotherapy focused specifically on interpersonal relationships and how to maximize them 
adaptively despite the constraints imposed by chronic disease.  Reduction in illness intrusiveness 
was examined in relation to three life domains: 1) relationships and personal development 
(family relationships, other social relationships, self-expression), 2) intimacy (relationship with 
spouse, sex life), and/or 3) instrumental life (work, finances, active recreation).  Fifty-eight 
women participated in the group psychotherapy sessions while 66 women were assigned to a 
usual-care control condition.  Twelve group sessions, conducted weekly, were provided to the 
intervention group.  Three monthly ‘booster sessions’ were offered following the termination of 
intensive treatment to reinforce changes and to encourage the transfer of new experiences into 
daily life.  The primary outcome measures were administered on four occasions: 1) prior to the 
intervention, 2) immediately post-intervention, 3) 6 months later, and 4) at the final 12-month 
follow-up occasion.  The variables assessed included illness intrusiveness, disease activity and 
disease damage, and psychological symptoms as measured by the Symptom Checklist 90-R 
(SCL90-R).  
Edworthy et al. (2003) stated that, in many cases, effective coping involves distracting 
oneself from psychosocial threats or other stressors in order to carry on with life.  This can be 
adaptive when the problems cannot be controlled or eliminated, and the most effective response 
is to focus on day-to-day challenges.  Issues that were associated with significant psychological 
pain at an earlier point in the disease experience may thus decrease in salience.  However, the 
destructive effect of these issues may be reactivated.  For example, when in good health people 
may be insensitive to others affected by chronic illness but feel guilty about this after the onset of 
their own illness.  Such unresolved conflicts and concerns may threaten psychological well-being 
repeatedly over the years.  Group psychotherapy, according to Edworthy et al., may be especially 
helpful in relation to such stressors because it assists people in recognizing these issues and in 
resolving them effectively.  However, participation in group psychotherapy may initially be 
unpleasant if the process temporarily increases awareness of issues that have previously been 
suppressed.  
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Edworthy et al.’s (2003) findings following therapy for women with SLE are consistent 
with the notion that therapy is initially challenging and improvements may not be observed early 
in the process.  The benefits of the group psychotherapy intervention included reduced illness 
intrusiveness, but this did not emerge until well after the termination of therapy and was not 
evident until the 6-month follow-up.  The reductions were statistically significant by the 6-month 
follow-up and these reductions were intensified by the 12-month follow-up.  The reduced illness 
intrusiveness was observed in two of the domains, relationships and personal development, and 
intimacy.  This supports the position that women are especially responsive to stressors that arise 
in domains of life that involve relationships with others as compared to instrumental domains 
such as work and finances (Gillespie & Eisler, 1992).  Edworthy et al. suggested that the key to 
effective psychological interventions, therefore, may depend on a careful matching of therapeutic 
processes with the particular vulnerabilities of those affected by the illness. In addition, 
demonstration of the effectiveness of therapy also depends on the selection of measurement 
instruments that are sufficiently focused and sensitive.  
Integrative Psychodynamic Psychotherapy 
There is a subsample of chronic pain patients who fail to benefit from every existing 
treatment for chronic pain, no matter how efficacious it is (Grzesiak et al., 1996). These patients 
may benefit initially but return to pretreatment levels of pain, suffering, and disability. Grzesiak 
et al. argued that psychosocial factors play a role in the development of chronic pain, and some 
of the psychological factors that have been implicated are unlikely to respond to the relatively 
short-term psychological interventions that now constitute the standard of care for chronic pain 
patients (e.g. CBT). This integrative psychotherapeutic approach to the individual with chronic 
pain emphasizes the importance of “integrating behavioural strategies and cognitive techniques 
within a psychodynamic perspective that values the importance of developmental history, 
intrapsychic conflict, interpersonal difficulties, and failure to adapt to chronic illness and 
persisting pain” (p. 148).  
The importance of customizing treatment for people with chronic pain is emphasized in 
the literature. Turk (1996) has emphasized the importance of examining the biological, 
psychological, and social processes that operate for each individual patient, and then designing a 
treatment program to address the relevant and individualized problem areas. Grzesiak et al. 
(1996) stated that chronic pain patients differ based on a number of individual factors, including: 
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personality, character, premorbid level of adaptation, capacity to cope with adversity, and 
varying degrees of resourcefulness and resilience. They argue that differences in personality 
should form part of the foundation for customizing psychological treatment.  The interpersonal 
component of the manualized treatment proposed in this thesis allows for the expression of 
personality characteristics and interpersonal patterns to a greater extent than the cognitive-
behavioural component of the treatment.  The interpersonal component allows for greater 
customization of treatment.  Although the treatment is conducted in a group, the interpersonal 
component provides opportunity for each participant to express personality traits through 
interaction with group members and the therapist.  These personality traits and styles of 
interpersonal relating are factors that can affect the individual’s ability to cope with 
fibromyalgia.  
The concept of pain–proneness, or vulnerability to suffering, is important in 
understanding the potential role of psychodynamically-oriented psychotherapy in the 
management of chronic pain (Grzesiak et al., 1996). Pain-proneness, introduced by Engel (1959), 
is an unconscious process that has its origins in negative early life experiences such as trauma, 
loss, and abandonment. These experiences lay a foundation of vulnerability to pain-proneness 
and psychic suffering.  Grzesiak et al. (1996) stated that, in many cases, these unconscious 
factors lie dormant until life events, such as physical or psychic trauma or illness, provide an 
opportunity for the expression of these hidden conflicts.  The authors argued that it is often not 
pain, but suffering, that poses the primary problem for chronic pain patients.  For example, 
Harness and Donlon (1988) presented two cases of facial pain that were initially unresponsive to 
treatment. It was not until the patients developed a strong therapeutic alliance with their 
therapists that they were able to disclose that they had been physically abused.  Following their 
disclosure of abuse the facial pain abated.  
Another characteristic that is important in understanding the potential role of 
psychodynamically-oriented psychotherapy in the management of chronic pain has been labeled 
‘ergomania’.  Ergomania is a conflicted work ethic that is believed to be an important 
characteristic of many chronic pain patients (Blumer & Heilbronn, 1989).  The authors suggested 
that ergomanic pain patients have a history of excessive work performance, relentless activity, 
and self-sacrifice.  These patients also have marked difficulty trusting caretakers, including 
health providers.  In a study examining proposed antecedents of chronic pain, Gamsa and Vikis-
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Freibergs (1991) found that ergomania was one of only two psychological variables that were 
consistently associated with pain, the other being emotional repression.  Grzesiak et al. (1996) 
have observed in clinical practice that many people with chronic pain have the premorbid 
characteristics of ergomania.  
Grzesiak et al. (1996) are not suggesting that chronic pain has a psychogenic origin. 
Rather, the authors believe that the source of chronic pain is a combination of biological, 
psychological, and social factors, which is consistent with the biopsychosocial model. They 
suggested that individuals who have suffered from early trauma are more likely to develop a 
chronic pain syndrome in response to physical pathology. Early developmental trauma and the 
personality traits associated with it provide a vulnerability to pain and suffering that, in the 
presence of current disease or injury, compromises the patient’s ability to adapt to the sick role, 
to rely appropriately on health care providers, and to regain health or make a reasonable 
adjustment to changes in physical functioning. 
Trauma and Fibromyalgia 
Based on Grzesiak et al.’s (1996) argument that early developmental trauma and 
associated personality traits create a vulnerability to pain and, hence, a compromised ability to 
cope, it is useful to examine literature regarding trauma and fibromyalgia.  
Anderberg, Marteinsdottir, Theorell, and Knorring (2000) examined negative life events 
in female fibromyalgia patients and in healthy controls matched for age and socioeconomic 
status. Although ‘negative life events’ may not constitute ‘trauma’, it can be argued that 
experiencing an event as traumatic is a subjective perception. Anderberg et al. found that 51% of 
the fibromyalgia patients had experienced very negative life events as compared to 28% of the 
controls. Conflict with parents was the most common life event. Before onset, 65% of the 
patients experienced some negative life event; economic problems and conflicts with 
husband/partner were common. Also, the life events were experienced as more negative by the 
fibromyalgia patients than the life events experienced by healthy controls.  
Turk et al. (1996) investigated the differences between two types of symptom onset in 
patients with fibromyalgia: post-traumatic versus idiopathic onset. Symptoms of fibromyalgia 
occur either following a specific incident (motor vehicle accident, surgery, flu), which is referred 
to as post-traumatic or reactive; or the symptoms are attributed to an insidious or spontaneous 
onset with no identifiable precipitating event, referred to as idiopathic. Turk et al. examined 
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whether type of onset has any specific effect on the adjustment of fibromyalgia patients to their 
chronic conditions in physical, medical, and psychological domains. The clinical severity of 
post-traumatic chronic pain may be exacerbated in the presence of persistent, adverse effects of 
physical injuries. If so, it may be that post-traumatic chronic pain patients will present with 
greater psychological distress and disability. For example, Greenfield, Fitzcharles, and Esdaile 
(1992) found that patients with traumatic onset tended to be more impaired socially, financially, 
and functionally than patients with idiopathic fibromyalgia. Indeed, preliminary results from a 
number of studies (Turk & Okifuji, 1996; Waylonis & Perkins, 1994) suggest that there might be 
some specific factors that are uniquely related to fibromyalgia with traumatic onset. On the other 
hand, pain conditions with idiopathic onset generally lack ‘justification’ for their pain complaints 
in the absence of an identifiable incident. This leads some to question the veracity of a patient’s 
complaints, which may aggravate psychological distress. Thus, psychological distress might be 
expected to be greater for those without an identified trauma. In this case, the distress would be a 
reaction to the symptoms and to the suggestion that the pain is not real or is exaggerated for 
secondary gain. In an effort to clarify these issues, Turk et al. (1996) found that patients with 
traumatic onset reported significantly higher levels of pain severity, perceived disability, 
affective distress, and life interference as well as lower level of activity, compared to the patients 
with idiopathic onset. These results are consistent with the results of Geisser, Roth, Bachman, 
and Eckert (1996) for chronic pain in general and those of Greenfield et al. (1992) for 
fibromyalgia. The findings were demonstrated even when compensation status, a potential 
mediator, was controlled. Similarly, the differences between the two onset groups cannot be 
attributed to the differences in physical abnormalities.  Thus, pain severity and disability may not 
be determined solely on the basis of physical pathology.  Results suggest heterogeneity of the 
fibromyalgia population.  The need to identify subgroups of fibromyalgia patients has been 
argued by others (Turk & Flor, 1987; Turk et al., 1996).  Identification of subgroups will help to 
develop efficient and cost effective treatments for fibromyalgia.  
Aaron et al. (1997) examined the relation between perceived physical and emotional 
trauma and health-care seeking in patients with fibromyalgia.  The researchers compared 80 
patients with fibromyalgia who had sought treatment, with 33 non-patients who had not sought 
treatment for their muscular aches and pains in the last 10 years, but met criteria for fibromyalgia 
upon assessment.  Aaron et al. found that only events perceived as emotionally traumatic (e.g. 
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family member death or illness) significantly differentiated patients who had sought care for 
fibromyalgia in a tertiary care rheumatology practice from non-patients.  Neither physical trauma 
nor sexual or physical abuse was related to seeking treatment.  Patients with a history of 
emotional trauma also reported making a significantly greater number of physician visits related 
to fibromyalgia symptoms in the preceding 6 months than did patients with physical trauma or 
no trauma history.  These findings are consistent with a number of studies indicating that 
perceived stressful life events and reports of emotional distress predict health care-seeking 
behaviour in the general population and in patients with rheumatic diseases (Bradley & Alberts, 
1999).  Aaron et al. also found, using the FIQ, that emotional trauma was associated with reports 
of greater functional disability than was either physical trauma or no trauma.  This finding 
illuminates the importance of tailoring psychological interventions for fibromyalgia to address 
emotional trauma in addition to addressing cognitive and behavioural components, since 
emotional trauma appears to be linked to patients’ experience of functional disability.  Aaron et 
al. hypothesized that the high ratings of functional disability among fibromyalgia patients with 
perceived emotional trauma may be related to the higher levels of fatigue reported by these 
patients.  Indeed, the fatigue ratings of the fibromyalgia patients in this study exceeded those of 
patients with lupus, and the highest mean fatigue levels were among those fibromyalgia patients 
with a history of emotional trauma.  No differences in pain threshold levels or in current pain 
intensity were found as a function of trauma history.  The results of this study reveal the 
importance of examining trauma history and of tailoring psychotherapeutic interventions to 
address emotional trauma.  It is possible that interventions that specifically address emotional 
trauma may have an impact on post-treatment measures of fatigue and functioning.  
An additional subtype of trauma history has been assessed among chronic pain patients. 
Finestone et al. (2000) examined chronic pain and health care utilization in women with a history 
of childhood sexual abuse.  Findings demonstrate a higher incidence of current chronic pain in 
the women with a history of sexual abuse compared to two control groups (nurses and 
psychiatric controls).  Also, women with a history of childhood sexual abuse reported a greater 
number of painful points over their bodies and reported that the pain was present over larger 
areas of their bodies than controls.  A statistically significant number of the women with a 
history of childhood sexual abuse stated that they had been diagnosed with fibromyalgia. 
However, Taylor, Trotter, and Csuka (1995) did not find a significantly higher prevalence of 
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childhood sexual abuse in women with fibromyalgia compared to a community sample, although 
they found that individuals with fibromyalgia who report sexual abuse had a greater severity of 
illness than those fibromyalgia patients not reporting sexual abuse.  Finestone et al. suggested 
that the medical community could profit form supportive literature embracing the concept that 
dealing with issues of childhood sexual abuse in adulthood can have a positive medical benefit.   
In summary, the supportive-expressive and integrative psychodynamic approaches can 
contribute unique therapeutic components to current psychological treatments for fibromyalgia. 
Research suggests that the focus on interpersonal relationships and how to maximize their 
benefits and minimize their interference on coping, despite the constraints imposed by chronic 
disease, is a critical component of effective treatment.  Importantly, these areas are generally not 
addressed by CBT.  Therefore, incorporating aspects of integrative group psychotherapy into a 
treatment for fibromyalgia would likely be a useful addition to the cognitive-behavioural model.  
Based on the positive results obtained by CBT with a number of chronic pain conditions, such as 
rheumatoid arthritis, it seems necessary to supplement the cognitive-behavioural model with 
additional treatment components, rather than replace it.  Supplementing the cognitive-
behavioural approach seems necessary since the well-designed randomized controlled trials of 
CBT for fibromyalgia have yielded modest results.   
The current study will investigate the efficacy of a manualized cognitive-behavioural and 
interpersonal approach to the treatment of fibromyalgia.  Efficacy trials test whether a program 
does more good than harm when delivered under optimum conditions.  Such trials often include 
strong controls, standardization of programs, and narrowly defined target audiences. 
Effectiveness trials, on the other hand, test a program under real-world conditions.  A 
randomized controlled design using pre- and post-intervention measures of pain and 
psychological and physical functioning will be employed.  Also, because previous studies have 




Adult women with fibromyalgia, as diagnosed by a rheumatologist, were recruited from 
Saskatoon, Prince Albert, and surrounding areas in Saskatchewan.  One hundred and fifty-seven 
women contacted the investigator to inquire about the study.  The majority of patients were 
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recruited through posters placed in the community advertising the study, letters sent to patients 
of Dr. Janet Markland, a rheumatologist in Saskatoon, and through an article in the newspaper.  
See Appendix B for a complete description of recruitment efforts and procedures. 
Because of the differential prevalence rates of fibromyalgia in women compared to men, 
(Wolfe et al., 1995), there would be potential for unequal male/female ratios in the groups which 
could act as a confounding variable.  Therefore, only women were eligible for participation in 
the current study.  Those patients with organic brain disorders, psychotic disorders, DSM-IV axis 
II pathology, or substance abuse problems were ineligible for participation.   
One hundred and fifty-seven women inquired about the study.  Thirty-nine women chose 
not to participate, or were ineligible because they could not confirm that they were diagnosed 
with fibromyalgia by a rheumatologist.  Therefore, they did not attend the intake assessment.  
Reasons for not participating included: time constraints, distance to travel, lack of transportation, 
or being asymptomatic, too unwell due to other health problems, involved in another program, or 
uncomfortable in a group setting.  Please see Appendix C for a flowchart based on the 
Consolidated Standards of Reporting Trials (CONSORT).  The flowchart depicts the passage of 
participants through the study (Moher, Schulz, & Altman, 2001).  Thirteen women, who were 
initially interested in the study and did attend the intake assessment, did not participate in the 
study and were not randomized.  Two of the thirteen were ineligible, one due to substance abuse 
and one due to a language barrier.  Two were eligible but felt that they were too unwell to 
participate due to other health problems, including visual impairment.  Reasons for not 
participating, provided by the remaining 9 of 13 women, included: time constraints, difficulty 
with transportation, or uncertainty about what they could gain from the study.   
A total of 105 women participated in the study.  Demographic information, including age, 
marital status, and ethnicity, can be found in Table 2.  Six women withdrew from the study, five 
from the treatment condition, and one from the control condition.  Reasons included: family 
emergency, death in the family, illness of a family member, and discomfort in the group.  Four 
women did not drop out of the study, but they missed more than two of eight treatment sessions.  
Reasons for missing sessions included: conflicting medical appointments, migraine headaches, 
fatigue, and being busy.  Prior to starting the treatment, participants were informed that it was 
very important to attend at least 6 of 8 sessions and the first and last sessions were mandatory.  If 
they missed more than 2 sessions, it was thought that they could not benefit maximally from the 
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treatment and it was unfair to others who made the commitment to attend regularly.  One 
participant did complete the treatment but she had a significant hearing impairment.  During the 
course of treatment it became apparent that she did not hear a substantial portion of the 
information and discussion and, as a result, she likely was not able to participate fully or benefit 
from the treatment to the fullest extent possible.  Nevertheless, all 105 participants’ data were 
used in the analysis.  This is a conservative approach, since those participants who missed more 
than 2 sessions and the participant with the hearing impairment could have been excluded from 
the analysis.  Using the data only from participants who precisely followed protocol, however, 
would likely not be an accurate reflection of treatment outcomes that would be expected if the 
treatment were run in a community setting.   
Measures 
Participants were assessed on a variety of outcome measures at pre-intervention (time 1), 
post-intervention (time 2), and 1- and 3-month follow-up (time 3 and time 4 respectively).  The 
measures have been utilized in a number of fibromyalgia intervention studies, thereby improving 
comparability of results (see Table 1).  The primary outcome is fibromyalgia impact and a 
number of secondary outcomes were also measured.  Only those measures with demonstrated 
reliability and validity were used to assess behavioral and psychological variables, unless 
otherwise specified.  For example, in some instances single items are used in addition to 
subscales or scales.  In some cases, a single item reflects a different aspect of a construct and, 
therefore, can add to our understanding of the effect of treatment on various dimensions of the 
construct.  Tender points were not assessed because a qualified person was not available to 
conduct standardized tender point assessments for each participant at multiple time periods 
throughout the study.  
Fibromyalgia Impact Questionnaire (FIQ).  The FIQ is a brief 20-item self-administered 
instrument that measures the impact of fibromyalgia, physical functioning, workdays missed, 
depression, anxiety, sleep, pain, stiffness, fatigue, and well-being (see Appendix D).  Responses 
to the first set of items are given on a Likert scale, ranging from 0 representing ‘always able to 
do’ to 3 representing ‘never able to do’. The next two items ask patients to circle the number of 
days in the past week that they felt good and the number of days that they missed work. 
Responses to the last 7 items are given by marking a category or point on a 100 mm anchored 
visual analog scale (Burckhardt, Clark, & Bennett, 1991).  In a study examining responsiveness 
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of fibromyalgia clinical outcome measures, Dunkl, Taylor, McConnell, and Alfano (2000) 
concluded that the FIQ was the most responsive measure to perceived clinical improvement and 
recommend its inclusion as a primary endpoint in FM clinical trials. 
Numerical pain rating scale (NPRS).  The NPRS was used to measure pain intensity, 
frequency, and duration (see Appendix E).  The pain intensity rating is a composite of current, 
worst, least, and average (last 2 weeks) pain intensity ratings.  Each of which were rated on a 0-
100 scale.  The composite was the sum of these four ratings, with a potential range of 0-400.  
According to Jensen, Turner, Romano, and Fisher (1999), a composite rating should be used 
rather than an individual 0-100 rating of pain intensity when maximal reliability is necessary, 
i.e., small sample sizes.  Jensen et al. state that 0-100 ratings have sufficient psychometric 
strengths to be used in chronic pain research.  Frequency of pain was measured by indicating ‘the 
number of days in the past week with pain’ (0-7) and duration of pain was measured by 
indicating ‘the longest period of non-stop or continuous pain in past week’ (rated in minutes, 
hours, or days, then converted to hours for analysis). 
Chronic Disease Questionnaire (CDQ) – Stanford Patient Education Research Center, 
Stanford University School of Medicine.  This questionnaire assesses a number of variables that 
are important for evaluation in chronic disease research, including: demographic data, health 
behaviour, health status, health care utilization, and self-efficacy.  The CDQ includes the 
following disability measure and self-efficacy measure: 
Health Assessment Questionnaire – 8 Item Disability (HAQ).  The HAQ assesses health 
status and is available in a number of versions, including a long or short form and a disability 
scale.  In the current study, the 8-item (short) disability scale was used (see Appendix F, items 
12a-h).  The HAQ was developed by the Stanford Patient Education Research Center as a 
measure of physical disability, not a measure of activities of daily living.  Patients rate their level 
of ability on functional tasks from ‘without any difficulty’ to ‘unable to do.’ Lorig, Sobel, Ritter, 
Laurent, and Hobbs (2001) reported that the internal consistency reliability of the 8 item HAQ is 
0.85.   
Arthritis Self-Efficacy – 8 Item Scale (ASES).  This instrument measures participant’s 
self-efficacy for controlling arthritis symptoms (Lorig, Chastain, Ung, Shoor, & Holman, 1989; 
see Appendix  F, items 13a-h).  The scale has been applied to fibromyalgia populations by 
substituting the word ‘fibromyalgia’ for ‘arthritis’ where applicable, which was done in the 
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current study (Gowans, deHueck, & Richardson, 1999; Lorig et al., 1989).  Items include, “how 
certain are you that you can decrease your pain quite a bit?” Items are rated on a scale from 1, 
representing ‘very uncertain,’ to 10, representing ‘very certain.’  The ASES met reasonable 
standards for construct and concurrent validity and test-retest reliability.  Lorig et al. report that 
the internal consistency reliability for the Arthritis Self-Efficacy – 8 Item scale is 0.92.   
Symptom Checklist 90-R (SCL90-R).  Depression and anxiety were measured using this 
90-item questionnaire (see Appendix G).  The SCL90-R assesses the presence of a variety of 
symptoms, including: depression, anxiety, somatization, and interpersonal sensitivity.  Each item 
is rated on a 5-point Likert scale, ranging from 0 representing ‘not at all’ to 4 representing 
‘extremely’.  Adequate test-retest reliability and internal consistency have been documented 
(Derogatis, 1977).  The SCL90-R has good reliability and validity (Derogatis, 1994).   
Chronic Pain Coping Inventory (CPCI).  The CPCI is a 65-item questionnaire, measuring 
11 pain coping dimensions (see Appendix H).  There are six illness-focused responses (e.g. 
guarding and resting), four wellness-focused responses (e.g. relaxation or task persistence), and 
one involving support from others (seeking social support). Responses are based on the number 
of days (0-7) that the person implemented a coping strategy.  For example, participants select the 
number of days in the past week that they “imagined calming or distracting images to help 
relax,” or “avoided activity” with the intention of coping with pain (Jensen, Turner, Romano, & 
Strom, 1995).  Hadjistavropoulos, MacLeod, and Asmundson (1999) suggested that the CPCI is 
a valuable tool, above and beyond established coping measures, in the clinical assessment and 
research of pain.  Tan, Nguyen, Anderson, Jensen, and Thornby (2005) further validated the 
CPCI after conducting a confirmatory factor analysis.  The results strongly support the factor 
structure and the predictive validity of the CPCI scales, as indicated by their association with 
measures of patient adjustment to chronic pain. 
Quality of life (QOLS).  This instrument measures participant’s satisfaction with areas of 
physical and mental well-being (Flanagan, 1978; see Appendix I).  This measure is important, as 
it allows us to determine improvements outside of pain and coping related areas (e.g., happiness 
in marital relations).  The QOLS is a 15-item questionnaire and the items are rated on a 7-point 
Likert scale, ranging from 1 (terrible), to 7 (delighted).  Burckhardt, Woods, Schultz, and 
Ziebarth (1989) stated that the QOLS is a conceptually clear and content-valid instrument, with 
positive psychometric properties.  
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Procedure 
This study includes the construction of a cognitive-behavioural and interpersonal group 
therapy intervention for the treatment of fibromyalgia.  The intervention is presented in manual 
form, in order to ensure that the group sessions are presented to all participants in a standardized 
manner (see Appendix J for the manual).  The manual may also serve as a resource for other 
investigators who wish to replicate, or refine, the group therapy intervention.  
Manual Construction 
Construction of the manual was based on an extensive review of existing psychological 
treatments for fibromyalgia.  Francis Keefe developed a cognitive-behavioural manual for 
chronic pain, which has been identified as an empirically supported treatment for chronic pain by 
the Task Force on Empirically Supported Treatments, Section on Clinical Psychology of the 
Canadian Psychological Association.  Keefe’s manual acted as the foundation for the manual 
constructed in this study.  CBT for chronic pain, described by Philips and Rachman (1996) and 
Wilson and Pancyr (revised 2001), were also primary resources upon which the manual was 
based.  During the construction of the manual, a number of researchers and authors were 
consulted (personal communication, 2002: L. A. Bradley; L. Mason; J. Parker; D. Bakal; P. C. 
Nielson).  The information gained by examining existing treatments and by consulting with 
various professionals was critical.  In addition, practical information was sought that would 
prove beneficial to the construction of the manual.  For example, the author of the manual 
(Melanie Langford) co-facilitated a CBT group, offered by the Clinical Health Psychology 
Department of the Royal University Hospital, Saskatoon, Saskatchewan.  Laurene Wilson, Ph.D., 
led the treatment along with psychology intern, Nelson Byrne, M.A.  The clinical experience, 
supervision, and consultation gained through this experience provided rich information that 
informed the construction of the manual.  In addition, Dr. Wilson reviewed the manual and 
provided detailed feedback, which was used to improve subsequent drafts.  A brief description of 
each session follows. 
Session 1. The first session begins with an introduction and an overview of the treatment, 
followed by a description of fibromyalgia, a review of gate control theory, and an introduction to 
the formative phase of the interpersonal component.  
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Session 2. The second session provides a review of sleep difficulties and strategies to 
improve sleep.  Relaxation techniques are also presented.  The formative phase of the 
interpersonal component is continued.  
Session 3. The third session provides a rationale for coping skills, and expands on 
relaxation strategies.  The reactive phase of the interpersonal component begins.  
Session 4. The fourth session begins with a review of relaxation strategies, and introduces 
new coping skills.  The reactive phase of the interpersonal component is continued.  
Session 5. The fifth session presents additional coping strategies, and introduces the topic 
of identifying and changing cognitions.  The reactive phase is continued.  
Session 6. The sixth session reviews cognitive techniques, introduces new coping skills, 
and the mature phase of the interpersonal component begins.  
Session 7. The seventh session focuses on the application of coping skills, and provides 
problem-solving techniques.  The termination phase of the interpersonal component begins. 
Session 8. The last session provides a review of progress, and a plan for maintaining 
progress is provided.  The termination phase continues and the main theme revolves around 
saying good-bye.  
In accordance with the intervention manual, cognitive-behavioural and interpersonal 
therapy groups were conducted.  Each group, consisting of 4 to 10 patients, met for 8 sessions of 
2-hours over an 8-week period.  
The study also included an attention-control condition.  A number of studies to date have 
been uncontrolled, or employ a wait list control condition.  An attention-control condition can 
improve upon the wait-list or standard care conditions, because it is more similar to the treatment 
condition.  Some factors are shared between the treatment and control condition, which improves 
the ability to draw conclusions regarding the effects of treatment.  If a wait list control condition 
was used in the current study, for example, it could be argued that the treatment participants 
benefited from attention and compassion from the researcher, whereas the control participants 
would have minimal contact with the researcher.  As such, an attention-control condition was 
used, in which the investigator contacted each participant by phone over the course of the 8 
weeks of treatment.   
Random Assignment 
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After providing consent, participants were randomized to the treatment condition, or the 
attention-control condition.  (Please see Appendix K for consent forms, debriefing forms, and 
ethics approval).  Participants completed the NPRS after providing consent, and the total pain 
score was used to match participants into pairs in order to reduce the chance of pre-existing 
differences between conditions.  For example, two participants with scores of 200 were matched, 
or two participants with the scores that were closest together, such as 195 and 190, were 
matched.  A coin was tossed to determine which member of the matched pair would be assigned 
to the treatment condition, and which would be assigned to the control condition.  As a result of 
this procedure, participants were randomly assigned and the treatment and respective control 
participants had similar total pain scores.  This pain data was not used for the pre-treatment data, 
since it was collected at variable lengths of time prior to starting the treatment or control 
intervention.  The pre-treatment data were collected on the first day of treatment for the 
treatment condition, and within 2 days of that for the control condition.  Identification numbers 
were used, rather than names, to ensure that the investigator was not aware of the condition to 
which a particular participant was being assigned.   
Data Collection   
The pre-treatment data were collected from the participants in the treatment condition on 
site, at the University of Saskatchewan, on the same day as the first group session began.  The 
data were collected from the attention-control participants on site as close to the same date as 
possible that the treatment condition began the first session.  Generally, it was within 2 days, in 
order to minimize potentially confounding effects such as weather, or current events that could 
impact mood or pain.  Completion time for the questionnaires ranged from approximately 40 
minutes to 1.5 hours.  Participants completed the forms either in isolation, but were checked on 
periodically by the investigator, or in a group, where they were supervised in order to avoid 
discussion and potential bias of results.   
The post-treatment data were collected from the participants in the treatment condition on 
site, on the day of the last group session, immediately following conclusion of the group.  The 
data were collected from the attention-control participants as close to the same date as possible, 
either on site or by mail when necessary.  All participants were encouraged to complete the 
forms on site whenever possible at all time periods.  However, questionnaires were mailed out 
when necessary in order to increase the number of participants completing the data.  If 
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participants were required to come to the university each time, data would have been lost, as 
many people were not prepared to do so.    
Study 1.  The intervention was first pilot tested with a group of five participants.  They 
were assessed using the procedures outlined above, and feedback was solicited regarding the 
delivery of the intervention.  Anonymous qualitative feedback was requested in order to improve 
the intervention or make any necessary changes.  Feedback was positive overall, and no 
substantial changes were necessary to the treatment, handouts, or protocol.  The assessments 
measures were administered at pre- and post-intervention and at 1- and 3-month follow-up.  
Study 2.  The intervention was subsequently administered with approximately half of the 
group of eligible participants, while the other half of the participants were in the attention-control 
condition.  There were 7 different treatment groups, and 7 respective control groups, in addition 
to the pilot study treatment group.  The number of participants in the treatment groups ranged 
from five to ten, with an average of six to seven.  Treatment participants attended weekly 2-hour 
sessions, at the University of Saskatchewan, for 8 consecutive weeks (with the exception of one 
group that was conducted in Prince Albert).  Control participants were contacted weekly by 
telephone by the primary investigator for the same 8-week period.  Conversations lasted between 
10 and 15 minutes, and the investigator asked scripted questions regarding fibromyalgia 
symptoms, the effects of symptoms on daily living and interpersonal situations, and coping 
strategies (see Appendix L for protocol).  The investigator did not provide education or coping 
strategies to the control participants.  
Each treatment session involved two components.  The first 45 minutes of each treatment 
session was cognitive-behavioural in nature and was led by the primary investigator (Melanie 
Langford).  The room was set up in a classroom style with a large table in the center and chairs 
around the perimeter.  The investigator/therapist stood at the front of the room and presented 
information using slides (both verbal and pictorial).  The therapist also facilitated discussion and 
led exercises, for example, relaxation exercises.  After the 45 minutes of CBT, participants had a 
brief break, (5-10 minutes), and proceeded to a therapy room on another floor of the building 
(this was not the case for the Prince Albert group).  It was thought that the transition from CBT 
to interpersonal therapy could be difficult.  Therefore, the environment was purposefully 
adjusted to represent, and hopefully facilitate, a transition.  The therapist facilitating the 
interpersonal therapy component of each session was not the same as the cognitive-behavioural 
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therapist.  It would be difficult for participants to adjust to a different form of therapy if the same 
therapist facilitated both components.  The same person facilitated all sessions of the 
interpersonal groups for all 8-treatment groups (Ms. Tarah Hook, PhD student in Clinical 
Psychology).  The interpersonal therapy room was not a classroom, but rather it was designed as 
a group therapy room.  The interpersonal component of each session was also 45 minutes in 
duration.   
Primary Outcome 
H1) Fibromyalgia impact.  It is expected that the treatment condition’s fibromyalgia 
impact scores will significantly improve (decrease) from time 1 to time 2, while the control 
condition’s scores will not.  The change in the treatment condition will be maintained from time 
2 to time 4, while the control condition’s scores will not change. 
Secondary Outcomes 
For the following variables, it is expected that scores in the treatment condition will 
significantly improve (decrease) from time 1 to time 2, while scores in the control condition will 
not.  It is also expected that the change in the treatment condition will be maintained from time 2 
to time 4, while the scores in the control condition will not change.  
H2) Pain (intensity, frequency, and duration)    
H3) Functional disability 
H4) Workdays missed 
H5) Health care utilization 
H6) Depression 
H7) Anxiety 
For the following variables, it is expected that scores in the treatment condition will 
significantly improve (increase) from time 1 to time 2, while scores in the control condition will 
not.  It is also expected that the change in the treatment condition will be maintained from time 2 
to time 4, while the scores in the control condition will not change.  
H8) Coping   
H9) Relaxation   
H10) Self-efficacy   




The data were analyzed using analysis of covariance (ANCOVA).  The most common 
reason to use ANCOVA is to increase the sensitivity of the test of main effects and interactions 
by reducing the error term.  The error term is reduced by the relationship between the dependent 
variable and the covariate (Tabachnik & Fidell, 2001).  The covariate, in this case, is the pre-
treatment score for each variable.  The test examines a mean difference between the treatment 
condition and the control condition on a dependent variable, after post-test scores are adjusted 
for differences in pre-test scores (the covariate).  ANCOVAs were conducted for the primary 
variable and each secondary variable separately. 
When a number of analyses of variance or covariance are conducted, some suggest that a 
correction, such as the Bonferroni procedure, be made to reduce Type I error (Tabachnick & 
Fidell).  However, others argue that the Bonferroni procedure is too conservative and should not 
be used.  Bender and Lange (1999) state that the Bonferroni ignores dependencies among the 
data and is, therefore, much too conservative if the number of tests is large.  Hence, it should not 
be routinely used.  The current study implemented conservative approaches to statistical analysis, 
which will be reviewed next.  In light of these conservative approaches, it may not be appropriate 
to implement an additional conservative approach to correct for multiple ANCOVAs.  
Intention-to-Treat 
First, the data from the 105 participants that were randomly assigned were used in the 
analysis.  This includes data from participants who withdrew from the study (6), participants who 
missed more than 2 of 8 treatment sessions (4), and a participant who missed information due to 
a hearing impairment (1).  This is a conservative approach, since it could be argued that those 
participants did not participate in the treatment as it was intended.  Their results, therefore, are 
not reflective of the full potential of the treatment.   
Second, there were missing data at time 2, time 3, and time 4 (see Table 3).  This was not 
due solely to participants who withdrew.  Some participants who completed the treatment 
sessions or the control protocol failed to complete or return the questionnaires at certain time 
points.  For example, a participant may have completed the measures at time 1, 2, and 4, but not 
at time 3.   
Intention-to-treat is an important method of analysis in randomized controlled trials of 
health care interventions (Hollis & Campbell, 1999; Newell, 1992).  The concept has become 
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widely accepted in theory, but it is not always implemented in practice.  Failure to analyze results 
by intention-to-treat can result in misleading interpretations (Newell).  Intention-to-treat provides 
a pragmatic estimate of the benefit of a treatment, including changes in treatment protocol, rather 
than of the potential benefit to patients who receive the treatment exactly as planned (Hollis & 
Campbell).  The purpose of intention-to-treat is to include the data of all randomized 
participants, to the greatest extent possible, in order to provide the most realistic picture of the 
effects of the intervention.  Full application of intention-to-treat is possible only when complete 
outcome data are available for all randomized participants (Hollis & Campbell).  In health care 
research this is rarely the case.  In the current study, the missing data were addressed by carrying 
forward the last observation for that participant.  For example, in more extreme cases, time 1 
data would be repeated (carried forward) for time 2, 3, and 4.  In less extreme cases of missing 
data, time 2 data may be carried forward for time 3 only because the participant may have 
completed data for time 4 (and time 1).    
The ANCOVAs were conducted with two sets of data: the original data set with missing 
data and the intention-to-treat data, which replaced missing data by carrying forward the last 
observation.  The main analysis in the current study is the ANCOVA with the intention-to-treat 
data.  The analysis using the original data is presented in Appendix M as background 
information.  
The results of the intention-to-treat analysis represent all patients, rather than only those 
who were able to complete the program, or all of the measures at each time period.  There may 
be differences between those participants who complete the assessment measures at all time 
periods, or who complete the study, versus those who do not.  If an intention-to-treat analysis is 
not conducted, selection factors, such as motivation, can bias the results.  For example, those 
participants who are highly motivated and are better therapy candidates are more likely to 
continue than those who are less motivated.  By including all participants, and using the last 
observation carried forward in the intention-to-treat analysis, the results are more realistic. 
Unit of analysis.  The question can be raised as to whether the unit of analysis should be 
the group or the individual.  The issue is whether the scores of each individual (each participant) 
are independent.  Since both the treatment condition and the control condition consist of smaller 
groups (therapy groups and attention/control groups), the argument can be made that each person 
in the treatment condition is affected by the other people in the group.  This is not the case for 
 47
participants in the control condition because they do not have contact with each other.  It could 
be argued that each treatment participant’s responses on the dependent variables are not 
independent.  It is difficult to determine the manner by which this ‘independence issue’ could 
affect results.  The responses of group members, on measures of pain intensity for example, may 
be either reduced or increased due to the influence of another group member with either high or 
low ratings of pain intensity.  However, participants are not directly influenced by each other 
when completing the assessment measures because they are either isolated or supervised while 
doing so.  It is possible to explore independence but this would require an extremely large 
sample size, one that is not feasible for this study. 
 In the chronic pain treatment literature, it appears that authors do not overtly specify 
whether the unit of analysis is the individual or the group.  However, the degrees of freedom 
reported in the results sections indicate that the unit of analysis is the individual.  For example, if 
the study had 100 participants, the degrees of freedom are of that magnitude.  If the unit of 
analysis was the group, the degrees of freedom would be much smaller and the power to detect 
change would also be reduced.  Therefore, in the current study the unit of analysis is the 
individual.     
Data Matrix  
Participants in the treatment condition and the attention-control condition were assessed 
at four time periods: pre-treatment, post-treatment, 1-month and 3-month follow-up.  The 
number of participants that responded at each time period is shown in Table 3.  
All participants whose responses were substantially complete have been included in 
Table 3.  In some cases, participants did not complete all questionnaires in all four time periods.  
Consequently, the statistical analyses were, in certain cases, forced to use a smaller number of 
observations than indicated in Table 3.  
Questionnaire Responders versus Non-responders 
Table 4 compares the pre-treatment means on the variables of interest between those who 
responded to the questionnaires (responders) and those who did not (non-responders) overall, 
and for treatment versus control responders and treatment versus control non-responders (P. 
Faris, personal communication, 2007).  For this purpose, responders are defined as those 
participants who completed the measures (responded to the questionnaires) at T1 and T2.  Non-
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responders are those who completed the measures at T1 but not at T2. 1  The intention-to-treat 
analysis was conducted in order to adjust for any differences between participants who 
completed all measures versus those who did not.  Some of the non-responders withdrew from 
the study, whereas some completed the study but failed to complete measures at all time periods.  
 There was a significant overall difference between responders and non-responders for 
one variable: NPRS duration (longest length of time of continuous pain).  The mean score for 
responders was 78.00 and the mean score for non-responders was 99.21.  That is, the non-
responders reported a longer duration of continuous pain at pre-treatment.  Although the 
continuous pain scores differ, the groups do not differ on the overall pain score, which is a 
composite of current, worst, least, and average pain (NPRS total).   
Data Screening and Assumption Testing 
Data screening and assumption testing were conducted on the original data set rather than 
the intention-to-treat data set.  Missing variable analysis was conducted to determine the pattern 
of missing values.  Results indicated that the pattern of missing values was random, that is, there 
was no selective attrition.  Mean substitution was carried out only for participants whose data 
were substantially complete (Field, 2005; Tabachnik & Fidell, 2001).  Mean substitution was 
conducted by identifying missing items on each scale at each time period.  The mean score, 
based on the existing data for the item at a particular time period, was calculated and substituted 
for those participants who left that item blank (see Table 5 for the number of items missing and 
the number of mean substitutions made).  Under the circumstance that an entire measure was not 
completed, or all measures at a certain time period were not completed, data were not substituted 
with mean substitution.  Rather, the last observation was carried forward as discussed in the 
intention-to-treat section above.   
Z-scores were calculated for all variables at all time periods in order to identify outliers.  
Extreme outliers were truncated to three standard deviations in order to reduce their impact 
(Tabachnik & Fidell, 2001).  The data were tested for normality and homogeneity of variance. 
The results of the Shapiro-Wilks test demonstrate that 3 of the 11 variables are normally 
distributed for both the treatment condition and the control condition (fibromyalgia impact, 
                                                 
1 Non-responders may have completed T3 and/or T4 therefore they did not all withdraw from the study. Similarly, 




coping, and self-efficacy).  Four variables are non-normally distributed for both the treatment 
condition and the control condition.  Four variables are normally distributed for either the 
treatment condition or the control condition but not both.  Zar (1998) stated that analysis of 
variance is robust with respect to the assumption of the underlying populations’ normality.  The 
validity of the analysis is affected only slightly by even considerable deviations from normality, 
especially as sample size increases.  In addition, the analysis is robust when group sizes are 
equal, or close to equal (Tabachnik & Fidell; Zar).  In the intention-to-treat data set, the sample 
sizes are close to equal for the treatment group and the control group.  The results of Levene’s 
test demonstrate that all 11 variables met the homogeneity of variance assumption.   
Reliability Analyses 
Table 6 provides a summary of the reliability analyses, along with means and standard 
deviations for each scale and subscale.  Reliability analyses were conducted using Cronbach’s 
alpha, the most common measure of scale reliability (Field, 2005).  According to Cicchetti 
(1994), a Cronbach’s alpha of less than 0.7 is unacceptable, 0.7-0.79 is fair, 0.8-0.89 is good, and 
greater than or equal to 0.9 is excellent.  Cronbach’s alphas were calculated separately at time 1 
and time 2 and were not computed for single item subscales. 
 In addition, corrected item-total correlations, mean inter-item correlations, and 
Cronbach’s alphas if item deleted were examined.  When the corrected item-total correlation for 
a given item on a scale is less than 0.3 it may be appropriate to remove the item (Field, 2005). 
Items 7, 9, 10, and 11 on the FIQ at time 1 were less than 0.3.  However, there is likely no 
advantage to removing these items since the overall alpha for the scale does not improve if they 
are deleted.  The same can be said for item 10 of the FIQ at time 2, item 1 of the NPRS at time 2, 
and item 4 of the QOLS.  
Overall, the reliability data demonstrate that the measures used in the current study have 
adequate internal consistency, ranging from ‘fair to excellent’, with the vast majority in the 
‘good’ reliability category. 
ANCOVA Results: Intention-to-Treat Analysis 
The means and standard deviations for each variable, along with the F-statistics for the 
ANCOVAs, based on the intention-to-treat data, are listed in Table 7.  The results based on the 
intention-to-treat data follow.  The analyses were conducted using the pre-treatment, post-
treatment, and 3-month follow-up data (T1, T2, and T4).  Time 3 data (1- month follow-up) was 
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not used in the ANCOVAs, or included in the tables, because of the paucity of data at time 3 (see 
Table 3).  In addition, there is twice as much data for the treatment condition than the control 
condition at time 3, which can be problematic for statistical analyses.    
The original data set is smaller due to missing data, while the intention-to-treat data set is 
larger due to data substitution (last observation carried forward).  The ANCOVA results differ 
based on the data sets; a summary is provided in Appendix M.  See Appendix M for the 
ANCOVA results based on the original data and a table with the means and standard deviations 
for each variable for the treatment condition and the control condition, based on the original data.   
Primary Outcome Variable 
H1) Fibromyalgia impact.  To test the hypothesis that the treatment condition’s 
fibromyalgia impact scores would significantly improve (decrease) from time 1 to time 2, while 
the control condition’s scores would not, an ANCOVA was conducted.  The dependent variable 
for the analysis was fibromyalgia impact time 2.  That is, the impact that fibromyalgia symptoms 
have on various aspects of life, measured by the FIQ total score.  The independent variable was 
condition (treatment condition or attention-control condition).  The fibromyalgia impact total 
score at time 1 served as the covariate.   
The covariate, fibromyalgia impact time 1, was significantly related to the fibromyalgia 
impact time 2 score, F (1, 102) = 120.10, p < .001.  There was also a significant effect of 
condition on fibromyalgia impact time 2, after controlling for the effect of fibromyalgia impact 
time 1, F (1, 102) = 4.39, p < .05.  At time 2, the treatment condition experienced significantly 
less impairment due to fibromyalgia symptoms compared to the control condition.  A higher 
score on the FIQ indicates greater impairment due to fibromyalgia symptoms.  
To test the hypothesis that the treatment condition’s improvement in fibromyalgia impact 
scores would be maintained from time 2 to time 4 and the control condition’s scores would not 
change substantially, an ANCOVA was conducted.  The covariate, fibromyalgia impact time 2, 
was significantly related to the fibromyalgia impact score at time 4, F (1, 102) = 111.01, p < 
.001.  There was not a significant effect of condition; therefore, the treatment effect was not 
maintained at time 4.  
Secondary Outcome Variables 
H2) Pain (intensity, frequency, duration). An ANCOVA was conducted to test the 
hypothesis that the treatment condition’s pain intensity scores would significantly improve 
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(decrease) from time 1 to time 2, while the control condition’s scores would not.  The dependent 
variable for the analysis was pain intensity at time 2, which is a composite of current, worst, 
least, and average pain ratings measured by the NPRS.  The independent variable was condition 
(treatment condition or attention-control condition).  The pain intensity score at time 1 served as 
the covariate.   
The covariate, pain intensity time 1, was significantly related to pain intensity time 2, F 
(1, 101) = 68.07, p < .001. There was not a significant effect of condition on pain intensity time 
2, after controlling for the effect of pain intensity time 1.  
Since a treatment effect was not observed at time 2 there will not be maintenance of a 
treatment effect at follow-up.  However, to test the hypothesis that the treatment condition and 
control condition would differ on pain intensity at time 4, an ANCOVA was conducted.  The 
dependent variable for the analysis was pain intensity time 4.  The covariate, pain intensity time 
2, was significantly related to pain intensity time 4, F (1, 102) = 82.14, p < .001.  There was not a 
significant effect of condition observed at follow-up.   
To test the hypotheses for the frequency of pain and the duration of pain, ANCOVA’s 
were also conducted.  Frequency of pain refers to the number of days in a week that a person 
experienced pain.  Duration refers to the longest length of time that a person experienced 
continuous pain during a week.  Frequency and duration of pain were also measured by the 
NPRS.  The effect of condition was not significant for either frequency of pain or duration of 
pain, after controlling for the effect of frequency at time 1 and duration at time 1.  Nor was an 
effect observed at follow-up (time 4).  At time 2 and time 4 respectively, the covariates were 
significantly related to the independent variables: frequency, F (1, 101) = 49.18, p < .001, F (1, 
101) = 38.88, p < .001; duration, F (1, 101) = 67.59, p < .001, F (1, 100) = 67.91, p < .001. 
H3) Functional disability.  To test the hypothesis that the treatment condition’s level of 
functional disability would significantly improve (decrease) from time 1 to time 2, while the 
control condition’s scores would not significantly change, an ANCOVA was conducted.  The 
dependent variable for the analysis was functional disability at time 2, as measured by the HAQ.  
The independent variable was condition (treatment condition or attention-control condition).  
The functional disability score at time 1 served as the covariate.  
The covariate was significantly related to functional disability time 2, F (1, 102) = 
188.97, p < .001. The effect of condition was not significant.  
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To test the hypothesis that the treatment condition and control condition would differ on 
functional disability at time 4, an ANCOVA was conducted. The dependent variable for the 
analysis was functional disability time 4. The covariate, functional disability time 2, was 
significantly related to functional disability time 4, F (1, 102) = 164.34, p < .001.  There was not 
a significant effect of condition at follow-up.   
H4) Workdays missed.  To test the difference between conditions, the dependent variable 
for the analysis was the number of workdays missed at time 2, and the independent variable was 
condition (treatment condition or attention-control condition).  The number of workdays missed 
at time 1 served as the covariate.  An ANCOVA was used to test the hypothesis that the 
treatment condition’s number of workdays missed would significantly improve (decrease) from 
time 1 to time 2, while the control condition’s scores would not significantly change.  
The covariate was significantly related to workdays missed time 2, F (1,102) = 76.90, p < 
.001.  The effect of condition was not significant.  
Since a treatment effect was not observed at time 2, there will not be maintenance of a 
treatment effect at follow-up. However, to test the hypothesis that the treatment condition and 
control condition would differ on number of workdays missed at time 4, an ANCOVA was 
conducted.  The dependent variable for the analysis was workdays missed time 4.  The covariate, 
workdays missed time 2, was significantly related to workdays missed time 4, F (1,102) = 57.29, 
p < .001.  There was not a significant effect of condition observed at follow-up.   
H5) Health care utilization.  An ANCOVA was conducted to test the hypothesis that the 
treatment condition’s use of health care would significantly improve (decrease) from time 1 to 
time 2, while the control condition’s scores would not significantly change.  The number of visits 
to their family physician at time 1 served as the covariate, while the dependent variable was the 
number of visits at time 2.  The independent variable was condition (treatment condition or 
attention-control condition).  
The covariate was significantly related to appointments with physician time 2, F (1,102) 
= 53.36, p < .001. The effect of condition was not significant.  
Since a treatment effect was not observed at time 2, there will not be maintenance of a 
treatment effect at follow-up.  However, to test the hypothesis that the treatment condition and 
control condition would differ on health care utilization at time 4, an ANCOVA was conducted. 
The dependent variable for the analysis was visits to physician time 4. The covariate, visits to 
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physician time 2, was significantly related to visits to physician time 4, F (1,101) = 61.88, p < 
.001.  There was not a significant effect of condition observed at follow-up, time 4.   
H6) Depression.  To test the hypothesis that the treatment condition’s depression scores 
would significantly improve (decrease) from time 1 to time 2, while the control condition’s 
scores would not significantly change, ANCOVAs were conducted.  Depression was measured 
by the FIQ and the SCL90-R and an ANCOVA was conducted for each variable.  In each case, 
the independent variable was condition (treatment condition or attention-control condition) and 
the covariate was the time 1 score.  
The covariate, FIQ depression time 1, was significantly related to FIQ depression time 2, 
F (1,102) = 157.82, p < .001.  There was also a significant effect of condition on FIQ depression 
time 2, after controlling for the effect of FIQ depression time 1, F (1,102) = 5.44, p = < .05.  A 
higher score indicates greater impairment.  
To test the hypothesis that the treatment condition’s improvement in FIQ depression 
scores would be maintained at follow-up (time 4) and the control condition’s scores would not 
significantly change, an ANCOVA was conducted.  The covariate was significantly related to the 
FIQ depression score at time 4, F (1, 102) = 92.26, p < .001.  There was not a significant effect 
of condition; therefore, the treatment effect was not maintained at time 4. 
The covariate, SCL90 depression time 1, was significantly related to SCL90 depression 
time 2, F (1,95) = 164.00, p < .001. The effect of condition was not significant.  To examine 
follow-up effects, the covariate for SCL90 depression was significantly related to the SCL90 
depression time 4 score, F (1,91) = 209.50, p < .001.  However, the effect of condition was not 
significant.  
H7) Anxiety.  Anxiety was measured by the FIQ and the SCL90-R.  In each case, the 
independent variable was condition (treatment condition or attention-control condition) and the 
covariate was the time 1 score.  To test the hypothesis that the treatment condition’s level of 
anxiety would significantly improve (decrease) from time 1 to time 2, while the control 
condition’s scores would not significantly change, ANCOVAs were conducted.   
The covariate, anxiety FIQ time 1, was significantly related to anxiety FIQ time 2, F 
(1,102) = 133.61, p < .001.  The effect of condition was not significant.  The covariate, anxiety 
SCL90 time 1, was significantly related to anxiety SCL90 time 2, F (1,95) = 112.00, p < .001. 
The effect of condition was not significant.  
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To test the hypothesis that the treatment condition and control condition would differ on 
anxiety at time 4, ANCOVAs were conducted.  The covariate, anxiety FIQ time 2, was 
significantly related to anxiety FIQ time 4, F (1, 102) = 126.87, p < .001.  There was not a 
significant effect of condition.  The covariate, anxiety SCL90 time 1, was significantly related to 
the anxiety SCL90 time 4 score, F (1,91) = 190.80, p < .001.  The effect of condition was not 
significant.  
H8) Coping. A number of coping strategies were assessed and are grouped into 
categories: wellness focused, illness focused, and other.  To test the hypothesis that the treatment 
condition’s wellness focused coping strategies would significantly improve (increase) from time 
1 to time 2, while the control condition’s scores would not significantly change, ANCOVAs 
were conducted.  The dependent variable for each analysis was the strategy (relaxation, task 
persistence, self-statements) at time 2, as measured by the CPCI.  The independent variable was 
condition (treatment condition or attention-control condition) and the covariate was strategy at 
time 1.  
Each covariate (relaxation, task persistence, self-statements) was significantly related to 
the strategy at time 2, F (1, 88) = 99.21, p < .001; F (1,88) = 99.10, p < .001; F (1, 88) = 84.87, 
p< .001 (respectively).  The effect of condition was significant for relaxation, F (1, 88) = 28.63, 
p< .001 and task persistence, F (1,88) = 6.00, p< .05 (higher score indicates greater endorsement 
of the coping strategy).  At time 2, the treatment condition endorsed the use of task persistence 
less than the control condition.  
At follow-up (time 4), relaxation time 2 was significantly related to relaxation time 4, F 
(1,84) = 109.85, p< .001 and the effect of condition was significant, F (1,84) = 4.10, p < .05.  
Therefore, the treatment effect for relaxation as a coping strategy was maintained. At time 4, the 
covariate task persistence time 2, was significantly related to task persistence time 4, F (1, 84) = 
146.17, p< .001.  The effect of condition was not significant; therefore, the effect was not 
maintained. 
To test the hypothesis that the treatment condition’s illness focused coping strategies 
would significantly decrease from time 1 to time 2, while the control condition’s scores would 
not significantly change, ANCOVAs were conducted.  The dependent variable for each analysis 
was the strategy (guarding, resting, asking for assistance) at time 2, as measured by the CPCI. 
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The independent variable was condition (treatment condition or attention-control condition).  
The strategy at time 1 served as the covariate.  
Each covariate (guarding, resting, asking for assistance) was significantly related to the 
strategy at time 2, F (1, 88) = 97.10, p< .001; F (1,88) = 116.56, p< .001; F (1,88) = 158.05 p < 
.001 (respectively).  The effect of condition was significant for resting, after controlling for the 
effect of resting time 1, F (1,88) = 10.74, p < .01.  The effect was not maintained at follow-up 
(time 4).  The effect of condition was not significant for guarding or asking for assistance. 
However, for guarding there was a significant effect at follow-up.  The covariate, guarding time 
2, was significantly related to the guarding time 4 score, F (1, 84) = 179.72, p < .001.  There was 
a significant effect of condition on guarding time 4, after controlling for the effect of guarding 
time 1, F (1, 84) = 6.04, p < .05.   
Seeking social support is another coping strategy, but it is considered neither wellness 
focused nor illness focused.  To test the hypothesis that the treatment condition’s seeking social 
support coping strategy would significantly improve from time 1 to time 2, while the control 
conditions scores would not significantly change, an ANCOVA was conducted.  The dependent 
variable for the analysis was seeking social support time 2, as measured by the CPCI.  The 
independent variable was condition (treatment condition or attention-control condition).  Seeking 
social support at time 1 served as the covariate.  There was no effect of condition at time 2 or at 
follow-up. 
H9) Relaxation.  In addition to relaxation as a coping strategy, relaxation was also 
measured by the CDQ.  To test the hypothesis that the treatment condition’s relaxation scores 
would significantly improve (increase) from time 1 to time 2, while the control condition’s 
scores would not significantly change, an ANCOVA was conducted.  The dependent variable for 
the analysis was relaxation time 2, measured by the CDQ.  The independent variable was 
condition (treatment condition or attention-control condition).  The relaxation score at time 1 
served as the covariate.   
The covariate, relaxation time 1, was significantly related to the relaxation time 2 score, F 
(1, 102) = 63.74, p < .001.  There was also a significant effect of condition on relaxation time 2, 
after controlling for the effect of relaxation time 1, F (1, 102) = 16.05, p < .001.  A higher score 
indicates greater use of mental relaxation techniques.  Therefore, at time 2 the treatment 
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condition utilized mental relaxation techniques to a greater extent compared to the control 
condition.  
To test the hypothesis that the treatment condition’s improvement in relaxation scores 
would be maintained at follow-up (time 4) and the control condition’s scores would not 
significantly change, an ANCOVA was conducted.  The covariate was significantly related to the 
relaxation score at time 4, F (1, 102) = 203.77, p < .001.  There was also a significant effect of 
condition, after controlling for relaxation time 2, F (1, 102) = 3.80, p = .05.  Therefore, the 
treatment effect was maintained at time 4.  
H10) Self-efficacy.  To test the hypothesis that the treatment condition’s self-efficacy 
scores would significantly improve (increase) from time 1 to time 2, while the control 
condition’s scores would not significantly change, an ANCOVA was conducted.  The dependent 
variable for the analysis was self-efficacy time 2, as measured by the ASES.  The independent 
variable was condition (treatment or attention-control).  Self-efficacy at time 1 served as the 
covariate.   
The covariate was significantly related to the self-efficacy time 2 score, F (1,102) = 
68.76, p < .001.  There was also a significant effect of condition on self-efficacy time 2, after 
controlling for the effect of self-efficacy time 1, F (1, 102) = 11.51, p < .001.  A higher score 
indicates greater self-efficacy or greater confidence in ability to do various tasks.  Therefore, at 
time 2, the treatment condition experienced greater self-efficacy compared to the control 
condition. 
To test the hypothesis that the treatment condition’s improvement in self-efficacy would 
be maintained at follow-up (time 4) and the control condition’s scores would not significantly 
change, an ANCOVA was conducted.  The covariate was significantly related to self-efficacy 
time 4, F (1, 102) = 94.56, p < .001.  There was not a significant effect of condition; therefore, 
the treatment effect was not maintained at time 4.  
H11) Quality of life.  An ANCOVA was conducted to test the hypothesis that the 
treatment condition’s quality of life would significantly improve (increase) from time 1 to time 
2, while the control condition’s scores would not significantly change.  The dependent variable 
for the analysis was quality of life, as measured by the QOLS at time 2. The independent 
variable was condition and the covariate was quality of life at time 1. 
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The covariate was significantly related to quality of life time 2, F (1, 91) = 88.11, p < 
.001.  There was not a significant effect of condition.  The covariate was significantly related to 
quality of life time 4, F (1, 85) = 99.26, p < .001.  The effect of condition was not significant at 
time 4.  
Summary 
There was a statistically significant improvement from pre-treatment to post-treatment for 
the treatment condition, compared to the control condition, after controlling for pre-treatment 
scores, for the following variables:  
• primary outcome - impact of fibromyalgia (FIQ) 
• secondary outcomes - depression (FIQ), coping - relaxation and resting (CPCI), 
relaxation (CDQ), self-efficacy (ASES).   
There was a statistically significant reduction from pre-treatment to post-treatment in the 
use of the coping strategy task persistence (CPCI) for the treatment condition, compared to the 
control condition.  
There was a statistically significant improvement from post-treatment to follow-up for 
the treatment condition, compared to the control condition, after controlling for pre-treatment 
scores, for the following variables: secondary outcomes - coping - relaxation and guarding 
(CPCI), and relaxation (CDQ).   
The treatment condition did not improve significantly from pre-treatment to post-
treatment, compared to the control group, on the following variables:  
• secondary outcomes: pain - intensity, frequency, and duration (NPRS), functional 
disability (HAQ), workdays missed (FIQ), health care utilization (CDQ), depression 
(SCL90-R), anxiety (FIQ, SCL90-R), coping - self-statements, asking for assistance, 
seeking social support (CPCI), quality of life (QOLS). 
Discussion 
The literature on psychological treatment for fibromyalgia is limited and almost 
exclusively cognitive-behavioural in nature (or based on a comparable education/self-
management program), and there are few studies that employ CBT alone (Burckhardt et al., 
1994; Nicassio et al., 1997; Vlaeyen et al., 1996).  The majority of the studies with a 
psychological component combine it with other modalities, such as exercise, into a 
multidisciplinary treatment (Hooten et al., 2007; Mason et al., 1997; Nielson et al., 1992).  In 
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these cases it is difficult, if not impossible, to separate the effects of the psychological treatment 
from the other treatments (e.g. exercise, education, biofeedback, etc.).  Further, a number of the 
multidisciplinary CBT trials are single condition uncontrolled trials (Bennett et al., 1996; 
Creamer et al., 2000; Nielson et al., 1992; Turk et al., 1998; White et al., 1995; Worrel et al., 
2001).  There seem to be more nonpharmacological interventions examining the effects of 
exercise or physical therapy, often in combination with education, than trials examining the 
effects of psychotherapy (Bailey et al., 1999; Buckelew et al., 1998; Gustafsson et al., 2002; 
Mannerkorpi et al., 2000; Mengshoel et al., 1995). 
 Due to the paucity of research examining CBT in combination with other forms of 
psychotherapy for the treatment of fibromyalgia, or chronic pain in general, it is not possible to 
compare the results of the current study to a study employing a similar treatment program (that is 
combined CBT and interpersonal therapy).  Therefore, the discussion will focus on comparing 
the results of the current study to those studies that employed a strictly CBT approach.  However, 
comparisons will also be made to the multidisciplinary controlled and uncontrolled studies when 
possible.  
The first section of the discussion will highlight the major findings from the current 
study, based on the intention-to-treat data, in the same sequence as outlined in the hypothesis 
section.  The results of the primary outcome variable will be presented first, followed by the 
secondary variables.  Each finding will be examined in light of current literature, identifying 
consistencies and/or inconsistencies.  After reviewing the major findings, the clinical 
implications and strengths and weaknesses of the study will be reviewed, followed by 
suggestions for future research. 
The Primary Outcome Variable 
The primary variable of interest in this study was fibromyalgia impact, as measured by 
the FIQ total score.  This is a measure of health status that includes: physical functioning, work 
status, depression, anxiety, sleep, pain, stiffness, fatigue, and well-being (Burckhardt et al., 
1991).  
The intention-to-treat data did support the hypothesis.  That is, the treatment condition 
experienced significantly less impact of fibromyalgia symptoms compared to the control 
condition at time 2.  Although the means for the treatment and control conditions are similar at 
time 2, the mean for the treatment condition was higher at time 1 and thus showed more change. 
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However, the treatment effect was not maintained at 3-month follow-up; therefore, the 
hypothesis regarding maintenance of a treatment effect was not supported.  It may be that post-
treatment, the participants practiced the coping skills less over time and this resulted in greater 
impact of symptoms.  During the treatment period, homework was assigned weekly and this was 
reviewed at each session.  Therefore, there was motivation to practice.  During the follow-up 
phase this motivation was not present.  This, combined with not having the weekly group 
support, may have increased the impact of symptoms over time.  
In terms of a clinically meaningful difference, the mean and standard deviation for the 
original FIQ data at time 1 are 55.36 and 15.44 respectively, which is consistent with other 
findings (Mannerkorpi, Rivano-Fischer, Ericsson, Nordeman, & Gard, 2007).  To determine 
clinically meaningful change, one-third of a standard deviation is proposed, which is 
approximately 5 points.  In terms of effect size, one-third of a standard deviation is between a 
small and medium effect, according to Cohen’s d (Howell, 1997).  In the original data set, the 
mean from time 1 to time 2 for the treatment condition changed by 9.22 points.  Therefore, by 
the one-third standard deviation benchmark, this does constitute a clinically meaningful change.  
In comparison, the change in the control condition from time 1 to time 2 was 0.53 points.  There 
was a clinically meaningful improvement in 27 participants in the treatment condition compared 
to 10 participants in the control condition.  In the intention-to-treat data set, the mean from time 
1 to time 2 for the treatment condition changed by 6.13 points, which also constitutes a clinically 
meaningful change.  Therefore, the combined cognitive-behavioural and interpersonal treatment 
reduced the impact of fibromyalgia symptoms in a statistically and clinically meaningful way, 
from pre- to post- treatment, compared to the control condition.     
The intention-to-treat analysis enables us to generalize the outcomes of the current study 
to a typical female fibromyalgia population, rather than to only those patients who are more 
likely to complete treatment or precisely follow protocol.  The results show that this 8-week 
cognitive-behavioural/interpersonal group treatment can significantly improve impairment from 
fibromyalgia symptoms in a statistically and clinically meaningful way.  Next, the results of the 
primary outcome, fibromyalgia impact, will be compared to the literature.  
Comparison of Results to CBT Alone (or Comparable Education Program)   
There are a limited number of studies assessing the impact of CBT alone, or a 
comparable education program, on fibromyalgia symptoms.  In a sample of 86 women, 
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Burckhardt et al. (1994) found no significant between-group change in fibromyalgia impact, as 
measured by the FIQ total score, when comparing an education condition (similar to a CBT 
program), an education plus physical therapy condition, and a control condition.  When 
analyzing within group differences, however, it was revealed that the education condition 
improved significantly on a subscale of the FIQ, which assessed the number of days during a 
week that the participant ‘felt bad’.  The education plus physical therapy condition and the 
control condition did not significantly improve on this subscale.  At follow-up the education 
condition’s improvement was maintained and also showed improvement on the physical function 
subscale but not the total score, while the education plus physical therapy condition had 
improvements on the fibromyalgia impact total score and additional subscales.  The authors 
suggest that the improvements from the physical therapy component may have taken longer to 
develop giving rise to more improvement at follow-up compared to the education only condition. 
Overall, though, Burckhardt et al. (1994) found that both treatments provided some benefit to 
patients and they did not find a sufficient difference between the education condition and the 
education/physical therapy condition when taking into account all outcome measures. 
Unfortunately there was not a physical therapy condition without education to use as a 
comparison.  In the fibromyalgia treatment literature it is necessary to establish which 
components of treatment are most effective in order to advance therapy.  
Comparison of Results to CBT as a Component of Multimodal Treatments   
In addition to studies looking at CBT alone there have been a limited number of studies 
that incorporated CBT into a multimodal treatment approach to fibromyalgia.  In a controlled 
trial of 21 participants, Mason et al. (1998) examined a multimodal treatment program that 
included a cognitive-behavioural component. The FIQ was used to assess the effect of 
fibromyalgia on physical and psychological functioning.  The results were consistent with the 
current study’s findings, in that there was a significant interaction effect of condition by time.  
However, this effect was not maintained at 6-month follow-up.  The treatment effect observed in 
both studies may be related to shared elements of the CBT portion of treatment.  That is, both 
studies incorporated education, challenged cognitive distortions, and taught relaxation 
techniques.  The improvements in functional impairment may not have been maintained at long-
term follow-up in both studies because maintenance of treatment gains depends largely on 
consistent practice and use of skills (Mason et al.).  Participants who adhere to program regimes 
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are more likely to maintain post-treatment levels (Basler & Rehfisch, 1990).  Also, being 
involved with a group has unique benefits.  Some treatment effects may diminish over time due 
in part to the absence of the group.  Mason et al. emphasized relapse prevention by encouraging 
patients to continue to exercise together and participate in regular support groups.  However, 
without a therapist or trained group leader support groups can be ineffective or detrimental.  In 
fact, many of the participants that were interested in the current study were concerned that it was 
a support group and if so did not want to be involved based on previous negative experiences.  
Adding follow-up sessions to the current study’s protocol may have helped to maintain gains by 
bringing the group together and reinforcing previously learned skills and the benefits of 
practicing those skills consistently over-time. 
Luedtke et al. (2005) measured fibromyalgia impact (FIQ total score) following a 1.5-day 
multidisciplinary program with a sample of 2600.  The program included self-management, 
education, occupational therapy, and time with physicians and nurses.  The nurses involved in 
the program received training to enable them to educate the patients about the process while 
engaging the patient and building rapport. The authors noted that many patients found this time 
with the nurse very positive because in the past many were not given time to talk about their 
“personal stories,” the variety of their symptoms, and their beliefs about contributing/alleviating 
factors.  Many stated that prior to this experience they did not feel “heard.”  The self-
management portion focused on CBT techniques that emphasized stress management, relaxation, 
sleep hygiene, and difficult day planning.  Patients also had the opportunity to discuss how 
fibromyalgia has impacted their lives.   
Luedtke et al. (2005) found that the overall impact of fibromyalgia improved 
significantly from pre-treatment to 6-month follow-up and improvement was maintained at 12-
month follow-up.  The authors conducted a satisfaction survey before and after the program and 
found a dramatic improvement in satisfaction: before the program 53% of patients rated their 
fibromyalgia care as excellent or good and after the program 87% rated the care in these 
categories.  Physician satisfaction also improved.  The time patients were able to spend with the 
health care providers and the opportunity to “tell their stories” about how their lives have been 
impacted by fibromyalgia appeared to be very important.  Research by Rybarczyk and Bellg 
(1997) supports the importance of listening to patients’ stories.  They found that for patients 
facing illness, listening to their life stories was effective in reducing stress and improving 
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satisfaction.  Perhaps these fibromyalgia impact findings are similar to the current study in part 
due to the positive effects of being heard.  The interpersonal therapy component of the current 
study provided the opportunity (above and beyond the CBT component) for the sharing of 
experiences, validation, and support.  In addition, each participant had a one-to-one assessment 
interview with the primary researcher, which provided the opportunity to build rapport and tell 
their personal stories about having fibromyalgia.  Unfortunately the Luedtke et al. study did not 
incorporate a control condition nor did they control for medication adjustments over time.  It is 
also not possible to ascertain which components of the treatment contributed to the effect.  
In summary, the literature is relatively consistent with the findings of the current study 
regarding fibromyalgia impact.  In fact, the current study shows much promise since a treatment 
effect was observed with the psychological intervention alone, whereas comparison studies used 
more complex and resource intensive multidisciplinary programs with substantial physical 
activity components (Luedtke et al., 2005; Mason et al., 1998).  The CBT alone comparison 
study (Burckhardt et al., 1991) found only a within group effect on one subscale of the FIQ 
rather than the total fibromyalgia impact score.  This effect was maintained at follow-up, 
whereas in the current study the effect was not maintained at 3-month follow-up.  
The Secondary Outcome Variables  
Pain (intensity, frequency, duration).  In the current study the data did not support the 
hypothesis that the treatment condition would have a reduction in pain intensity compared to the 
control condition after controlling for time 1 scores.  Nor was there a significant difference at 3-
month follow-up.  The data also did not support the hypothesis that the treatment condition 
would have a statistically significant reduction in pain frequency and pain duration compared to 
the control condition.   
The pain intensity findings are consistent with findings in other research in which there 
were no significant between group differences for self-reported pain using a visual analogue 
scale or a composite scale (Buckelew et al., 1998; Gowans et al., 1999; Nicassio et al, 1997; 
Wigers et al., 1996).  Burckhardt, Mannerkorpi, Hedenberg, and Bjelle (1994) and Vlaeyen et al., 
(1996) also found no effect on pain resulting from psychoeducational approaches.  Explanations 
for this are varied, including: the need for adjunctive pharmacological treatment to improve sleep 
and pain; identifying subgroups of patients based on pain ratings and coping strategies to cater 
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treatment more specifically; the need for observer report or objective pain ratings to supplement 
subjective patient reports of pain (Burckhardt et al., 1994; Turk & Okifuji, 1998).   
However, other researchers found a positive effect on pain related measures (Keel et al., 
1998; Lemstra & Olszynski, 2005; Mason et al., 1998; Nielson et al., 1992).  Keel at al. 
examined clinically significant improvement.  The criterion was at least 50% improvement in a 
number of parameters.  Changes in pain intensity were calculated from participants’ daily diary 
entries.  Keel et al. found that there was a clinically significant improvement in the pain score at 
post-treatment.  When examining the differences between participants who benefited from 
treatment versus those who did not, the authors found that successful participants had suffered 
from their pain for a significantly shorter period of time (6 years vs. 15 years).  Therefore, early 
intervention may improve outcomes for fibromyalgia patients.  Mason et al. found a moderate to 
large effect size on subjective pain measured by the FIQ pain subscale and a visual analogue 
scale.  Nielson et al. (1992) found a positive effect following inpatient CBT in a sample of 25 
participants.  It should be noted that, instead of using a measure of pain intensity, frequency, and 
duration they examined a number of dimensions of the chronic pain experience.  This included 
pain interference, sense of control over life, affective distress, and perceived support.  
Comparison of the pre-test and post-test scores indicated that the target variables, which included 
the Multidimensional Pain Inventory (MPI), changed in the expected direction and that this 
change was statistically significant.  Since the pain variable captured broader aspects of the pain 
experience it may be that the measured effect reflected improved sense of efficacy or coping 
rather than improvements in pain levels.  This study is also limited by a sample size of 25 and 
instead of a formal wait list or attention-control condition the treatment participants acted as the 
control condition prior to starting the treatment.  Future research directions based on the current 
study could include a pain measure, such as the MPI, in addition to intensity, duration, and 
frequency scales in order to gain a broader picture of the pain experience.   
Other researchers have chosen to examine pain with respect to coping behaviours or 
sense of control over pain rather than measuring intensity (Vlaeyen et al., 1996). This will be 
addressed in the discussion of the coping variables. 
Fordyce (1988; cited in Nicassio, 1997) noted that subjective pain and the functional 
effects of pain represent separate dimensions of the chronic pain problem.  Lack of improvement 
in subjective pain may not necessarily coincide with changes in psychological and behavioural 
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aspects of the condition.  Indeed, despite no improvement in pain ratings in the current study the 
impact of fibromyalgia on various aspects of life did improve.  It is important, therefore, to 
examine pain behaviours, functional factors, and mood symptoms in addition to pain ratings.  
For example, Nicassio et al. (1997) found that depressive symptoms and pain behaviours were 
markedly reduced despite subjective pain levels not improving across the trial.  This is indicative 
of the potential value of psychosocial treatments in treating mood disturbance and functional 
aspects of fibromyalgia.  
Functional Disability.  The intention-to-treat data did not support the hypothesis that the 
treatment condition would have a statistically significant reduction in functional disability 
compared to the control condition after controlling for time 1 scores.  Nor was there a significant 
difference at 3-month follow-up.  Nicassio et al. used the quality of well-being scale to assess the 
functional effect of fibromyalgia in a sample of 71 participants.  The scale measures symptoms, 
functioning mobility, social activity, and physical functioning.  This measure differs from the 
measure of disability in the current study, which is solely functionally based.  Nicassio et al. 
found no effect of condition or interaction of condition by time on the disability variable.  Nor 
did they observe a time effect.  Unfortunately there was not a wait list control condition in this 
study, instead they compared two treatment conditions (behavioural treatment versus education 
with group discussion/support).  Future studies could contribute to the area by including wait-list 
or attention-control conditions and by distinguishing between the contributions of particular 
interventions. 
After interacting with the participants in the current study and learning about their 
abilities and limitations, it is not surprising that there was not a treatment effect for functional 
disability based on the measure used.  The vast majority of patients were able to carry out these 
tasks without any difficulty, tasks such as lifting a glass to your mouth, washing/drying your 
body, and turning faucets on/off.  The items are rated from 0 to 3 (3 is ‘unable to do’ the activity) 
but the highest score was 1.88 and the pre-treatment mean was 0.62.  Therefore, pre-treatment 
status was likely not impaired enough on these tasks to show significant improvement.  The 
mean for the fibromyalgia participants was similar to that found by Lorig et al., 2001, in a large 
sample of chronic disease patients (M = 0.38, maximum 1.88).  Measures of fibromyalgia 
impact, used as the primary variable in the current study, may capture the effects of the 
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syndrome more specifically, since functional and social tasks, well-being, and severity of 
symptoms are assessed.  
Workdays missed.  The data did not support the hypothesis that the treatment condition 
would have a statistically significant reduction in workdays missed compared to the control 
condition after controlling for time 1 scores. Nor was there a significant difference at 3-month 
follow-up.  This is consistent with other findings; for example, in a sample of 79 participants 
Lemstra and Olszynski (2005) did not find statistically significant changes in work status in a 
multidisciplinary intervention condition compared to a control condition.  However, in the 
current study scores did improve and perhaps with a multiple-item measure and more power 
significant differences could have been detected.  It is important to assess work inside the home 
and ‘unpaid’ work such as babysitting grandchildren, for example, as many of the participants 
were not employed, on medical leave, or retired but had other responsibilities that fibromyalgia 
potentially interfered with.    
Health care utilization.  The data did not support the hypothesis that the treatment 
condition would have a statistically significant reduction in visits to their physician related to 
fibromyalgia compared to the control condition after controlling for time 1 scores. Nor was there 
a significant difference at 3-month follow-up.   
To my knowledge, health care utilization has not been examined in psychological 
treatment studies for fibromyalgia.  However, comparisons can be made to chronic pain 
literature.  Pfingsten et al., (1997) found a statistically significant reduction in physician visits 
from pre-treatment to 12-month follow-up in chronic low-back pain patients.  The multimodal 
treatment program included CBT and relaxation training.  The program was largely focused on 
functional restoration via stretching, and aerobic, strength, and endurance exercise.  It is possible 
that the intensive physical component of the treatment reduced physician visits either because 
symptoms improved and/or participants had the support of staff.  When concerns arose they may 
have enjoyed similar support/advice from staff that they would from their physician.  The same 
would not apply over the follow-up period, however.  Since the treatment was multimodal and 
largely functionally based, it is not possible to determine the effects of the psychological 
component on reductions in health care utilization.  Perhaps improved coping skills combined 
with the benefits of the exercise components led to greater self-efficacy and therefore less 
reliance on medical intervention.      
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Depression.  Depression was measured by the SCL90-R depression subscale and the FIQ 
depression item.  The data partially supported the hypothesis that the treatment condition would 
have a statistically significant reduction in depressive symptoms.  The FIQ data support the 
hypothesis for a treatment effect while the SCL90 data did not.  The improvement in depression 
measured by the FIQ was not maintained at follow-up. The FIQ measures only one item related 
to depression and it is rated on a 0-10 scale: ‘for the past week how depressed or blue have you 
felt.’  The SCL90 depression subscale is comprised of 13 items many of which are diagnostic 
and cover physical, cognitive and emotional symptoms.  It is possible that the 0-10 scale of the 
FIQ allowed for smaller improvements to be detected while assessing an overarching ‘blue’ 
feeling rather than other specific criteria related to the diagnosis of depression. 
The results of the literature regarding treatment effects on depression are mixed and 
drawing conclusions is difficult due to the variability in measures.  Gowans et al. (1999) also 
measured depression using the FIQ, following a combined exercise and education program.  At 
follow-up, they found that compared to a wait-list control group, participants in the treatment 
program showed a trend toward reduced depression.  Although it approached significance, it was 
not statistically significant.  Burckhardt et al. (1994) also measured depression using the FIQ but 
did not find a statistically significant treatment effect from pre- to post-treatment.  However, in 
the education and physical therapy condition there was a significant difference at follow-up.  
This difference was not observed in the education only condition.  Nicassio et al. (1997) found 
similar results using the Centre for Epidemiological Studies – Depression scale (CES-D) to 
measure depression.  There was no effect of treatment condition (behavioural vs. education 
control) on depression.  However, overall, there was a time effect such that there was a 
significant decrease in depression scores from pre- to post-treatment with maintenance of 
improvement at follow-up.  The authors hypothesize that the improvement in both conditions is 
due to a common therapeutic process related to provision of information and increasing sense of 
mastery.  In addition, the level of education was high in this sample and all participants had a 
support person participate in the study with them.  These differences and the lack of a wait-list 
control condition limit the ability to generalize the results.  Wigers et al. (1996) did not use the 
FIQ to measure depression; rather, they used a patient administered visual analogue scale.  Data 
analysis, according to the principle of intention-to-treat, showed no between-group differences 
on depression at post-treatment between the exercise, stress management, and control conditions.     
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In contrast, Lemstra and Olszynski (2005) and Nielson et al. (1992) found significant 
improvements on depression scores.  Lemstra and Olszynski assessed depression using the Beck 
Depression Inventory (BDI). The intervention condition had a statistically significant 
improvement in BDI scores compared to the control condition. The intervention condition 
maintained statistically significant change in BDI scores, but the degree of improvement was not 
compared to the control condition.  Neilson et al. assessed depression using the CES-D and 
found a significant improvement from pretest to posttest following a multidisciplinary program. 
Overall, the findings regarding symptoms of depression following treatment for 
fibromyalgia are mixed.  In some cases multidisciplinary treatment or the addition of exercise to 
an education based treatment may improve symptoms of depression.  The involvement of a 
support person during treatment and follow-up may also be a positive contributor (Burckhardt et 
al., 1994; Lemstra & Olszynski, 2005; Nielson et al., 1992).  More consistent use of validated 
measures to assess all facets of depression, including the cognitive, physical, and emotional 
symptoms as well as non-clinical symptoms of sadness or loss would contribute to the 
fibromyalgia treatment literature.       
Anxiety.  In the current study, anxiety was measured by the SCL90-R anxiety subscale 
and the FIQ anxiety item.  The psychometric strength of this subscale and the single item is less 
acceptable compared to other multi-item scales.  The data did not support the hypothesis that the 
treatment condition would have a statistically significant reduction in anxiety symptoms 
compared to the control condition.  
Although symptoms of anxiety were not a primary focus of the treatment, there was some 
focus on reducing worry, negative thinking, and catastrophizing, all of which could arguably 
contribute to feelings of anxiety.  There was also a great deal of focus on relaxation training.  
Treatment effects were observed for relaxation thus it could be speculated that increased 
relaxation may decrease anxiety.  However, the relaxation effect did not translate into improved 
measures of anxiety.  The SCL90 and FIQ assessed classic anxiety symptoms and perhaps did 
not capture other aspects of anxiety that may have been moderated by improvements in 
relaxation.  For example, the measures may not have captured anxiety related to illness, illness 
progression, or pain.  Future research may attempt to capture these illness related aspects of 
anxiety with alternative measures.    
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Burckhardt et al. (1994) found similar results such that the education condition did not 
significantly improve compared to the education/physical therapy condition or the control 
condition on the FIQ anxiety item from pre- to post-treatment.  However, at follow-up there was 
a significant improvement in the education/physical therapy condition.  The authors believe that 
this improvement was not observed at post-treatment due to the short (6-week) nature of the 
intervention and also because the exercise component may not have been vigorous enough.  
Whereas during the follow-up phase they found that many of the participants in that condition 
were doing more vigorous aerobic exercise 3 times a week.   
In contrast, Nielson et al. (1992) found a significant improvement from pretest to posttest 
in state trait anxiety following a multidisciplinary program.  Although scores changed in the 
direction of improvement from pre-treatment through to the 2.5-year follow-up, the improvement 
was not statistically significant (White & Nielson, 1995).  The small sample of 22 may have 
prevented the detection of significant change.   
In the future, examining illness related aspects of anxiety in fibromyalgia patients may 
capture symptoms related to progression of illness, role change, and loss of ability.  It may be 
that these concerns are not expressed as classic symptoms of anxiety but are poignant for 
fibromyalgia patients.  
Coping (wellness-focused, illness-focused, other).  The data partially support the 
hypothesis that the treatment condition would have a statistically significant improvement in 
coping compared to the control condition.  There was an improvement in the wellness-focused 
coping strategy of relaxation.  The treatment condition used relaxation to cope with pain 
significantly more than the control condition.  The use of relaxation as a coping strategy was 
maintained at follow-up.  Another wellness-focused strategy, called task persistence, 
distinguished the conditions.  However, the control condition used this strategy more than the 
treatment condition.  In the current study the treatment condition was taught ‘activity pacing’.  
Activity pacing is considered to be a key requirement for both increased activity tolerance and 
adaptive pain management (Hanson & Gerber, 1990; Nielson, Jenson, & Hill, 2001).  The goal 
of activity pacing is to avoid pain flare-ups and consequential days of inactivity by working on 
activities/errands in small stages with frequent breaks.  Patients were taught that in the long-term 
such a regime would allow them to be more productive, even with the breaks. Therefore, 
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‘persisting’ on a task is actually counter to the activity pacing philosophy and these results may 
indicate that patients in the treatment condition were applying the pacing philosophy. 
In terms of illness-focused coping strategies, the intention-to-treat data did not show a 
significant difference in ‘guarding a body part’.  The data did show a significant difference in 
‘resting’ at post-treatment.  However, the treatment condition was using resting to cope with pain 
significantly more than the control condition.  This may also be related to the activity pacing 
philosophy, since participants in the treatment condition were taught to take breaks and rest for 
short periods of time while doing activities and chores, particularly those that are physical.  In 
addition, participants in the treatment condition may have considered relaxation training with the 
CD, or visualization/imagery exercises as a form of ‘resting’.  In such cases it seems reasonable 
to consider resting as a wellness-focused strategy rather than an illness-focused strategy. 
The CPCI also assessed ‘seeking social support’ but this is considered neither a wellness-
focused nor an illness-focused strategy.  A treatment effect was not observed for this strategy nor 
was there a significant difference at follow-up.    
With respect to a comparison of coping strategy research findings, van Wilgen (2007) 
examined aspects of coping including catastrophizing, pain-coping, and internal and external 
pain control in a sample of 65 patients with fibromyalgia.  Catastrophizing improved 
significantly at post-treatment following a multidisciplinary program and this was maintained at 
follow-up.  However, the other coping strategies did not improve significantly.  The authors 
reported that catastrophizing is an important variable due to its positive relation to pain severity, 
affective distress, disability, and poor treatment outcome (Edwards et al., 2005).  Perhaps 
improvement in catastrophizing is a key factor in improving other domains.   
The CPCI, used to assess coping in the current study, does not include a catastrophizing 
subscale.  However, it seems reasonable to consider catastrophizing as an ‘illness-focused’ 
strategy.  In that sense the findings of van Wilgen following a multidisciplinary program are 
consistent on a broader level with the improvements in illness-focused coping (guarding and 
resting) found in the current study.   
Relaxation.  Relaxation was examined as a mental relaxation strategy using the CDQ and 
as a coping strategy using the CPCI.  As discussed above, relaxation (as a wellness-focused 
coping strategy) was used to cope with pain significantly more in the treatment condition 
compared to the control condition from pre- to post-treatment.  The difference between the 
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conditions remained significant at follow-up.  Also, the treatment condition used mental 
relaxation strategies significantly more than the control condition from pre- to post-treatment and 
a significant difference between the conditions was maintained at follow-up.  Although the 
difference maintained was significant, the number of times relaxation was used by the treatment 
condition decreased.  This also speaks to the importance of ‘booster’ sessions or long-term 
support in order to promote continued use of the skills learned during treatment.  Perhaps having 
an outside support person to report to would be helpful.  For example, if family physicians 
believe that practicing relaxation strategies improves functioning, they may ask patients how 
often they are practicing relaxation. Alternatively, an on-line group for participants following 
treatment may be helpful for reiterating the importance of the skills learned and supporting each 
other to maintain practice. An on-line log or journal outlining progress may help to motivate 
some participants.  Comparing the effectiveness of different types of booster sessions could 
provide a new avenue for future research.   
 In a sample of 131 patients with fibromyalgia, Vlaeyen et al. (1996) did not find a 
significant difference between conditions for relaxation, however, both the cognitive/education 
condition and the education/discussion control condition improved from pre-to post-treatment 
while the wait-list control condition did not.  Therefore, the cognitive treatment component did 
not contribute to improvement in relaxation skills above and beyond education/discussion.  It is 
plausible that education about the benefits of relaxation and the techniques would be adequate to 
improve relaxation skills in participants.  However, continuing to use the techniques over the 
long-term and during times of increased illness or stress is perhaps the greater challenge. This 
challenge may be better addressed by psychological interventions rather than a purely 
educational intervention.    
Self-efficacy.  The data support the hypothesis that the treatment condition would have a 
statistically significant increase in self-efficacy compared to the control condition after 
controlling for time 1 scores.  However, this was not maintained at 3-month follow-up. 
Prior to the study in 1994 conducted by Burckhardt et al., self-efficacy had not been 
measured in fibromyalgia clinical trials.  In that study, both interventions (education 
alone/comparable to CBT and education with physical therapy) resulted in significant 
improvements in self-efficacy compared to the control condition.  The differences between the 
two intervention conditions were not significant.  The authors reported that the most notable 
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change following the interventions was the change in self-efficacy.  At follow-up self-efficacy 
(pain related subscale) was significantly higher in the education and physical training condition.  
Although there was no difference between the intervention conditions at post-treatment the 
addition of physical training seemed to affect the participants over the follow-up period.  The 
participants continued their activity over this period and according to the authors many increased 
the rigor and frequency of exercise.  The activity may mediate efficacy but this may be a bi-
directional relationship.  Perhaps prior improvements in efficacy enabled improvements in health 
behaviour, i.e. exercise, and the increase in exercise in turn improved confidence and sense of 
control.  Indeed, there is strong evidence that changes in self-efficacy are enduring and affect 
changes in health behaviours and health status (Lorig et al., 1989).  In the current study, perhaps 
consistent practice of coping strategies, such as relaxation, over the follow-up period would have 
a similar mediating effect as exercise.  If the degree to which participants continued to practice 
coping strategies over the follow-up period was assessed, perhaps those who maintained or 
increased practice would, in turn, have more confidence in their ability to control symptoms and 
hence have greater self-efficacy.  Conversely, perhaps those with higher levels of self-efficacy 
post-treatment would be more inclined to continue to practice the coping strategies.    
Quality of life.  The data do not support the hypothesis that the treatment condition would 
have a statistically significant improvement in quality of life compared to the control condition 
after controlling for time 1 scores.  Nor was there a significant difference at 3-month follow-up.   
van Wilgen et al. (2007) assessed quality of life using the Short Form 36 Health Survey 
(SF-36).  They compared pre-treatment scores to a reference group (of the same age from the 
general population) and found that the initial scores on health related quality of life were 
significantly lower in fibromyalgia patients for all domains.  In six domains significant 
improvements were measured at follow-up: physical and emotional role limitations, mental 
health, vitality, pain, and health changes.  However, they remained lower than the reference 
group.  
Luedtke et al. (2005) also used the SF-36 to assess quality of life (Luedtke, personal 
communication, Jan. 11, 2008).  The mental health subscale and the physical function subscale 
improved from pre-treatment to 6-month follow-up and the improvements were stable at 12-
month follow-up. 
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 Burckhardt et al. (1994) found significant differences in quality of life for both treated 
conditions compared to the control condition.  There were no significant differences between the 
two treated conditions at post-treatment, but at follow-up, quality of life was significantly higher 
in the education and physical training condition.  Perhaps this finding is related to the self-
efficacy finding; with increased self-efficacy participants were better able to follow-through with 
health behaviours such as exercise.  With greater exercise participants may feel more control, 
pride, and higher levels of energy that may contribute to improved quality of life.  Although the 
post-treatment outcomes did not differ between conditions, the follow-up outcomes suggest that 
the addition of an exercise program is beneficial in improving long-term outcomes.  
 In the current study, almost half of the items on the quality of life measure focus on 
relationships and activities with others, for example, rearing children, helping others, and 
socializing.  In contrast, the measure included one item that is health focused (see Appendix I).  
Perhaps the intervention led participants to focus on other elements of quality of life that are not 
reflected in these relational items.  For example, strategies such as relaxation training and 
assertiveness are more individually focused.  Although they may be important in improving 
quality of life, the improvements may not be identified by the measure used.  The comparison 
studies assessed quality of life with different measures, which may be more sensitive to various 
aspects of the construct.     
Contributions of the Current Study 
  The aim of the current study was to expand on the fibromyalgia treatment literature by 
addressing the limitations of CBT for fibromyalgia.  A treatment manual was constructed, which 
consisted of important components of CBT for chronic pain and added an interpersonal process 
oriented approach.  The addition of this therapeutic approach was meant to address the 
idiosyncratic characteristics of fibromyalgia patients that have not been successfully addressed 
by existing cognitive-behavioural approaches.  The importance of addressing social and 
environmental context, sociocultural background, and the meaning of pain is well supported 
(Turk & Okifuji, 2002).  In particular, interpersonal roles and how they are shaped by significant 
others impact a person’s response to illness (Epker & Block, 2001; Romano et al., 1995; 
Schwartz, Slater, & Birchler, 1996).  These factors and their impact on coping with chronic pain 
can be addressed by an interpersonal therapy approach (Edworthy et al. 2003; Grzesiak et al, 
1996).   
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The current study also contributed to the literature by including a randomized controlled 
clinical trial.  There are few psychotherapy studies for fibromyalgia, cognitive-behavioural or 
otherwise, that are well designed.  That is, there are few studies that consist of an adequate 
control condition with adequate sample sizes.  Therefore, in the current study an attention-
control condition was compared to the treatment condition instead of a wait-list control or no 
control.  Also, significant recruitment efforts were made to accrue a reasonable number of 
participants resulting in a sample of 105 women with fibromyalgia. Importantly, only those 
patients who had received a diagnosis of fibromyalgia from a rheumatologist were eligible to 
participate. This is significant, since the literature includes some studies that did not use 
objective diagnostic inclusion/exclusion criteria.  In the current study, the participants were 
followed and assessed at 1-month and 3-months post-treatment.  A limitation of the current study 
is the short follow-up period.  A 6-month or 1-year follow-up would have contributed further to 
the literature.  However, with the resources available and the time constraints for completion of 
the research this was not possible.  By examining dropout rates and incomplete measures over 
time, it is likely that the return rate at long-term follow-up would be poor.  Additional resources 
would be necessary to improve return rates, either by calling participants to remind them, 
providing monetary or other incentives, or setting up a booster session in a convenient location 
that allowed additional time for completing questionnaires.    
Implications for Clinical Practice 
 The results of the current study have several implications for clinical practice with 
women diagnosed with fibromyalgia.  The intention-to-treat analysis allows us to generalize the 
results to a typical group of women entering treatment, rather than those who are more highly 
motivated to complete treatment or perhaps higher functioning.  The cognitive-behavioural and 
interpersonal treatment used in the current study was manualized, which enables others to 
provide the treatment.  Many chronic pain programs, and fibromyalgia programs specifically, are 
multidisciplinary.  The treatment used in the current study could be incorporated into 
multidisciplinary programs and the results may be more promising and/or longer lasting with 
more intense intervention and by incorporating physical activity and booster sessions during 
follow-up phases.     
 As demonstrated by the current study, the cognitive-behavioural and interpersonal group 
treatment can significantly decrease the impact of fibromyalgia symptoms, reduce symptoms of 
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depression, increase coping, promote use of relaxation strategies to cope with pain, and increase 
self-efficacy.  The timing of delivery of service may be an important area of study for the future.  
Perhaps newly diagnosed patients may benefit to a greater degree due to the extensive education 
about fibromyalgia that is provided by the treatment program.  Also, some less adaptive coping 
strategies and pain behaviours may be less apparent early on in the diagnosis and may be 
replaced more readily by adaptive coping strategies.  Earlier diagnosis and delivery of service 
may impact other variables of interest in the current study including workdays missed and health 
care utilization.  Presumably, the education and support provided by the treatment program 
would reduce the need for participants to see their family doctor regarding fibromyalgia related 
concerns.  Perhaps some of these visits to physicians could be replaced by visits to health care 
providers focusing on adopting health behaviours, maintenance of such behaviours, and 
addressing barriers to healthy changes/coping strategies using motivational interviewing 
techniques.    
Informing Theory of Fibromyalgia 
 Interacting with the participants in the current study provided valuable information 
towards understanding the effects of fibromyalgia.  The information further validates a 
biopsychosocial model for fibromyalgia.  Patients experience the syndrome in all aspects of life, 
including emotionally, spiritually, physically, and socially.  Their stories reflect biological 
changes, including early menopause, hysterectomy, injury, and illness. Many participants believe 
that the onset of the physiological symptoms of fibromyalgia is linked to these biological 
changes.  It is difficult to know how or whether these experiences are linked to allodynia and 
hyperalgesia or whether the biological changes, in some cases, precipitate the onset of symptoms 
to which they are predisposed due to central nervous system abnormalities.  The physiological 
symptoms are experienced differently across time based on the context and environment.  
Stressors, coping style, personality, mental health, social roles, and degree of support were 
important themes addressed by participants.  It is necessary to address the psychological and 
social context and its impact on the biological factors.  Patients develop patterns of coping and 
ways to express illness.  The length of time prior to diagnosis is likely important since these 
patterns are developed during a time of stress, when patients are worried about their health, 
uncertain about their diagnosis and prognosis, they may feel misunderstood or dismissed, and 
they may be frustrated by lack of support.  Similarly, duration of illness is important.  If less 
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adaptive coping strategies are employed for a longer duration they may become more entrenched 
and therefore more difficult to change with treatment.  Furthermore, the coping strategies 
themselves may alter the expression of symptoms or the development of the disorder.  For 
example, guarding a body part can result in altered biomechanics and chronic tension.  Thus, 
maladaptive attempts to cope can cause or exacerbate other problems.  These examples speak to 
the complexity of fibromyalgia syndrome and the importance of theorizing and designing 
interventions from a biopsychosocial framework.    
Limitations of the Current Study 
 Two main limitations of the current study are evident and both are in regards to 
comparison conditions.  First, it would be more informative to have additional comparison 
conditions.  That is, in addition to the combined cognitive-behavioural/interpersonal treatment 
condition and the attention-control condition, it would be ideal to have a treatment condition 
receiving the CBT alone and another condition receiving the interpersonal process therapy alone.  
The addition of these conditions would allow for examination of the specific contributions of 
each therapy type, and would also allow for discussion of whether the combined treatment is 
more effective than an individual treatment.  A limitation of the fibromyalgia treatment literature 
overall is the lack of well-designed trials and the use of multimodal or multidisciplinary 
programs in the absence of careful examination of the effectiveness of unimodal programs.  
Although a multidisciplinary approach to chronic pain is well documented, it seems to be critical 
to first examine the effectiveness of each individual component.  Otherwise, it is impossible to 
determine which components of a multidisciplinary program are effective and therefore 
determine where improvements need to be made.     
 Second, although the attention-control condition is a strength of the current study, it 
could be improved upon.  By including a more comprehensive attention-control condition the 
effects of the treatment could be more clearly observed above and beyond common factors or 
biases.  An attention-control condition that is able to mimic a treatment condition would allow 
for double-blind methodology in which case treatment expectancy effects could be accounted for 
more adequately.   
Adherence 
An additional limitation of the current study is that adherence to the program was not 
assessed.  This is more frequently done in exercise trials, however, practicing coping skills such 
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as relaxation exercises could be monitored.  In order to improve accuracy this could be done 
anonymously, but it would be helpful to identify the participants since this information could be 
used when examining treatment effects and long-term effects.  Adherence could be assessed with 
respect to homework completion and practicing skills.  For example, perhaps participants who 
continue to regularly practice relaxation exercises maintain treatment effects compared to those 
who do not.  Adherence could also be assessed with respect to participation in treatment.  For 
example, the results of those participants who attended all 8 sessions of the group therapy could 
be compared to those who missed two or more sessions.  
Expectancy Factors 
The expectations that participants have regarding the effects of the treatment could also 
be assessed and examined in light of treatment response.  It is possible that participants’ 
expectancies about the effectiveness of the treatment could impact their response to the 
treatment.  Those who believe that the therapists are competent, that the program was developed 
from existing effective programs, and that they will feel better after the program may actually 
improve to a greater degree than those who are skeptical about the program.  In order to assess 
expectancy effects, prior to starting treatment participants could be asked to rate their confidence 
in the treatment program and the degree to which they believe it will improve their symptoms or 
ability to manage their illness.  These ratings could be examined in relation to the outcome 
measures at post-treatment.  
Directions for Future Research 
It is important to consider differences across chronic pain disorders and to treat them, to 
some degree, as heterogeneous conditions.  When treating fibromyalgia, examining individual 
patient characteristics may also be important.  That is, it is likely inappropriate to view a group 
of patients with the same illness as a homogeneous group.   Researchers have identified subtypes 
of chronic pain patients and suggest that tailoring treatment based on these subtypes can improve 
treatment efficacy.  For example, coping styles can be used to identify subgroups and treatments 
can be tailored to various coping styles.  Turk and Okifuji (1998) suggest that pre-treatment 
patient characteristics are important predictors of treatment response and may serve as a basis for 
matching treatments to patient characteristics.    
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Efficacy of Treatment 
To improve efficacy of treatment, more intense clinical service may be beneficial.  When 
inpatient or day treatment programs are not possible an outpatient group that met more than once 
a week may be realistic (Stans et al., 1989).  Perhaps adding some individual follow-up sessions 
during and after treatment would increase treatment efficacy since identifying barriers to change, 
problem-solving, and motivational interviewing may be more feasible on an individual level.  
Also, some participants have unique stressors that may need special consideration.  For example, 
it may be more challenging for a mother of young children to fit in relaxation time.  Or in a 
troubled marriage it may be more difficult to practice assertiveness skills or activity pacing.   
Attrition 
The dropout rate in the current study was 5.71%.  When including the participants who 
did not withdraw but missed more than 2 of 8 sessions the rate was 9.52%.  In a review by 
Burckhardt (2006) the dropout range was 0-29% with an average of 12%.  Although the attrition 
rate in the current study is lower than this average this does not speak to the completion or rate of 
return of the assessment measures at each time period.   
It appears that the more individual time participants have with therapists/researchers 
improves adherence and completion.  Luedtke and colleagues (2005) noted that the participants 
found that the one-on-one time with the nurse to tell their stories was very meaningful.  It may be 
that the individual contact participants had with the researcher in the current study impacted the 
relatively good attrition rate.  However, in future studies it would be important to attempt to 
improve the completion rate of the questionnaires at post-test and follow-up.  If the location was 
more convenient it may be useful to ask participants to complete the questionnaires on-site. In 
addition, with adequate resources financial incentive could be provided and reminder phone-calls 
may also improve completion for packages that are mailed out.   
Logistics are also important to consider when attempting to reduce attrition or improve 
completion of assessment measures.  In the current study participants had to attend sessions at 
the university (except for the group that was conducted in Prince Albert).  Although the 
researcher made every effort to organize parking it did present difficulties for some participants.  
Some considered the parking lot to be too far away.  Finding closer parking was difficult.  In hot, 
cold, or slippery conditions the walk from the parking lot to the building was an issue for some.  
The cost of parking was covered for participants and this likely led to a larger enrollment since 
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cost was a consideration for many.  For those participants who did not drive, holding the sessions 
at the university was not a significant barrier since public transit to the university is good.  
However, the walk from the bus stop to the building was considered fair for some participants.  
The ideal would be a facility with free parking very close by, easily accessible by public transit, 
and minimal stairs and/or wheelchair accessible.      
Sex and Spousal Involvement 
The current study was limited to women with fibromyalgia because there was a concern 
that relatively few men diagnosed with fibromyalgia would participate.  Men are diagnosed with 
fibromyalgia less than women, and among men that would meet criteria for fibromyalgia it may 
be that alternative diagnoses are provided that appear more sex appropriate, such as chronic 
widespread pain, or regional pain disorder.  In addition, men may be less likely to seek treatment 
for fibromyalgia, especially in a group therapy setting.  There was concern that a group may 
consist of only one man or there would be a sex difference between groups in which some may 
have a male participant and others may not, potentially changing the dynamics of the group.  In 
future studies it would be informative to provide a similar group treatment for men with 
fibromyalgia.   
In addition, providing treatment to mixed groups and involving spouses/support persons 
in the treatment may be beneficial, particularly for maintaining progress over the long-term.  For 
example, a patient’s perception of spousal support may moderate the pain experience and 
associated depression (Goldberg, Kerns, & Rosenberg, 1993).  The effects of chronic pain are 
not limited to the individual with the diagnosis; rather, the family and social network can be 
affected.  Therefore, educating the primary support person about fibromyalgia and involving 
them in treatment can impact the roles taken in the home, elicitation of pain behaviours, use of 
adaptive coping skills, and understanding of activity pacing, relaxation training, and other coping 
skills.   
Summary 
The manualized group therapy for fibromyalgia syndrome that was developed for the 
current study is novel, in that it combined CBT and interpersonal therapy.  CBT is widely 
acknowledged as an empirically validated treatment for chronic pain conditions, including 
arthritis.  However, the results of the well-designed studies examining CBT for fibromyalgia 
show that, overall, CBT is not superior to a credible attention placebo (L. Bradley, personal 
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communication, 2002).  The aim of the current study, therefore, was to utilize the necessary 
components of CBT while adding the interpersonal approach with the goal of addressing factors 
that are idiosyncratic to fibromyalgia and that are better suited to a process based therapy rather 
than a therapy based on psycho-education.  CBT can be effective at addressing patients’ beliefs 
regarding their illness and how their beliefs influence emotional and behavioural factors.  For 
example, negative or unrealistic beliefs regarding pain can result in negative affect, pain, and 
reduced attempts to develop effective coping strategies (Okifuji and Turk, 1999).  There are 
additional factors that are critical in understanding the patients’ experience of living with chronic 
pain.  Interpersonal patterns and personality characteristics affect relationships and the quality of 
relationships can, in turn, affect symptoms and the ability to cope with illness.  The interpersonal 
therapy component of treatment provided a safe atmosphere for addressing the impact of the 
social and environmental context, including social support, social roles, and personal history. 
The results of the randomized-controlled trial show that the cognitive-behavioural and 
interpersonal approach was effective with respect to a number of meaningful variables, including 
fibromyalgia impact, coping, and self-efficacy.  The impact that fibromyalgia symptoms had on 
various aspects of participants’ lives was reduced.  This improvement was both statistically and 
clinically significant.  This finding is important since the improvement in fibromyalgia impact 
resulted from a psychological intervention alone, whereas similar findings in the literature 
resulted from more complex and resource intensive multidisciplinary programs.  Therefore, the 
cognitive-behavioural and interpersonal approach holds promise for improving impact of 
fibromyalgia symptoms in light of resource utilization considerations.   
Some improvement in mood was demonstrated, although not across all measures.  This is 
consistent with the literature; findings regarding depression following treatment for fibromyalgia 
are mixed.  More consistent use of validated measures to assess multiple facets of depression 
would be an important contribution.  Participants in the current study felt significantly less 
depressed or blue following treatment compared to the control condition.   
Notable improvements in coping strategies were observed following treatment.  Use of 
wellness-focused strategies, such as relaxation, increased while illness-focused strategies, such 
as guarding a body part, decreased.  Less guarding behaviour may reduce muscle tension, which 
can become chronic and exacerbate pain.  A philosophy and skill taught during treatment, called 
activity pacing, also appeared to have positive effects on other coping strategies such as task 
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persistence and resting.  Pacing may have reduced the tendency to persist on activities when in 
pain or fatigued and to use scheduled rest for short periods of time as a break from activity that 
may have otherwise led to an exacerbation of symptoms.   
Perhaps the most meaningful result of the current study is the improvement in self-
efficacy.  Self-efficacy beliefs have been related to pain, coping efforts, disability, and 
psychological functioning (Anderson et al., 1995; Buckelew et al., 1995; Jensen et al., 1999; 
Stroud et al., 2000; Turk & Okifuji, 1997; Turner, Jensen, & Romano, 2000).  In the future, the 
effectiveness of the combined cognitive-behavioural and interpersonal treatment for 
fibromyalgia will hopefully be improved upon by focusing on maintaining the treatment effects 
over the long-term.  Perhaps long-term maintenance of improvement on a number of outcomes 
could be mediated by further improvements in self-efficacy.  There is strong evidence that 
changes in self-efficacy are enduring and affect changes in health behaviours and health status 
(Lorig, 1989).  For example, self-efficacy may promote improvement in health behaviours such 
as exercise, relaxation training, and the continued practice of adaptive coping strategies.  The 
hope is that greater self-efficacy and positive health behaviour changes will improve people’s 
ability to manage fibromyalgia syndrome and enjoy a greater quality of life.   
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Description of a Selection of Fibromyalgia Intervention Studies 
 
Author Design Sample Intervention Intervention Format Outcome Measures Follow- Treatment Efficacy 
    Size       up (Significant Differences) 
Attention Placebo Controlled Trials     
Vlaeyen et al. RCT 131 1. experimental: education/cognitive 12 sessions over 6 weeks, knowledge of FM, pain coping, 12 mths Value of cognitive 
(1996)       (includes exercise) group format, max 6 people pain control, relaxation (CSQ),   treatment added to 
   2. attention control: education/discussion per group. Cognitive: 12, 90 catastrophizing (PCL), pain  group education 
       (includes exercise) min sessions. Education: intensity (MPQ) and behaviour,   was not supported. 
   3. wait-list control 12, 2-hr sessions.  depression (BDI)   
        
Nicassio et al. RCT 71 1. behavioural intervention 10 weeks, 90 min weekly, pain, pain behaviour, depression  6 mths No signif. differences 
(1997)   2. education/control group format, 3-7 people per (CES-DS), disability, pain coping  between conditions.   
    group (plus support persons (PMI), social support   
    in behavioural condition).    
        
Buckelew et al. RCT 119 1. biofeedback and relaxation training 6 weeks, 1.5-3 hrs weekly, tender point index, disease 2 yrs No signif. between group 
(1998)   2. exercise individual. 2-year group severity, pain behaviour, VAS,   differences among 
   3. combination therapy (1. and 2.) maintenance phase, once health status (AIMS), SCL90-R,  treatment groups. All  
   4. educational/attention control a month, 1hr. depression (CES-D), self-  treatment groups had 
     efficacy, sleep problems  improved self-efficacy 
       for function compared 
       to control.  
        
Keel et al. RCT 32 1. integrated group therapy (tx program 15 weeks. Group 1: weekly medication use, sleep, pain,  3 mths Changes in illness 
(1998)       includes: education, self-control 2-hr group sessions. Group  patient's global assessment,   parameters for 
       strategies, gymnastics, relaxation, 2: weekly 45-60 min general symptom checklist  experimental group 
       group discussion sessions.    overall were not signif 














Table 1 (continued) 
 
Description of a Selection of Fibromyalgia Intervention Studies 
 
Author Design Sample Intervention Intervention Format Outcome Measures Follow- Treatment Efficacy 
    Size       up (Significant Differences) 
Wait-list Controlled Trials      
Burckhardt et al. RCT 99 1. education (includes: coping strategies, 6 weeks. Education: 1.5 hr FM impact (FIQ), sense of control 12 wks No signif. between 
(1994)   problem solving, assertiveness, relaxation) self-management class (FAQ), quality of life (QOLS),   group difference from  
   2. education and physical therapy weekly. 5-6 people per  self-efficacy (SELF), physical  pre to post on FIQ 
   3. delayed treatment control group. Physical therapy: 1 hr fitness, tender points, depression  change score. Both  
    weekly of exercise training.  (BDI)  intervention groups 
        had signif. improvement  
       on quality of life and  
       self-efficacy. 
        
Wigers et al. RCT 60 1. aerobic exercise 14 weeks, 10 people per pain, sleep, fatigue (VAS), tender 4 yrs Exercise and stress 
(1996)   2. stress management (includes cognitive group. Exercise: 45 min,  point threshold, global subjective  management conditions 
       behavioural stress management package) 3 times per week. Stress improvement, depression (VAS)  showed positive short- 
   3. treatment as usual management: 90 min, 2   term effects. Exercise 
    times a week for first 6   overall most effective.  
    weeks, once a week for    No group differences at 
    remaining 8 weeks.   follow-up in symptom 
       severity between groups. 
        
Mason et al. CT 21 1. multimodal treatment (physical therapy, 1 month, full day program, tender point pain, pain intensity 6 mths Signif. improvement in 
(1998)       exercise, monitor medication, patient 6 days per week. CBT (VAS), coping skills (CSQ),   coping skills, depression, 
       education in cognitive-behavioural portion of treatment is FIQ, depression (BDI)  and subjective pain, 
           techniques) a 2 hr class daily.    maintained at follow-up. 
   2. control group    No treatment effects on 
       objective pain measures. 
        
Gowans et al. RCT 41 1. exercise and educational program 6 weeks. 2 multidisciplinary FM impact (FIQ), self-efficacy 3 or 6 Signif. improvement in  
(1999)   2. wait-list control group education sessions (ASES), knowledge mths well-being, fatigue, self- 
    per week, 1 hr, followed by  questionnaire, walk test  efficacy for symptom 
    an exercise class in the   control, and knowledge.  
    pool, 30 min.   follow-up gains in fatigue, 






Table 1 (continued) 
 
Description of a Selection of Fibromyalgia Intervention Studies 
 
Author Design Sample Intervention Intervention Format Outcome Measures Follow- Treatment Efficacy 
    Size       up (Significant Differences) 
Uncontrolled Trials       
Nielson et al. quasi- 25 1. inpatient cognitive-behavioural 3 weeks, inpatient.   target variables: pain severity,  Statistically signif. change 
(1992)/ experimental  treatment (relaxation, cognitive  perceived interference, 30 mths in target variables but not  
White & Nielson follow-up  techniques, exercise, pacing,  control over pain, emotional  nontarget variables from 
(1995)   family education, in vivo rehearsal)  distress. nontarget: perceived  pre to post. At follow-up 
   2. participants acted as their own  support, signif others' response  improvements in target 
   wait-list control group prior to  to pain, marital adjustment,   variables were maintained. 
   treatment  activity level   
        
Bennett et al. description 117 1. Multimodal approach: education, 6 months, group format, FM impact (FIQ), tender point 2 yrs Overall signif. improvement 
(1996) of treatment   behaviour modification, exercise,  90 min, once a week.  score, quality of life, coping  in all measures at post- 
 program  medication by injection for trigger  strategies, attitudes to illness,   treatment. At 2-year follow- 
   points, (some patients also received  aerobic conditioning, depression  up FIQ improvement 
   counselling and medication)  (BDI), anxiety (BAI)  stabilized and quality of life 
       continued to improve. 
        
Turk et al. pre, post, 67 1. interdisciplinary treatment: medical, 4 weeks. 3 half-day pain severity and interference 6 mths Signif. improvement in pain 
(1998) follow-up,  physical, psychologic (based on  session in first week, (MPI), depression (CES-D),   (severity, interference, 
 single group  cognitive-behavioural model), and 1 half-day session per perceived disability (ODI),  control, affectve distress) 
   occupational therapies week for next 3 weeks. marital adjustment (LWMAS)  and maintained at follow-up. 
    4-7 people per group.   FIQ (physical impairment,  
       fatigue, anxiety, depression) 
       improvements not maintained. 
       Relapse in fatigue.  
        
Creamer et al. pilot study, 28 1. education/cognitive-behavioural 8 weeks. 2.5 hr weekly FM impact (FIQ), sleep, health 4 mths Signif. improvement in FIQ total 
(2000) single group  component, relaxation/meditation, sessions. Each session:  status (RAND), depression  sleep, disability, some domains 
   and Chinese movement therapy 30 min education/CBT, (BDI), helplessness (FAI),   of health status, depression, and 
   (Qi Gong) 1 hr relaxation/meditation, coping (CSQ), functional  coping, tender points, pain 
    I hr Qi Gong.   disability (HAQ), physical  threshold. Improvements in  
     activity, tender points, pain  depression and some domains  







Table 1 (continued) 
 
Description of a Selection of Fibromyalgia Intervention Studies 
 
Author Design Sample Intervention Intervention Format Outcome Measures Follow- Treatment Efficacy 
    Size       up (Significant Differences) 
Uncontrolled Trials (continued)      
Worrel et al. quasi- 100 1. self-management approach includes 1 1/2 day program. FM impact (FIQ) and pain 1 mth Improvement in total FIQ score, 
(2001) experimental  education, stress management,  variables (MPI)  pain severity and interference. 
   relaxation, sleep hygeine, coping    FIQ benefits maintained at 
   skills, occupational and physical    follow-up. High pre-treatment 
   therapy    level of impairment associated 
       with better response to 
       treatment. 
        
Luedtke et al. description 1939 1. self-management approach includes 1 1/2 day program.  health status (HSQ) and 12 mths Signif. improvement in: impact 
(2005) of program  education, stress management,  FM impact (FIQ)  of FM (FIQ), mental health 
   relaxation, sleep hygeine, coping    and physical function (HSQ) 
   skills, occupational and physical    from pre to post and stable at  
   therapy    follow-up. 
        
Hooten et al. prospective 159 1. cognitive-behavioural group sessions, 3 weeks. 8 hrs daily pain (MPI), health status no Signif. improvements include: 
(2007) case series  physical and occupational therapy. for 15 consecutive (SF-36), coping (CSQ),  pain severity, interference,  
    working days.  depression (CES-D)  affective distress, life control, 
       social activity, perception of 
       health, physical function,  
       depression. 
        
Rooks et al. RT 135 1. aerobic and flexibility exercise 16 weeks. Exercise primary outcome: change 6 mths Signif. improvement in FIQ total 
(2007)   2. strength training, aerobic, flexibility sessions: 60 min twice in physical function.  score, social function, and  
   exercise weekly and additional secondary: social and  mental health in group 4   
   3. FM self-help course day weekly on own. FM emotional function,   compared to FM self-help alone. 
   4. combination of 2 and 3 course: 7 session, 120 symptoms, self-efficacy   








Table 1 (continued) 
 
Description of a Selection of Fibromyalgia Intervention Studies 
 
Author Design Sample Intervention Intervention Format Outcome Measures Follow- Treatment Efficacy 
    Size       up (Significant Differences) 
Uncontrolled Trials (continued)      
        
van Wilgen et al. prospective 65 1. education program: cognitive 7 sessions of education FM impact (FIQ), quality of 3 mths Signif. improvement from pre to 
(2007) single group  restructuring, goal setting,  and 25 sessions of  life (RAND), pain coping  post on domains of feeling good, 
 study  assertiveness training, relaxation, physical therapy. Groups and cognitions (PCCL),   pain, stiffness. Signif. improve- 
   and physical therapy sessions. of 8-12 for education and  pain and injury beliefs,   ment in catastrophizing from pre 
    4-6 for exercise.  step test, vertical row.   to post and pre to follow-up. No  
              changes in anxiety or depression. 
Note. CSQ = Coping Strategies Questionnaire; MPCL = Multidimensional Pain Locus of Control Scale; MPQ = McGill Pain Questionnaire; BDI = Beck Depression Inventory;  
CES-D = The Center for Epidemiological Studies-Depression Scale; PMI = PainManagement Inventory; VAS = Visual Analogue Scale; AIMS = Arthritis Impact Measurement  
Scales; SCL90-R = Symptom Checklist 90-Revised; FIQ = Fibromyalgia Impact Questionnaire; FAI = Fibromyalgia Attitudes Index; QOLS = Quality of Life Scale; SELF = Self- 
Efficacy Scale; BAI = Beck Anxiety Inventory; MPI = Multidimensional Pain Inventory; ODI = Oswestry Disability Index; LWMAS = Locke-Wallace Marital Adjustment Scale; RAND = 
36-item Health Survey; HAQ = Health Assessment Questionnaire; SF-36 = Short Form-36 Health Status Questionnaire; PCCL = Pain Coping and Cognition List.  








Demographic Characteristics of the Sample 
 
Variable       Treatment        Control            Total 
Age in years, M (SD)    51.91 (10.11)    53.04 (8.55)    52.44 (9.39) 
     N           54                    47                101 
  
Education in years, M (SD)    13.52   (2.20)    13.39 (2.76)    13.46 (2.48) 
     N           52                    51                103 
  
Ethnic Origin, N (%)       
     white      47 (87.00)       47 (94.00)       94 (90.40) 
     hispanic        3   (5.60)        0    (0.00)         3   (2.90) 
     asian        1   (1.90)        1    (2.00)         2   (1.90) 
     german        1   (1.90)        0    (0.00)         1   (1.00) 
     other        2   (3.70)        2    (4.00)         4   (3.90) 
  
Marital status, N (%)  
     married       39 (73.60)       34 (68.00)       73 (69.50) 
     single        6 (11.30)        2    (4.00)         8   (7.60) 
     divorced/separated        8 (15.10)       11 (22.00)       19 (18.10) 








Number of Participants Completing Measures at Four Time Points 
 
Condition Time 1 Time 2 Time 3 Time 4 
  (pre-treatment) (post-treatment) (1-month follow-up) (3-month follow-up)
     
Treatment 54 41 20 27 
     
Control 51 30 10 20 
     
Total 105 71 30 47 
          







Pre-treatment Means Comparing Questionnaire Responders to Non-responders 
 
      
Responders 
M        
Non-
responders 
M   
Variable Total n Treatment Control  Total n Treatment Control 
NPRS - Total 207.00 73 212.95 198.10 204.00 32 215.50 199.99
NPRS - Frequency 5.80 73 5.58 6.28 6.25 32 6.16 6.30
NPRS - Continuous* 78.00 73 66.39 95.69 99.21 32 95.58 100.87
FIQ - Total 54.77 73 55.51 53.65 56.00 32 64.85 52.07
FIQ - Work missed 3.00 73 2.73 3.40 2.10 32 3.86 1.29
ASES 4.88 73 4.60 5.32 4.58 32 3.55 5.05
Disability 0.57 73 0.58 0.55 0.67 32 0.74 0.64
Physician visits 3.73 73 3.53 4.03 3.65 32 4.90 3.07
SCL90-R - Anxiety 0.92 71 1.03 0.76 1.12 30 1.95 1.18
SCL90-R - Depression 1.58 71 1.61 1.52 1.44 30 1.61 0.72
QOLS - Total 71.32 69 73.03 68.50 74.86 30 74.55 75.02
CPCI - Coping 3.05 67 3.18 2.85 2.90 30 2.67 3.01
CPCI - Guarding 3.35 67 3.60 2.85 3.12 30 3.03 2.60
CPCI - Relaxing 1.23 67 1.12 1.40 1.21 30 2.19 1.73
CPCI - Task 4.62 67 4.46 4.88 5.01 30 4.48 5.28
CPCI - Asking 2.38 67 2.53 2.14 1.94 30 1.85 1.38
CPCI - Resting 3.19 67 3.34 2.95 2.74 30 4.17 2.71
CPCI - Support 2.52 67 2.51 2.53  1.93 30 1.90 1.89
Note. Responders are defined as those participants who responded to the questionnaires (completed  
the measures) at T1 and T2. Non-responders are those who completed the measure at T1 but not at T2. 
Asterisk denotes difference between responder total mean and non-responder total mean.  NPRS =  
Numerical Pain Rating Scale; FIQ = Fibromyalgia Impact Questionnaire; ASES = Arthritis Self Efficacy 
Scale; SCL90-R = Symptom Checklist 90 Revised; QOLS = Quality of Life Scale; CPCI = Chronic Pain  

















Number of Items with Missing Data and the Number of Mean Substitutions Performed  
for each Measure 
 
Measure  # of Participants # of Items with # of Mean    
(Total # of Items on Scale) with Blank Items Missing Data Substitutions 
FIQ (20)    
    Time 1 4 3 5 
    Time 2 5 2 5 
    Time 4 1 1 1 
    
NPRS (6)    
    Time 1 3 3 3 
    Time 2 1 1 1 
    Time 4 1 1 1 
    
CDQ (42)    
    Time 1 25 20 48 
    Time 2 16 15 30 
    Time 4 22 7 25 
    
SCL90-R (90)    
    Time 1 14 16 18 
    Time 2 6 7 7 
    Time 4 3 3 4 
    
QOLS (16)    
    Time 1 4 7 8 
    Time 2 2 2 2 
    Time 4 1 2 2 
    
CPCI (63)    
    Time 1 8 22 25 
    Time 2 8 8 8 
    Time 4 1 1 1 
Note. FIQ = Fibromyalgia Impact Questionnaire; NPRS = Numerical Pain 
Rating Scale; CDQ = Chronic Disease Questionnaire; SCL90-R = Symptom  
Checklist 90-Revised; QOLS = Quality of Life Scale; CPCI = Chronic Pain 
Coping Inventory.     
Table 6  
 
Cronbach’s Alphas, Mean Inter-Item Correlations, Means, and Standard Deviations for Scales 
 
Scale/Subscale Cronbach's Alpha M Inter-Item Scale M Scale SD Cronbach's Alpha M Inter-Item Scale M Scale SD
  T1 Correlation T1 T1 T1 T2 Correlation T2 T2 T2 
FIQ – Total 0.85 0.22 60.45 15.80 0.91 0.32 59.21 19.92
FIQ - Work missed*   2.75 3.34   2.44 2.82
NPRS – Total 0.75 0.43 206.87 60.42 0.83 0.54 204.11 70.57
NPRS – Frequency*   6.61 6.50   5.39 2.04
NPRS - Continuous*   84.49 67.73   79.32 74.11
Disability 0.84 0.40 5.75 3.45 0.86 0.44 4.43 3.51
ASES 0.86 0.44 38.28 13.33 0.92 0.60 47.61 15.58
Physician visits*   3.71 2.98   3.74 3.56
QOLS – Total 0.88 0.31 72.65 13.34 0.88 0.31 73.08 13.89
FIQ - Depression*         
SCL90-R - Depression 0.90 0.40 19.77 10.67 0.90 0.41 18.22 12.46
FIQ - Anxiety*         
SCL90-R – Anxiety 0.88 0.42 9.54 7.56 0.85 0.36 7.65 7.01
CPCI – Coping 0.89 0.41 33.32 19.22 0.87 0.37 35.78 18.39
Note. Based on original data, does not include the last observation carried forward. Asterisk denotes a single item. FIQ = Fibromyalgia Impact  
Questionnaire; NPRS = Numerical Pain Rating Scale; ASES = Arthritis Self-Efficacy Scale; QOLS = Quality of Life Scale; SCL90-R = Symptom 









Means, Standard Deviations, and F values for the Intention-to-Treat Comparison of the 
Treatment Condition and the Control Condition over Time 
 
Variable Group      Time 1      Time 2      Time 4 N F N F 
    M SD M SD M SD   t1 to t2   t2 to t4 
Primary Variable            
     FIQ total Treatment 57.37 15.38 51.24 19.28 54.00 18.02 54 4.39** 54 1.96 
 Control 53.23 15.36 52.70 15.70 53.96 13.86 51  51  
Secondary Variables            
     Pain            
           intensity Treatment 213.42 63.20 203.01 68.90 201.30 75.33 54 0.97 54 0.63 
 Control 199.21 56.63 203.86 66.57 198.43 62.85 50  51  
            
           frequency* Treatment 5.69 1.99 5.25 2.12 5.33 2.21 54 2.56 54 0.68 
 Control 6.34 1.48 6.12 1.50 5.98 1.67 50  50  
            
           duration Treatment 71.80 65.07 70.12 69.46 72.13 68.18 54 2.36 53 0.01 
 Control 97.93 68.53 103.57 72.03 89.19 74.83 50  50  
            
     Functional disability Treatment 0.61 0.48 0.58 0.46 0.54 0.48 54 0.50 54 2.61 
 Control 0.59 0.46 0.60 0.44 0.63 0.56 51  51  
            
     Work missed* Treatment 2.94 3.56 1.65 2.13 1.86 2.34 54 0.09 54 0.28 
 Control 2.55 3.08 1.59 1.73 1.89 2.03 51  51  
            
     Health care utilization* Treatment 3.65 2.68 3.74 3.02 3.56 3.15 54 0.08 53 0.02 
 Control 3.63 2.65 3.57 3.47 3.62 3.55 51  51  
            
     Depression            
           FIQ* Treatment 4.44 2.95 3.76 2.82 4.13 2.68 54 5.44** 54 0.64 
 Control 3.64 2.52 3.92 2.47 3.90 2.54 51  51  
            
           SCL90-R Treatment 1.68 0.89 1.51 0.97 1.56 0.94 53 0.51 51 1.21 
 Control 1.41 0.76 1.36 0.78 1.44 0.76 45  43  
            
     Anxiety            
           FIQ* Treatment 5.27 2.81 4.80 2.80 4.98 2.75 54 1.11 54 1.15 
 Control 4.06 2.70 4.27 2.68 4.49 2.54 51  51  
            
           SCL90-R Treatment 1.14 0.80 1.06 0.81 1.00 0.72 53 1.18 51 0.05 







Table 7 (continued) 
 
Means, Standard Deviations, and F values for the Intention-to-Treat Comparison of the 
Treatment Condition and the Control Condition over Time 
 
Variable Group      Time 1      Time 2      Time 4 N F N F 
    M SD M SD M SD   t1 to t2   t2 to t4 
Secondary Variables            
     Coping            
           self-statements Treatment 3.08 1.84 3.25 1.65 3.09 1.90 51 0.37 46 0.01 
 Control 2.94 1.64 3.11 1.70 2.91 1.58 46  41  
            
           task persistence Treatment 4.46 1.92 4.15 1.79 4.33 1.99 49 6.00** 46 1.04 
 Control 5.04 1.32 5.17 1.31 5.12 1.39 42  41  
            
           relaxation Treatment 1.96 1.37 3.23 1.51 2.53 1.57 49 28.63*** 46 4.10** 
 Control 2.01 1.51 197.00 1.71 2.06 1.63 42  41  
            
           guarding Treatment 3.22 2.13 3.03 1.81 2.71 1.64 49 0.01 46 6.04** 
 Control 2.76 1.51 2.68 1.64 2.88 1.76 42  41  
            
           asking for help Treatment 2.16 1.92 2.46 1.94 2.34 1.95 49 1.01 46 0.26 
 Control 1.65 1.52 1.77 1.67 1.79 1.59 42  41  
            
           resting Treatment 3.89 1.64 4.04 1.44 3.83 1.70 49 10.74** 46 2.6 
 Control 3.03 1.42 2.75 1.62 2.79 1.49 42  41  
            
           seeking support Treatment 2.36 1.46 2.57 1.60 2.40 1.60 49 1.18 46 0.15 
 Control 2.15 1.46 2.23 1.49 2.33 1.46 42  41  
            
     Relaxation (CDQ) Treatment 3.39 4.33 8.80 10.21 6.07 8.55 54 16.05*** 54 3.80** 
 Control 5.10 13.43 4.06 8.16 5.16 13.61 51  51  
            
     Self-efficacy Treatment 4.40 1.63 5.80 2.18 5.24 2.03 54 11.51*** 54 3.29 
 Control 5.14 1.66 5.32 1.70 5.33 1.60 51  51  
            
     Quality of life Treatment 73.32 12.11 74.80 14.58 73.43 15.20 52 0.23 47 0.26 
  Control 71.42 14.88 72.58 11.07 72.93 10.52 42   41   
Note. The means and standard deviations for time 2 and time 4 are based on the ANCOVA results. * indicates a 
single item. **indicates a statistically significant result (p = or < 0.05), ***indicates a statistically significant result 
(p = or < .001). FIQ = Fibromyalgia Impact Questionnaire, SCL90-R = Symptom Checklist 90-Revised, CDQ = 



















Recruitment Effort List 
 
1. Contacted rheumatologists in Saskatoon by letter.  
2. Followed up with phone calls and emails. 
3. Dr. Markland offered to help me and we did a mail out from her office to approximately 
350 patients. One letter was from Dr. Markland endorsing the study while the other was 
from Melanie Langford and Michael MacGregor inviting people to participate and to 
contact us.  
4. Posters were placed at RUH, St. Paul’s hospital and City Hospital.  
5. The Fibromyalgia Society was contacted and I spoke at one of their meetings at RUH. 
One of the coordinators offered to place my letters in her next mail out to the members.  
6. I spoke with Dr. Pancyr and he spoke to a rheumatologist, Dr. Sibley for me. Dr. Sibley 
invited me to speek at one of the rheumatologist’s meetings at RUH. I described the study 
and asked if anyone would be interested in helping me with recruitment. I provided a 
number of options, with an emphasis on making it as convenient for them as possible. I 
did not have offers of help from any of the other rheumatologists present at the meeting.  
7. Dr. Sibley took some of my posters and letters to distribute to the rheumatologists that 
were not present. 
8. I followed up by phone with Dr. Sibley and others. 
9. Efforts to contact Dr. Joe Schnurr via phone and email. I met him at the Fibromyalgia 
Grand Rounds and spoke with him about the research. 
10. Efforts to contact Dr. Epstein, also involved with the Grand Rounds. 
11. Spoke with a physiotherapist at the Pain Clinic downtown, and also placed posters there. 
The physiotherapist said that she would hand out letters to patients. 
12. I have posters in a couple of psychology private practice settings.  
13. Placed posters in the arts tunnel.  
14. I have been to some chiropractic/exercise facilities with posters. 
15. I have asked participants whether they would mind letting other people know about the 
study. One participant distributed letters to a health cooperative that she is involved in. 
16. Met with Angela Busch, researcher in physical therapy, provided recruitment suggestions 
and is kindly allowing me to do a mail out from her office to 81 of her participants with 
fibromyalgia who consented to be contacted in the future. 
17. Spoke with Dr. M. Z. Hussain in Prince Albert, he runs a fibromyalgia clinic there and 
passed on letters to 50-60 people and placed posters in waiting area. 
18. Sent a package to Dr. Joe Schnurr and he placed posters in 2 offices and is going to tell 
patients about the study and pass on letters to them. 
19. A mail out was done to all family physicians/GPs in Saskatoon, Prince Albert, and 
surrounding areas with information about the study and posters.  
20. Advertising in the Sheaf, Saskatoon Sun, and Star Phoenix. Newspaper article was also 





The CONSORT Flowchart Depicting Passage of Participants through the Study 
 
 










Assessed for eligibility 
(n = 118) 
Excluded (n = 13) 
 
Not meeting inclusion criteria  
(n = 4) 
Declined to participate or unable 
for other reasons (e.g. schedule, 
transportation, illness)  
(n = 9) 
Analyzed (n = 54) 
Excluded from analysis (n = 0) 
When data was missing for a time 
period the last observation was 
carried forward for intention-to- 
treat analysis. 
Lost to follow-up 
t2 (n = 13) 
t3 (n = 34) 
t4 (n = 27) 
Allocated to treatment (n = 54) 
 
Received allocated intervention  
(n = 44) 
Did not receive allocated intervention 
(n = 10) 
Lost to follow-up 
t2 (n = 21) 
t3 (n = 41) 
t4 (n = 31)
Allocated to attention-control (n = 51) 
 
Received allocated intervention  
(n = 50) 
Did not receive allocated intervention 
(n = 1) 
Analyzed (n = 51) 
Excluded from analysis (n = 0) 
When data was missing for a time 
period the last observation was 
carried forward for intention-to- 










Fibromyalgia Impact Questionnaire (FIQ) 
Name: _________________________________     Date:  
 
Directions: For questions 1 through 11, please circle the number that best describes how you 
did overall for the past week. If you don't normally do something that is asked, cross the question 
out. 
  
     Always   Most       Occasionally        Never 
 
Were you able to: 
 
Do shopping? ……………………………   0    1  2   3  
 
Do laundry with a washer and dryer? ......    0    1  2   3  
 
Prepare meals? ........................................     0    1  2   3  
 
Wash dishes/cooking utensils by hand?….. 0    1  2   3  
 
Vacuum a rug?...........................................   0    1  2   3 
 
Make beds? ...............................................   0    1  2   3  
 
Walk several blocks? ................................   0    1  2   3  
 
Visit friends or relatives? ........................... 0    1  2   3  
 
Do yard work?..........................................… 0    1  2   3 
 
Drive a car? ...............................................  0    1  2   3 
 





12. Of the 7 days in the past week, how many days did you feel good? 
 





13. How many days last week did you miss work, including housework, because of fibromyalgia? 
 





Directions: For the remaining items, mark the point on the line that best indicates how you felt 
overall for the past week. 
 
14. When you worked, how much did pain or other symptoms of your fibromyalgia interfere with your ability 
to do your work, including housework?  
 
●___І ___І___І ___І___І ___І ___І ___І ___І___● 
 




15. How bad has your pain been?  
 
 
●___І ___І___І ___І___І ___І ___І ___І ___І___● 




16. How tired have you been? 
 
●___І ___І___І ___І___І ___І ___І ___І ___І___● 




17. How have you felt when you get up in the morning? 
 
●___І ___І___І ___І___І ___І ___І ___І ___І___● 




18. How bad has your stiffness been? 
 
●___І ___І___І ___І___І ___І ___І ___І ___І___● 




19. How nervous or anxious have you felt? 
 
●___І ___І___І ___І___І ___І ___І ___І ___І___● 




20. How depressed or blue have you felt? 
 
●___І ___І___І ___І___І ___І ___І ___І ___І___● 





Numerical Pain Rating Scale (NPRS) 
Please rate your pain on the following 0 to 100 scales by checking one box that best represents 
your pain on each scale.  
0 represents ‘no pain’ and 100 represents ‘worst possible pain’. 
For example, less than 30 may be mild, 50 is moderate, and above 70 is severe pain.  
 
 
Rate your worst pain.  
                     
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
 
 
Rate your pain today. 
                     
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
 
 
Rate your least pain. 
                     
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
 
 
Rate your average (or usual pain) over the last 2-week period. 
                     




Please indicate the number of days that you have experienced pain within the last week. You 





Please indicate the longest length of time that you have experienced non-stop or continuous pain 
within the last week.  
If the continuous pain lasted less than 60 minutes, write the number in minutes. 
If the continuous pain lasted more than 60 minutes, write the number in hours (you can use half 
hours). 
Or, if the continuous pain lasted more than 24 hours (a day) write the number in days (you can 
use half days).  




Chronic Disease Questionnaire (CDQ) 
Stanford Patient Education Research Center, Stanford University School of Medicine 
 
1. Ethnic origin (check only one):  
 
 __ White not Hispanic __ Asian or Pacific Islander  
 __ Black not Hispanic __ Filipino 
 __ Hispanic __ American Indian/Alaskan Native 
   __ Other:   
 
 
2. Please circle the highest year of school completed: 
 
 1  2  3  4  5  6     7  8  9  10  11  12     13  14  15  16     17  18  19  20  21  22     above 22 
           (primary)             (high school)            (college)            (graduate school)   
 
 
3. Are you currently (check only one): 
 
 __ married            __ separated           __ widowed           __ single           __ divorced  
 
 
4. Other than fibromyalgia do you have any other health problems? __  No __ Yes  
   If yes, what are they?   
 
 
5. In general, would you say your health is: (Circle one) 
  Excellent ...................1 
  Very good..................2 
  Good..........................3 
  Fair ............................4 















6. How much time during the past 2 weeks... 
 
  None A little Some A good Most All 
  of the of the of the bit of the of the of the 
  time time time time time time 
 
a. Were you discouraged by your  
 health problems? 0 1 2 3 4 5 
 
b. Were you fearful about your  
 future health? 0 1 2 3 4 5 
 
c. Was your health a worry 0 1 2 3 4 5 
 in your life? 
 
d. Were you frustrated by your  
 health problems? 0 1 2 3 4 5 
 
7. In the past week (even if it was not a typical week) how many times did you practice a 
mental relaxation exercise?  
__  None, OR _______ times   
 






8. During the past week, even if it was not a typical week, how much total time (for the entire 
week) did you spend on each of the following?  (Please circle one number for each question.) 
 
   less than 30-60 1-3 hrs more than 
  none 30 min/wk min/wk per week 3 hrs/wk 
a. Stretching or strengthening exercises 
 (range of motion, using weights, etc.)..............0 1 2 3 4 
 
b. Walk for exercise .............................................0 1 2 3 4 
 
c. Swimming or aquatic exercise .........................0 1 2 3 4 
 
d. Bicycling (including stationary exercise bikes)0 1 2 3 4 
 
e. Other aerobic exercise equipment 
 (stairmaster, treadmill, elipse, etc.)..................0 1 2 3 4 
 
f. Other aerobic exercise 
 Specify_________________________ ...........0 1 2 3 4 
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9. We are interested in learning whether or not you are affected by fatigue.  Please circle the 
number below that describes your fatigue in the past 2 weeks: 
 
           0      1       2       3       4      5       6       7       8       9     10
          No                                                                                                Severe
       fatigue                                                                                             fatigue
 
10. We are interested in learning whether or not you are affected by pain.  Please circle the 
number below that describes your pain in the past 2 weeks. 
 
 
11. During the past 2 weeks, how much...(Circle one) 
             Not                                 Quite   Almost 
  at all Slightly Moderately    a bit      totally 
a. Has your fibromyalgia interfered  
 with your normal social activities with family, 
 friends, neighbors or groups? ...............................0 1 2 3 4 
 
b. Has your fibromyalgia interfered  
 with your hobbies or recreational activities?........0 1 2 3 4 
 
c.  Has your fibromyalgia interfered  
 with your household chores?................................0 1 2 3 4 
 
d. Has your fibromyalgia interfered   
 with your errands and shopping?..........................0 1 2 3 4 
 
           0       1       2      3       4      5       6       7       8       9     10
          No                                                                                        Severe
         pain                                                                                        pain 
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12. Please circle the number that best matches your abilities. 
 
 Without With With  
At this moment, are you able to: ANY SOME MUCH UNABLE 
 difficulty difficulty difficulty to do                         
a.  Dress yourself, including tying     
   shoelaces and doing buttons? ……………………. 0 1                  2                    3 
  
b. Get in and out of bed? ....................................... 0 1 2 3 
 
c. Lift a full cup or glass to your mouth?.................. 0 1 2 3 
 
d. Walk outdoors on flat ground? ............................ 0 1 2 3 
 
e. Wash and dry your entire body? ...............................0 1 2 3 
 
f. Bend down to pick up clothing from the floor?........0 1 2 3 
 
g. Turn faucets on and off? ...........................................0 1 2 3 
 
h. Get in and out of car?……………………………….0 1 2 3 
 
 
13. For each of the following questions, please circle the number that corresponds to how 
certain you are that you can do the following tasks regularly at the present time. 
 
a. How certain are you that you can ___________________________ 
 decrease your pain quite a bit?  very | | | | | | | | | | very 
  uncertain 1 2 3 4 5 6 7 8 9 10 certain 
 
b. How certain are you that you can ___________________________ 
 keep your fibromyalgia pain from very | | | | | | | | | | very 
 interfering with your sleep?  uncertain 1 2 3 4 5 6 7 8 9 10 certain 
  
 
c. How certain are you that you can ___________________________ 
 keep your fibromyalgia pain from  very | | | | | | | | | | very 
 interfering with the things you  uncertain 1 2 3 4 5 6 7 8 9 10 certain 
 want to do? 
 
 
d. How certain are you that you can ___________________________ 
 regulate your activity so as to be   very | | | | | | | | | | very 





e. How certain are you that you can ___________________________ 
 keep the fatigue caused by your    very | | | | | | | | | | very 
 disease from interfering with the uncertain 1 2 3 4 5 6 7 8 9 10 certain 
 things you want to do? 
 
f. How certain are you that you can ___________________________ 
 do something to help yourself feel    very | | | | | | | | | | very 
 better if you are feeling blue? uncertain 1 2 3 4 5 6 7 8 9 10 certain 
  
g. As compared with other people with ___________________________ 
 fibromyalgia, how certain are you very | | | | | | | | | | very 
 that you can manage pain during uncertain 1 2 3 4 5 6 7 8 9 10 certain 
 your daily activities? 
 
h. How certain are you that you can ___________________________ 
 deal with the frustration of  very | | | | | | | | | | very 
 fibromyalgia? uncertain 1 2 3 4 5 6 7 8 9 10 certain 
  
14. In the past 4 months, how many times did you visit a physician? 
 Do NOT include visits while in the hospital or hospital emergency room....__________ visits 
 
15. In the past 4 months, how many TIMES were you hospitalized 
 for one night or longer?..................................................................................__________ times 
 
16. How many total NIGHTS did you spend in the hospital in the 
 past 4 months? ..............................................................................................__________nights  
 
17. Please list each medication you took for pain during the past week, and indicate 
      the number of days you took each medication during the past week. Some common 
      medications taken for pain are: Aspirin, Tylenol®, Advil®, Nuprin®, Naprosyn®,  
      Percodan®, Tylenol #3®, Valium®, Soma®, Fiorinal®, and Flexeril®. However,  
      there are many others, so please list ALL of the medications you are taking for pain, 
      not just the ones listed above.  
      …………………………………………………………………………………0 1 2 3 4 5 6 7 
      …………………………………………………………………………………0 1 2 3 4 5 6 7 
      …………………………………………………………………………………0 1 2 3 4 5 6 7 
      …………………………………………………………………………………0 1 2 3 4 5 6 7 
      …………………………………………………………………………………0 1 2 3 4 5 6 7 





Symptom Checklist 90-Revised (SCL90-R) 
Below is a list of problems people sometimes have.  Please read each one carefully, and on the 
accompanying answer sheet fill in the answer that best describes HOW MUCH THAT 
PROBLEM HAS DISTRESSED OR BOTHERED YOU DURING THE PAST 7 DAYS 
INCLUDING TODAY.  Only provide one answer for each problem. Please do not skip any 
items. 
 
  Not at All     A little bit     Moderately     Quite a bit     Extremely 
       0          1           2               3             4 
 
HOW MUCH WERE YOU DISTRESSED BY… 
 
1. Headaches 
2. Nervousness or shakiness inside. 
3. Repeated unpleasant thoughts that won’t leave your mind. 
4. Faintness or dizziness. 
5. Loss of sexual interest or pleasure. 
6. Feeling critical of others. 
7. The idea that someone else can control your thoughts. 
8. Feeling others are to blame for most of your troubles. 
9. Trouble remembering things. 
10. Worried about sloppiness or carelessness. 
11. Feeling easily annoyed or irritated. 
12. Pains in heart or chest. 
13. Feeling afraid in open spaces or on the streets. 
14. Feeling low in energy or slowed down. 
15. Thoughts of ending your life. 
16. Hearing voices that other people do not hear. 
17. Trembling. 
18. Feeling that most people cannot be trusted. 
19. Poor appetite. 
20. Crying easily. 
21. Feeling shy or uneasy with the opposite sex. 
22. Feelings of being trapped or caught. 
23. Suddenly scared for no reason. 
24. Temper outbursts that you could not control. 
25. Feeling afraid to go out of your house alone. 
26. Blaming yourself for things. 
27. Pains in lower back. 
28. Feeling blocked in getting things done. 
29. Feeling lonely. 
30. Feeling blue. 




Not at All     A little bit     Moderately     Quite a bit     Extremely 
   0   1    2        3                 4 
 
32. Feeling no interest in things. 
33. Feeling fearful. 
34. Your feelings being easily hurt. 
35. Other people being aware of your private thoughts. 
36. Feeling others do not understand or are unsympathetic. 
37. Feeling that people are unfriendly or dislike you. 
38. Having to do things very slowly to insure correctness. 
39. Heart pounding or racing. 
40. Nausea or upset stomach. 
41. Feeling inferior to others. 
42. Soreness of your muscles. 
43. Feeling that you are watched or talked about by others. 
44. Trouble falling asleep. 
45. Having to check and double-check what you do. 
46. Difficulty making decisions. 
47. Feeling afraid to travel on buses, subways, or trains. 
48. Trouble getting your breath. 
49. Hot or cold spells. 
50. Having to avoid certain things, places, or activities because they frighten you. 
51. Your mind going  blank. 
52. Numbness or tingling in parts of your body. 
53. A lump in your throat. 
54. Feeling hopeless about the future. 
55. Trouble concentrating. 
56. Feeling weak in parts of your body. 
57. Feeling tense or keyed up. 
58. Heavy feelings in your arms or legs. 
59. Thoughts of death or dying. 
60. Overeating. 
61. Feeling uneasy when people are watching or talking about you. 
62. Having thoughts that are not your own. 
63. Having urges to beat, injure, or harm someone. 
64. Awakening in the early morning. 
65. Having to repeat some actions such as touching, counting, or washing. 
66. Sleep that is restless or disturbed. 
67. Having urges to break or smash things. 
68. Having ideas or beliefs that others do not share. 
69. Feeling very self-conscious with others. 
70. Feeling uneasy in crowds, such as shopping or at movies. 
71. Feeling every thing is an effort. 
72. Spells of terror or panic. 
73. Feeling uncomfortable about eating  or drinking in public. 
74. Getting into frequent arguments. 
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Not at All     A little bit     Moderately     Quite a bit     Extremely 
         0         1           2               3             4 
 
75. Feeling nervous when you are left alone. 
76. Others not giving you proper credit for your achievements. 
77. Feeling lonely even when you are with people. 
78. Feeling so restless you couldn’t sit still. 
79. Feelings of worthlessness. 
80. The feeling that something bad is going to happen to you. 
81. Shouting or throwing things 
82. Feeling afraid you will faint in public. 
83. Feeling that people will take advantage of you if you let them. 
84. Having thoughts about sex that bother you a lot. 
85. The idea that you should be punished for your sins. 
86. Thoughts and images of a frightening nature. 
87. The idea that something is seriously wrong with your body. 
88. Never feeling close to another person. 
89. Feelings of guilt. 






Chronic Pain Coping Inventory (CPCI) 
 
During the past week, how many days did you use each of the following, at least once a day, to 
cope with your pain? Note: you may have used some of these coping strategies on days that you 
did not have pain, to prevent or minimize pain in the future. On the accompanying answer sheet, 
please fill in the answer corresponding to the number of days you used each strategy FOR PAIN, 
whether or not you were experiencing pain at the time. 
 
Number of days 
0   1   2   3   4   5   6   7 
          
107. Imagined a calming or distracting image to help me relax               
108. Kept on doing what I was doing      
109. Stretched the muscles in my legs and held the stretch for at least 10 seconds   
110. Ignored the pain     
111. I took a rest     
112. Made arrangements to see a friend or family member     
113. I went to bed early to rest     
114. I got support from a friend     
115. Asked someone to do something for me     
116. Reminded myself that things could be worse      
117. Avoided using part of my body     
118. Focused on relaxing my muscles     
119. Sat on the floor, stretched, and held the stretch at least 10 seconds     
120. Told myself things will get better     
121. Held on to something when getting up or sitting down     
122. I got support from a family member     
123. Exercised to strengthen the muscles in my arms for at least 1 minute     
124. I rested as much as I could      
125. Thought about someone with problems worse than mine     
126. I talked to someone close to me     
127. Told myself that I am adjusting to my pain problem better than many other people   
128. Called a friend on the phone to help me feel better     
129. Thought about all the good things I have     
1304. Listened to music to relax     
131. Asked for help with a chore or task     
132. Stretched the muscles in my neck (and held the stretch) for at least 10 seconds   
133. Told myself my pain will get better     








Number of days 
0   1   2   3   4   5   6   7 
 
135. Exercised to strengthen the muscles in my legs for at least 1 minute     
136. Thought about a friend who has coped well with a problem     
137. Listened to a relaxation tape to relax     
138. Engaged in aerobic exercise (that made my heart beat faster) for at least 15 minutes  
139. Limited my walking because of pain      
140. Just didn’t pay attention to the pain     
141. Walked with a limp to decrease the pain 
142. Meditated to relax     
143. Reminded myself that I had coped with the pain before     
144. Lay on my back, stretched, and held the stretch for at least 10 seconds    
145. Held part of my body (e.g. arm) in a special position     
146. Rested in a chair or recliner     
147. Avoided putting weight on feet or legs     
148. Asked for help in carrying, lifting, or pushing something     
149. Exercised to improve my overall physical condition for at least 5 minutes    
150. Talked to a friend or family member for support     
151. Reminded myself that there are people who are worse off than I am     
152. Limited my standing time     
153. Lay down on a bed     
154. Avoided some physical activities (lifting, pushing, carrying)     
155. Reminded myself about things that I have going for me such as intelligence, good looks,  
       and good friends  
156. Used self-hypnosis to relax     
157. I just kept going     
158. Exercised to strengthen the muscles in my stomach for at least 1 minute   
159. Got together with a friend     
160. Reminded myself that others have coped well with pain problems     
161. Stretched the muscles where I hurt and held the stretch for at least 10 seconds   
162. Avoided activity     
163. Got together with a family member     
164. Went into a room by myself to rest     
165. Used deep, slow breathing to relax     
166. Exercised to strengthen the muscles in my back for at least 1 minute     
167. Stretched the muscles in my shoulders or arms and held it for at least 10 seconds  
168. Asked someone to get me something (e.g. medicine, food, drink)     
169. Did not let the pain affect what I was doing     




Quality of Life Scale (QOLS) 
 
Please read each item and use the scale below to describe how satisfied you are with each item. 
Fill in the answer that best describes how satisfied you are at this time on the accompanying 
answer sheet. Please answer each item even if you do not currently participate in an activity or 




Delighted   Pleased    Mostly    Satisfied    Mixed    Mostly Dissatisfied   Unhappy    Terrible 
       7               6              5                 4               3                         2                      1    0 
    
 
91. Material comforts - home, food, conveniences, financial security  
92. Health - being physically fit and vigorous 
93. Relationships with parents, siblings, and other relatives - communicating, visiting, helping 
94. Having and rearing children 
95. Close relationships with spouse or significant other 
96. Close friends 
97. Helping and encouraging others, volunteering, giving advice 
98. Participating in organizations and public affairs 
99. Learning - attending school, improving understanding, getting additional knowledge 
100. Understanding yourself - knowing your assets and limitations and knowing what life is 
about 
101. Work – a job or in the home 
102. Expressing yourself creatively 
103. Socializing - meeting other people, doing things, parties, etc. 
104. Reading, listening to music, or observing entertainment 
105. Participating in active recreation 
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Session 1:  
Introduction, Overview, What is Fibromyalgia? Review Gate Control Theory and 
Biopsychosocial Model, Introduce Coping Skills, and Introduce Interpersonal Issues 
 
I.  Psycho-educational Component 
 
A. Introduction and Overview [10 min]  
i. Introduce therapist(s) and co-therapist (if applicable) 
a. clinical psychologist with an interest in health psychology, chronic pain 
specifically 
• studies behavior, how the mind and body interact 
 
ii. Overview of what will happen in the group 
a. sessions divided into 2 sections: psycho-educational component led by therapist 1 
and interpersonal component led by therapist 2 
• psycho-educational component: learn about fibromyalgia syndrome and learn 
skills such as relaxation, imagery, combat negative thinking, pace activities to 
help manage symptoms (e.g. pain and depression) 
• interpersonal component: group discussion of relationship between various 
aspects of personal life and FM 
 
iii. Basic information about the group 
a.  organizational details 
• 8 sessions over 8 consecutive weeks 
• sessions build on each other, crucial to attend every session 
• when, where, time (be on time, allow for parking etc.) of meetings 
• 2 therapists: for first half and second half (change rooms) 
• phone numbers to reach therapist(s)  
• bring your workbook to each session, we will refer to the book 
• stretching: if you need to stand or stretch to be comfortable, do so, please try 
not to distract others  
• washroom (leave if needed and return), provide directions 
 
b. guidelines for group interaction  
• confidentiality of group 
• respect and dignity  
• questions and concerns: raise them in the group or with one of the therapists 
after a session, if you have a questions chances are others are wondering about 
the same thing 
 
c. groundrules for group (L.Wilson) 
• no focus on pain, everyone here has pain, that is understood, so no need to 
dwell on pain, it is generally not helpful to do this 
• be positive, sharing but not ‘telling’ others what to do, sharing between group 
members is very helpful when the sharing is positive and supportive in nature 
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(not when negative or when dwelling on past difficulties, or when criticizing 
others) 
• learn skills and must practice them and do homework (just attending group 
will not help, it is up to you to practice the skills on your own, on a daily 
basis), with practice the skills will become automatic, analogy like driving a 
car 
• willing to keep an open-mind, willingness to be self-reflective, be an active 
participant; if you have tried some things before you will need to give them 
another fresh try-might be different this time in combination with other things 
you are doing (or not doing)  
• attitude of openness, possibility, experimentation, like a scientist  
• try not to compare yourself to others, everyone progresses at a different rate; 
focus on your own progress 
• group vs. individual, group provides support and the encouragement and 
support from others in a similar situation is beneficial; people with chronic 
pain tend to feel that the only other people that can understand are other’s with 
chronic pain  
• key to progress in group, set reasonable goals, be actively involved in your 
own progress, practice skills consistently, learn about health in general  
 
B.  Fibromyalgia Syndrome [10 min]  
i.  Description of fibromyalgia syndrome 
a. nonarticular rheumatologic condition 
• rheumatism is a painful disorder of the joints, muscles, and connective tissues 
• FM is a nonarticular condition though, so the joints are not affected  
• not degenerative or deforming and has no known excess mortality 
 
ii.  Symptoms (pain, depression, sleep disturbance, fatigue, etc.) 
 a. pain 
• what is pain? unpleasant sensory and emotional experience that is associated 
with actual or potential tissue damage.  
• acute pain, heals and goes away (e.g. burn finger) 
• chronic pain, lasts 6 months or more 
• statistic on prevalence of chronic pain  
• doctors used to look for physical signs of damage, like damage from a cut or 
sprain; thought that following injury message travels from site of injury to 
brain; brain receives and registers pain; this enables us to remove self from 
further damage; we then attempt to reduce injury by resting, use ice, etc. this 
all leads to healing  
• diagram of simple pain response (Handout 1a.). 
• however, we now know that this is too simple and does not explain 
everything, for example, phantom limb pain…no nerves left or even a limb, 
but still sense pain in that limb; there is not a direct correspondence between 




• traditional thinking is too limited, we need a more complex model to 
understand pain; Gate Control Model   
 
b.  Gate Control Theory (Melzack & Wall) 
• use diagram of pain response with the gate (Handout 1b)  
• pain is more than a sensory process, other factors besides message from injury 
site to brain affect pain experience 
• there are messages sent from injury to brain, but also messages sent from the 
brain; these messages can intensify or reduce, even block the pain experience; 
we have a ‘gate’ that controls how much pain is felt 
• theory is that there is a gate located in the spinal cord in the middle of the pain 
pathway, the gate-like mechanism is related to bundles of nerves at the spinal 
cord, the brain can send messages to keep gate closed or open, this changes 
the actual amount of pain the person experiences 
 
c. Opening and closing the gate 
• the gate can be opened or closed, when the gate is closed it can stop pain 
messages from going up the pain pathway to the brain, but when open, 
messages can go up the pathway to the brain 
• scientists have discovered that your brain closes the gate by releasing natural 
pain killers called endorphins, these painkillers are very powerful 
• thought and feeling centers in brain can open or close gate, this is why we 
notice that our thoughts and feelings have a major effect on pain, e.g. of bad 
day vs. good day and pain, lottery win and injury/pain vs. root canal (L. 
Wilson) 
 
d. Depression, sleep disturbance, fatigue, anxiety 
• symptoms in addition to pain that may be experienced 
• can affect opening/closing of the gate 
• vicious cycles; example of pain causing low mood and feelings of low mood 
(depression) increasing pain (gate) 
 
iii. Associated disorders 
a. explain associated disorders such as Reynaud’s, Sjogren’s, IBS 
• prevalence of comorbid disorders 
• symptoms 
 
iv. Homework (Handout 1c) 
• ask group to think about how gate control theory and aspects of their personal 
lives are related, e.g. how pain is affected by relationships, mood, activities, 
etc.  
• what worsens your pain or opens the gate?  
• what helps reduce pain or close the gate? 
• categorize into physical, emotional, mental factors  
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• you will all have some different factors, this is individual; because you are 
individual we will learn a number of different coping techniques so each 
person can find something that suits them  
 
C. Fibromyalgia and Controversy [5 min] 
i.  Proposed models of FM (model of how it occurs, what causes it) 
 a.   contrast ‘medical model’ with an ‘integrated’ or biopsychosocial model (L. 
Wilson) 
• medical model for acute problems 
• biopsychosocial model supported in literature for chronic pain 
 
b. health psychologists are interested in thoughts, feelings, and physical health 
because they are related and act upon each other 
• in all chronic pain conditions (back pain, arthritis, migraine, etc.) 
psychologists have been involved in helping people manage their pain and 
associated difficulties 
• health psychologists also work with people who have cancer, have had 
strokes, many health problems, because your health affects all areas of life 
 
c. there are scientific organizations such as IASP and CPS to which many 
psychologists belong because they are interested in the physical, mental and 
emotional aspects of chronic pain conditions 
• chronic pain programs similar to this one are run throughout North 
America and other countries 
  
ii.  Fibromyalgia affects major areas of life 
 a. ask group to provide examples to be written on board 
• social, vocational, mood, physical activity, hobbies, etc. 
 
b. because fibromyalgia and all chronic pain conditions affect many major areas of 
life, a model which combines these elements was proposed and is widely 
accepted: The Biopsychosocial Model (an ‘integrated model’), this is the model 
we are operating under 
• describe and illustrate 
• provide examples of how this pertains specifically to FM and life 
 
D.  Introduce Coping Skills and Rationale for Coping Skills and Pain Management [10 min.] 
i.  Review: research shows that thoughts and feelings can have a big effect on how much 
pain we feel by opening or closing the gate in the pain pathway, provide example 
a.  pain coping skills and management techniques will teach you skills for controlling 
thoughts/feelings/ and actions that affect your pain  
b.  this will help you gain a sense of control over your pain, may help to  
decrease your pain and will affect other symptoms too 
 




a. in between sessions you will be asked to practice daily in order to learn them well 
enough to receive the full benefits 
b.  by the completion of the 8 sessions you will have a ‘menu’ of skills 
 
iii. List of skills (Handout 1d): 
a.  deep diaphragmatic breathing (session 1, 2, and 3) 
b.  progressive muscle relaxation (session 2 and 3) 
c.  pleasant activity scheduling (session 4 and 5) 
d.  imagery (session 4, 6 and 7)  
e.  cognition / distraction methods (session 5 and 6) 
f.  pacing (activity/rest cycling) (session 6) 
g.  problem solving (session 7)  
h.  interpersonal communication (sessions 1-8) 
 
E.  Relaxation Fundamental-Diaphragmatic Breathing [10 min.] (Handout 1e) 
i.  We will cover deep diaphragmatic breathing today so that you can start practicing a 
skill right away, emphasis on practice 
a.  demonstrate shallow chest breathing vs. diaphragmatic breathing by lying on floor 
• focus on comfortable position, eyes closed, hands on chest and stomach, and 
counting with breaths in and out 
• can introduce idea of counting or repeating a relaxing word while breathing 
 
b. importance of practicing this breathing, it is at the root of all relaxation exercises, 
it may not seem difficult at first but it does take practice  
 
ii.  Homework (Handout 1f) 
• log of times during day when practice breathing 
• 5 minute sessions a minimum of two times each set, throughout the day for 10 
cycles  
• do it laying down but not with the intention of going to sleep             
 
II. Interpersonal Component [45 min.]  
 
A. The Formative Phase (Rutan & Stone; Yalom) 
i. members learn groundrules for making group therapy work 
 
ii. members will attempt to establish level of intimacy 
a. level of intimacy that is safe for each individual, will vary 
 
iii. themes revolve around gaining information 
a. asking leader or peers how best to make the group work 
 
iv. members orient to group through trial and error  
a. to see what will be useful and safe 




B. Interpersonal Topics  
i.  Importance of interpersonal issues  
a.  manner by which these types of issues affect thoughts/feelings and hence affect 
the gate, pain, and illness/wellness  
• relationships, activities, career, etc. 
• provide examples 
 
ii.  Members provide examples of ways fibromyalgia affects their lives (not just pain but 
in general 
a.  affect on relationships 
• specifics: friendships/ hobbies/ physical activity/ sexually/ fun/ meeting needs 
of others, e.g. kids/grandkids 
  
b. interactions with family and friends 
• how do family and friends react, how do they help, how do they make things 
difficult? 
 
iii. Do members feel that people without chronic pain just can’t understand?  
a. simply being part of this group with people who understand can be helpful 
• how do you think it might be helpful? 
 
iv. Feelings involved with fibromyalgia 
 a.  depression, anxiety, fear 
• pain anxiety, learned associations or expectations of pain, increases in specific 
situations (L. Bradley) 
 
b. what can we do about these thoughts and feelings? 
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Session 2:  
Sleep, Introduce Relaxation Techniques, and Review Interpersonal Issues 
I. Psycho-educational Component  
  
A.  Review Homework [5 min.] 
i. Questions and comments about last week’s session? 
a. gate control theory 
b. deep diaphragmatic breathing 
• comments, how did it go?  
• important to address concerns now 
• how often did you practice? what effect did it have on you?  
• did people have difficulty or success?   
 
B.  Sleep Hygiene (L. Wilson; Philips & Rachman) (Handout 2a) [10 min.] 
i.  Regular schedule 
 a. up at same time each morning (exceptions on weekend) and to bed close to same 
time each night; allows body to adjust to routine  
• exposure to bright light in the morning can help awakening, reset circadian 
rhythm 
 
ii.  Necessities for sleep 
 a.  comfort and quiet 
• comfortable mattress/bed, dark room, quiet, no disturbances (pets) 
 
b. bedroom 
• use of bed and bedroom for sleep/sex only 
• should not lie in bed when not sleeping, perpetuates insomnia; should not be 
for lounging, reading, tv, snacking 
 
 c.  reduce pressure  
• allow sleep to come, don’t try to force it  
• put clock out of sight (clock increases pressure) 
 
iii. Stimulus control 
a.  avoid stimulants before bedtime 
• don’t exercise close to bedtime, avoid stimulants (caffeine, nicotine) and 
avoid alcohol (helps fall asleep but disrupts sleep in the night) 
• hypnotics should be used judiciously; if daily not for longer than 4 weeks, 
consult doctor; if in a ‘sleep crisis’, save for times when have had 3 nights 
disrupted sleep in a row 
 
b.  go to bed and lie down only when tired and ready to sleep, when feel drowsy  
• if cannot sleep after 20 minutes get out of bed and do something monotonous, 
return to bed when drowsy and ready to sleep 
• avoid napping during the day (unless it helps you fall asleep because less 




iv. Relaxation and cognition 
a.  avoid stress and rushing around right up until bedtime 
• physical and psychological hyperarousal contribute to insomnia 
• relaxation can be useful to combat arousal and can be used to help fall asleep 
and fall back to sleep if wake during night (especially if you ‘panic’ about not 
being able to sleep 
• however, you should not use relaxation as a way to fall asleep, it has another 
purpose, so when you have relaxation homework do not fall asleep while 
doing it 
• if you worry when you go to bed try scheduling a ‘worry time’ at another time 
in day or evening (not right before bed) 
• examine your thoughts about sleep, are they worries, ruminations, unrealistic 
expectations? examine the validity of these thoughts and try to change them 
 
C.  Introduce Relaxation Techniques with Deep Breathing [30 min.] 
i.  Relaxation (Handout 2b) 
 a.  what is relaxation? 
• relaxation is an alert and controlled state 
• concentration on physical calmness, reduced muscle tension, and emotional 
calmness  
• review muscle tension pain cycle (vicious cycles diagram) 
• complex skill, training is required over a number of weeks; in this treatment 
you can concentrate on this skill for 7-8 weeks 
 
b.  what is the purpose? (Philips & Rachman) 
• common response to acute injury is to tighten muscles, this tightening limits 
movement to promote healing; when pain is chronic the sufferer may develop 
permanent tension in certain muscles 
• this tensing, or guarding, can become habitual and unhelpful; the tension does 
not reduce pain levels but is likely to make pain worse 
• when this continues for years patients may lose awareness of how tense the 
muscles are; it is only after relaxation skills are learned that awareness of 
tense muscles grows 
• relaxation skills allow you to learn the difference between tension and 
relaxation; become aware of tension in the body and learn to ‘turn on’ a 
relaxation response in minutes to reduce tension 
 
c.  group lists different techniques they use to relax 
 
ii.  Different types of relaxation skills/exercises 
a.  diaphragmatic breathing, PMR, imagery/visualization, etc. 
• describe each briefly 
 
 iii. Group Exercise, Progressive Muscle Relaxation (PMR) 
a. short introduction to PMR (Bernstein and Borkovec method, 1973) 
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• while practicing deep breathing, tense right fist, notice the tension, relax fist, 
compare the feeling of tension to that of relaxation 
• continue with left fist; right foot; left foot 
• highlight contrast between tension and relaxation 
 
b. discuss feelings of warmth, fuzziness, heaviness, or other feelings associated with 
the lack of tension 
 
c. thoughts and reactions, discussion about relaxation 
• important to discuss skepticism, willing to try, open-mind 
 
d.  important to stress necessity of practice, we will do an exercise each session but 
members must also practice daily on their own 
 
iv. Homework 
  a. relaxation exercise 
• continue to practice deep diaphragmatic breathing, it is fundamental for all 
other relaxation skills, continue to log progress (Handout 1f copy) 
• give clients copy of relaxation tape and Handout 2c 
 
II. Interpersonal Component [45 min.] 
 
A. The Formative Phase (Rutan & Stone; Yalom) 
i. Members continue to attempt to establish level of intimacy 
 
ii. Themes revolve around gaining information 
a. asking leader or peers how best to make the group work 
 
iii. Members continue to orient to group through trial and error  
a. to see what will be useful and safe 
b. members approach this task with individual history, conflicts, needs 
 
iv. Common questions are addressed 
a. for example, ‘what information is relevant?’, ‘are past events significant?’, ‘am I 
expected to share all my secrets?’ 
b. these questions produce interaction among members and stimulate opinions and 
conflicts 
 
v. Under pressure to get to know each other patients usually ‘tell their story’  
 
vi. Anxiety and apprehension of formative phase represent first commonly shared 







B. Interpersonal Topics  
 
i.  Exploration of trauma 
a. broadly define ‘trauma’  
• meaning of trauma is individual, it is not always physical or sexual abuse, 
many types of experiences can be traumatic for a person 
• discuss whether such experiences change a person 
• do such experiences change how a person copes, with illness for e.g. 
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Session 3:  
 
Review Rationale for Coping Skills, Review Relaxation, Exercise on Controlling Pain through 
Relaxation [Keefe] 
 
I. Psycho-educational Component 
 
A.  Review Homework [10 min.] 
i. Discuss deep breathing and relaxation practice 
 
ii.  Discuss barriers 
a.  troubleshooting problems with relaxation (in Keefe, Bernstein and Borkovec, 
1973) 
  
B.  Functional Task and Relaxation Exercises-Breathing and PMR [30 min] 
i. Functional Task 
 a. ask patients to assess pain level during a functional task; ask them to do a simple 
activity for 15 seconds that is likely to increase pain and tension a little bit 
(walking, getting up out of chair, etc.) 
 b. ask them to rate pain on 1-10 scale (10 is worst possible pain) and rate tension on 
‘Tension Thermometer’ (Handout 3a) 
• after the activity and rating mention that we will return to this later in the 
session 
 
 ii. Relaxation Practice 
  a. deep breathing 
• practice breathing from diaphragm instead of shallow chest breathing 
• focus on slow, deep, steady breaths in through the nose (out through nose or 
mouth), can count (in head) while inhaling and exhaling 
 
b. progressive muscle relaxation (PMR) 
• conduct exercise with group 
• similar to brief exercise in previous session but expand to full body PMR 
(from head to toe) 
• see script (reference L. Wilson & G. Pancyr; Bernstein & Borkovec) 
 
c. demonstration of the effects of relaxation on functional task (Keefe) 
• ask patients to hold onto feelings of relaxation while they perform the same 
functional task that they performed earlier in the session 
• ask patients to rate pain during the task on 1-10 scale (10 is worst possible 
pain) and rate tension on the ‘Tension Thermometer’ 
• compare the ratings to pre-session ratings; note likely reasons for decreased 
pain and tension following relaxation exercise: tension reduction, attention 
diversion, reduction of emotional distress, improved rest 
• also explain why decreased pain or tension might not have occurred: need 
more practice, relaxation effect may be preventative not curative, high pain 
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level, etc.; understanding some of these reasons can help you get through bad 
episodes of pain 
 
 
ii.  Mini-practices of relaxation  
 a. learn to relax and calm yourself on command, method for mini-practice  
  (Handout 3b) 
• for relaxation to be of most benefit you need to learn to relax and calm 
yourself on command; this skill is very helpful when you feel increased 
tension or pain but are unable to go to secluded area to do progressive muscle 
relaxation 
• to do a mini practice begin by stopping yourself, take a long deep breath in, 
say the word ‘relax’ to yourself, slowly exhale, while you exhale allow 
yourself to relax and focus on sensations of relaxation 
• allow your jaw to relax, allow sensations of heaviness and warmth to flow 
downward to shoulders and throughout body 
• after 30 seconds go back to what you were previously doing (regardless of 
how well you succeeded at relaxation) 
• walk through 2-3 mini-practices with the group, while sitting, standing, 
walking 
• discuss group’s reactions and reinforce necessity of practice 
 
iii.  Homework 
a. relaxation exercise and mini-practices 
• continue to practice with the tape according to Handout 2c 
• do mini-practices according to Handout 3b 
 
II.  Interpersonal Component [45 min.] 
 
A. The Reactive Phase (Rutan & Stone; Yalom) 
i. Individuality of each member becomes more important 
a. members attempt to retain own identity while remaining part of the group 
 
b. tasks of this phase revolve around moving from sense of ‘we-ness’ to sense of 
belonging that includes ‘I-ness’ 
 
ii. Characterized by emotional outbursts and uneven commitment to group 
 
iii. Norms that arose in formative phase may be tested and modified 
 
iv. Many patients experience presenting problems most powerfully in this phase 
a. for example, members may say ‘this group is no different from my family’ 
b. important for therapist to help patients understand that changes in attitudes about 
group membership are helpful for therapy and groups are more effective when 




B.  Interpersonal Topics 
i. Barriers to relaxation, from an emotional level 
• not just logistics, but emotional challenges to relaxation 
• are there feelings associated with difficulty relaxing 
• do feelings such as anxiety intrude, safety issues 
 
 ii. ‘Somatic awareness’ and ‘letting go’ (ref. Bakal; Levine)  
a. somatic awareness, also called body awareness 
 b. being aware of your body, internally and externally, both physical feelings 
   and your influence over your body; sense of control  
• expand 
 
iii. Letting go, link back to trauma 
 a.  link to broad definition of trauma 
 b.  describe animal response to cycle and difficulty moving through cycle 
• consequences of becoming ‘stuck’ and not passing through cycle 
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Session 4:  
 
Review Relaxation and Introduce Another Coping Skill-Pleasant Activity Scheduling and 
Interpersonal Issues 
  
I.  Psycho-educational Component 
 
 A.  Review Relaxation Homework from Session 3 [10 min.]  
i.  Reactions to relaxation practicing 
 
ii.  Discussion of interference with breathing and relaxation practice 
a.  interpersonal interference 
b.  time 
c.  motivation 
 
ii. Brain Storming 
 a. how to overcome such interference and make time for relaxation 
• suggestions by group, strategies 
• additional suggestions by therapist may include: making a sign to hang on 
your bedroom door to let people know that you are doing relaxation exercises 
and not to disturb you, or turning off the ringer on the phone, or scheduling it 
for the same time everyday so it becomes routine 
 
B.  Introduction to Guided Imagery and Relaxation [25 min.] 
i.  Introduce Guided Imagery 
a.  review deep breathing 
 
b. imagery can strengthen the progressive muscle relaxation skill and is a good 
introduction to the skill of distraction 
 
c. induce relaxation as done in session 3 B ii.  
• follow 10-15 minutes of induction but spend the last 5 minutes on the use of 
imagery (peaceful and antagonistic to pain experience); suggest specific 
images to patients such as lying in a warm bath, sunbathing on a sandy beach, 
walking through a forest, etc. 
• toward the end of the 5 minutes of imagery encourage patients to generate 
their own images; explain that the use of peaceful imagery I conjunction with 
deep relaxation can reduce the pain experience 
• specific peaceful images are very helpful in achieving a calm, relaxed mental 
state to go along with the relaxed feeling achieved by the body (focus on 
quieting the mind) 
 
d. following exercise allow time for general discussion of patients’ increasing ability 
to relax and addition of imagery; make distinction between relaxed body and 
relaxed mind clear and emphasize importance of integrating the two 
 138 
 
• those with intense pain during the exercise need to be encouraged to ‘ride over 
the pain’ and attempt to relax despite the pain, this is a task requiring great 
concentration and demands encouragement from the therapist 
 
iii. Homework 
 a. relaxation and imagery exercise 
• practice relaxation with the tape (according to handout 2c), at the end of the 
tape continue relaxation for 10 minutes using imagery 
• see Handout 4a for guidelines for practice with imagery 
 
C.  Coping Skill-Pleasant Activity Scheduling [10 min.] 
i. Pleasant Activity: Describe how pleasant activity scheduling can be used to control and 
decrease pain, rationale 
 
ii. Identify pleasant activities, develop schedule [Handout, Activity Schedule 3-2C] 
 
 iii. Homework 
 
II.  Interpersonal Component 
 
 A. The Reactive Phase (Rutan & Stone; Yalom) 
i. individuality of each member remains important 
a. members attempt to retain own identity while remaining part of the group 
 
b. tasks of this phase revolve around moving from sense of ‘we-ness’ to sense of 
belonging that includes ‘I-ness’ 
 
ii. continued emotional outbursts and uneven commitment to group 
 
iii. patients continue to experience presenting problems powerfully in this phase 
 
iv. may be a time of conflict among members, ‘storming period’ 
a. some conflict may be displaced anger felt toward leader, some may be to 
demonstrate who is most powerful among members 
b. in emotional transactions that occur in this period, members bond to one another 
more strongly; this is important if groups are to gain maturity 
 
 v.  therapist must appreciate that this is a developmental phase 
 
 B. Interpersonal Topics 
i.  Focus on activities that can no longer be accomplished or enjoyed due to fatigue, 
pain, etc.  
• group therapy discussion on related issues 
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Session 5:  
 
Review Relaxation, Review Pleasant Activity Scheduling, Introduce Topic of Identifying and 
Changing Negative Automatic Thoughts and Interpersonal Issues 
 
I. Psycho-educational Component 
 
A.  Review homework [20 min.] 
i.  Relaxation homework 
a.  trouble shooting 
• discuss interference and whether brain storming from session 4 provided ways 
to overcome interference and make time for relaxation 
 
ii.  Assign new relaxation homework 
 
iii. Pleasant activity scheduling homework 
 a.  review rationale 
 b.  were members able to follow the schedule? 
 c.  what were the difficulties? 
 d.  what did the members notice after participating in pleasant activities? 
 e.  is this a helpful strategy for pain coping? 
 
B.  Identifying and Changing Negative Automatic Thoughts [20 min.] 
i.  Cognitive Therapy: discuss how distortion and errors in thinking can contribute to 
pain and suffering 
 
ii.  Rationale for cognitive therapy 
a.  automatic thinking 
b.  pain and automatic thinking 
 
iii. Teach basic concepts of cognitive restructuring 
 
iv.  Identify and Change Negative Cognitions: [Handout 4-4C] 
 a.  develop skill to recognize negative automatic thoughts 
b.  generate rationale comebacks 
• mini-practice of recognizing irrational negative thoughts 
• mini-practice of changing these thoughts  
 
v.  Homework 
 
II.  Interpersonal Component (Therapist 2) [45 min.] 
 
A. The Reactive Phase (Rutan & Stone; Yalom) 
i. continued conflict among members, ‘storming period’ 
a. some conflict may be displaced anger felt toward leader, some may be to 
demonstrate who is most powerful among members 
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b. in emotional transactions that occur in this period, members bond to one another 
more strongly; this is important if groups are to gain maturity 
 
 ii.  therapist must appreciate that this is a developmental phase; therapeutic task is to 
avoid focusing on individual dynamics or transference; rather, clinician engages 
others in expressing feelings 
 
B. Interpersonal Topics 
i. focus on thoughts about self 




















Session 6:  
Review Identifying and Changing Thoughts, Introduce New Coping Skills: Pleasant Imagery and 
Pacing 
 
I. Psycho-educational Component 
 
A.  Review Homework [10 min.] 
i.  Discuss identifying and changing thoughts 
 
ii.  Discuss difficulties encountered with certain thoughts 





B.  Pleasant Imagery [20 min.] 
i.  Rationale for pleasant imagery as pain coping skill 
 
ii.  Relaxation practice with imagery 
a.  control pain using pleasant imagery 
• practice pleasant imagery as distraction technique [Handout 4-5C] 
 
 iii. Home practice 
 
C.  Pacing: Activity-Rest cycle [15 min.] 
i. Introduce activity rest cycle 
 a.  what it is, why it is important 
b.  focus on the cyclical nature 
• diagram 
 
ii.  Overactivity 
 a.  negative consequences of overactivity 
 b.  ask members to provide examples  
 
 iii. Basic steps in setting up activity/rest cycle 
a.  practice using relaxation in different daily activities [Handout 6-1C, 6-2C, 6-3C] 
 b.  homework 
 
iv. Fitness/exercise 
a.  research evidence of benefits of exercise on FM 
b.  importance of activity/rest cycle for fitness/exercise 
 
II.  Interpersonal Component 
 
A. The Mature Phase (Rutan & Stone; Yalom) 
i. group begins to perform and work together in a goal directed manner 
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ii. members interact spontaneously and carry themes from session to session 
 
iii. leadership is shared and members assume tasks and emotional leadership roles 
 
iv. strong emotions and conflicts begin to be better tolerated and are not prematurely cut-
off 
  
v. flexibility allows for shift of focus from intragroup to extragroup to personal events 
 
vi. members begin to develop confidence in ability to tolerate anxiety and examine 
problems themselves 
  
vii. members begin to gain understanding and appreciation for each other’s strengths and 
weaknesses  
 
 B. Interpersonal Topics 
i. introduce termination  












Session 7:  
Review Pleasant Imagery and Pacing, Applying Pain Coping Skills 
I. Psycho-educational Component 
 
 A.  Review Homework [5 min.] 
i.  Were group members able to successfully use pleasant imagery as a relaxation 
technique? 
 
ii.  Discuss relaxation homework 
 
 iii. Discuss Pacing 
 
B.  Practice Guided Imagery with Group [15 min.] 
i.  Group Exercise 
 
ii.  Home practice assigned 
a.  with consideration to difficulties presented by group 
• problem-solving with respect to these difficulties 
 
C.  Applying Pain Coping Skills [25 min.] 
i.  Develop skills in applying pain coping techniques to problematic situations 
a.  write list of coping skills learned on board 
b.  write recommended practice of each skill 
• e.g. progressive relaxation listen to tape twice a day, mini-practices 15 times a 
day: 1 time with imagery, 1 with focal point, 1 with auditory, etc., calming 
self-statements, activity scheduling, activity-rest cycle [ref. Keefe session 7] 
 
ii.  Apply pain coping skills to problem situations: Problem Solving 
a.  rationale for problem solving 
• many members have experienced positive benefits of applying pain coping 
skills 
• there are some problem situations that make it very difficult to cope with pain 
using only one coping skill (e.g. relaxation) 
• but can often manage these situations by combining different pain coping 
skills 
• will teach a 3 step problem solving technique [Keefe session 7] 
 
iii. Problem Solving: 3 step technique 
a.  step one: describe the situation (e.g. visitors) 
 
b.  step two: difficulties you are likely to have in the situation (e.g., tension, worry, 
pain) 
c.  step three: coping skills you can apply (e.g. relaxation, activity-rest cycle)-
specifics, when and how! 
• ask members to identify a problem situation and work through the 3 steps, 
brainstorm solutions, repeat if time.  
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• Handout, 7-3C, applying problem solving [keefe] 
• Home Practice 
 
II. Interpersonal Component 
 
A. The Termination Phase (Rutan & Stone; Yalom) 
i. final sessions are completely devoted to the ending of the group 
 
ii. members may be tempted to discount the importance of the end of the group 
 
iii. exploring the forthcoming ending of the group can be complicated by the fact that 
members may have more work to do  
a. need to have balance between temptation to discount the end of group and the fact 




Session 8:  
Review Progress and Previous Sessions, Develop a Plan for Maintaining Progress and 
Interpersonal Issues 
 
I.  Psycho-educational Component 
  
A.  Review homework/home practice from previous session [5 min.] 
 
B.  Review Previous Sessions [10 min.] 
 i. Review gate control theory 
 a.  diagram of pain pathway  
 
ii. Thought and Feeling Centers in brain can close gate in Pain Pathway 
 a.  draw thought and feeling centers on diagram 
 b.  draw nerves from these centers to gate 
 
 iii. Summary and Main Statement of Rationale 
a.  thoughts and feelings can have big effect on how much pain we feel by causing 
the gate to open or close 
b.  group was designed to teach coping skills for controlling thoughts, feelings, and 
actions that affect pain and other symptoms of FM 
  c.  coping skills you have learned will help control and decrease symptoms 
d.  in each session you learned new skills, you practiced the skills and in between 
sessions you practiced in order to master the skills. You will need to continue 
using the coping skills after you’ve stopped coming here. 
[reference Keefe session 9] 
 
C.  Coping Skills [5 min.] 
 i. Review of coping skills menu 
 a.  deep diaphragmatic breathing (session 1) 
b.  progressive muscle relaxation 
c.  imagery 
d.  pleasant activity scheduling 
e.  distraction methods 
f.  pacing (activity/rest cycling) 
g.  problem solving 
h.  communicating about your syndrome with others 
 
D.  Plan for Maintaining Progress 
 i. Based on Keefe’s Session 10 [25 min.] 
 
II. Interpersonal Component  
 
A. The Termination Phase (Rutan & Stone; Yalom) 
i. members may still be tempted to discount the importance of the end of the group 
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ii. exploring the forthcoming ending of the group can be complicated by the fact that 
members may have more work to do  
a. need to have balance between temptation to discount the end of group and the fact 
that members have more work to do 
 
iii. therapist can clarify metaphors such as death, divorce, graduation to help patients 
understand how they are managing feelings about end of group 
a. may be a time when some members work on unresolved grief 
 














1. How do you make sense of the gate control theory in your life? 
 How do aspects of your personal life relate to the theory? 














2. What worsens your pain or ‘opens the gate’? 
 What helps reduce your pain or ‘closes the gate’? 
 Try to think of categories such as physical, emotional, and mental factors. 

















List of Coping Skills 
 
a. deep diaphragmatic breathing 
b. progressive muscle relaxation 
c. pleasant activity scheduling 
d. imagery 
e. cognition / distraction methods 
f. pacing (activity / rest cycle) 
g. problem solving 




Diaphragmatic Deep Breathing  






Handout 1f Deep Breathing Log  
Cycle Track Day 1 Day 2 Day 3 Day 4 
1 Time     
 Length     
 Notes     
2 Time     
 Length     
 Notes     
3 Time     
 Length     
 Notes     
4 Time     
 Length     
 Notes     
5 Time     
 Length     
 Notes     
6 Time     
 Length     
 Notes     
7 Time     
 Length     
 Notes     
8 Time     
 Length     
 Notes     
9 Time     
 Length     




Sleep Hygiene: The Do’s and Don’ts of Sleep 
 
Listed below are some suggestions that may help you fall to sleep more easily. 
Do’s 
1. Keep a regular schedule. Go to sleep and wake up roughly at the same time each day. 
2. Exercise regularly (in the morning or afternoon). 
3. Have a comfortable bed in a quiet and dark room. 
4. If hungry before bed, eat a light snack or have a glass of milk. 
5. Schedule a relaxing period before retiring to bed. 
6. Keep the bedroom just for sleeping and sex. Not as an all-purpose activity area. 
Don’ts 
1. Don’t use alcoholic beverages or street drugs as sedatives. 
2. Don’t do late evening exercise.  
3. Don’t have your room too hot or too cold. 
4. Don’t eat a heavy meal before retiring and do not snack during the night. 
5. Don’t try too hard to fall asleep. Get out of bed and return only when you feel sleepy. 
6. Avoid napping during the day. 











Vicious Cycles and Relaxation 
Philips & Rachman 
 
 
A common response to acute injury is to tighten muscles, this tightening limits movement, which 
promotes healing; when pain is chronic the sufferer may develop permanent tension in certain 
muscles. 
 
This tensing, or guarding, can become habitual and unhelpful; the tension does not reduce pain 
levels but is likely to make pain worse.  
 
When this continues for years, patients may lose awareness of how tense the muscles are; it is 
only after relaxation skills are learned that awareness of tense muscles grows.  
 
What is relaxation? 
• relaxation is an alert and controlled state 
• concentration on physical calmness, reduced muscle tension, and emotional 
calmness 
• review muscle tension pain cycle (vicious cycles diagram) 
• complex skill, training is required over a number of weeks; in this treatment you 
can concentrate on this skill for 7-8 weeks 
 
What is the purpose? 
• relaxation skills allow you to learn the difference between tension and relaxation 
• learn to become aware of the tension in the body and learn to ‘turn on’ a 
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Progressive Muscle Relaxation 
(Keefe) 
 
What is Progressive Muscle Relaxation Training? 
 
1. Progressive muscle relaxation (PMR) is a way to learn how to relax. 
 
2. In order to learn how to relax, you need to pay attention to feelings of tension and 
relaxation in your body. 
 
3. You will learn to keep tension in your body at a low level. 
 
4. Relaxation is a skill that can be learned, just like any other skill, such as driving a car, 
playing an instrument, or typing. 
 





Practicing with the relaxation tape 
 
1. It takes several weeks of daily practice with the relaxation tape to learn the relaxation 
response. It is recommended that you practice with the relaxation tape twice a day, 
everyday.  
 
2. It is critical to have a quiet, comfortable place to practice. There should be no 
interruptions, no phone calls, no worry about doing chores, etc. 
 
3. During the learning phase you should practice at a time when you are most relaxed, 
usually early in the day. Do not start with a time when your pain or other symptoms 
are most intense. 
 
4. Don’t be discouraged if at first it is difficult for you to relax completely. If you try too 










When practicing with relaxation and other coping skills you will sometimes be asked to rate your 






The Tension Thermometer 
 
Describe how tense you feel at the moment by circling the number and word that best describe 
your tension.  
 
    0 = absolutely calm and relaxed 
  25 = very relaxed 
  50 = somewhat relaxed 
  75 = very tense and anxious 













For relaxation to benefit you the most, you need to learn how to relax and calm yourself upon 
your command. This skill can be very helpful when you are feeling increased tension or pain, but 
are unable to go to a secluded area to do progressive muscle relaxation.  
To do a mini-practice: 
1. Stop yourself 
2. Take a deep breath 
3. Say the word “relax” to yourself 
4. Slowly exhale 
5. As you exhale, focus on the sensations of relaxation 
6. Allow your jaw to relax, allow sensations of heaviness to flow downward from 
your shoulders throughout your body 
7. After 30 seconds, go back to what you were doing, regardless of how well you 
have succeeded in relaxing 
 
Reminders to do mini-practices: 
Your goal is to do about 5 mini-practices the first day and then gradually build up to about 20 
mini-practices each day over the next few weeks. You can remind yourself to do a mini-practice 
in many different ways. Some people will do a mini-practice every time they feel annoyed or 
tense. Some people do one every time they stop at a stoplight or after they have been on the 
telephone. You can remind yourself by placing adhesive ‘dots’ or ‘sticky notes’ around the 
house. Every time you see a dot or a note you will be reminded to do a mini-practice. It is 
important that you practice frequently. Little by little you can develop a habit of keeping yourself 








Controlling Pain and Tension using Pleasant Imagery 
 
Thinking about pleasant events can help control pain in several ways. First, when you are 
concentrating on something pleasant you are not able to attend to pain as much. Second, pleasant 
imagery can help you relax even more than relaxation training alone. Third, pleasant imagery 
helps reduce anxiety, frustration, anger, tension, and depression. Finally, this method can help 
you rest and sleep better.  
 
When you use pleasant imagery you are in control of what imagery you use and the length of 
time that you use imagery. You may choose to think of a real event from the past, such as a walk 
on the beach. Or, you may wish to think of something you would like to do, such as visit a 
tropical island.  
 
 
There are several guidelines for using pleasant imagery. 
1. Induce relaxation prior to practice with imagery. 
2. Try to involve all of your senses in imagery. 
3. Practice for a specific time period. 





Imagine yourself in a very pleasant scene. This can be a scene that is individually tailored to you. 
See everything in as much detail as possible. Instead of ‘watching yourself’ as though you were 
watching a home movie, try to be ‘in the scene’ and see it through you own eyes. Try to be in 
your imaginary scene as much as possible. Involve all of your senses. What are the scents and 
sounds, what can you feel? It is important to not only relax but to also experience a pleasant 




Pleasant Activity Scheduling 
 
List a number of pleasant activities that you would like to do in the next week. These activities 
should be things that you would enjoy doing that you may not usually make the time to do. They 
do not have to require a lot of time or money. They may be as simple or as involved as you 
would like.  
 
List a number of pleasant activities:  
1.        4.  
2.        5. 
3.        6. 
 
Try to develop an approximate schedule of when you plan to engage in each of these activities 
within the next week.  
 



































We all have thoughts that are automatic. Although some automatic thoughts are true, many are 
either untrue or have just a grain of truth. These ‘distorted’ thoughts or mistakes in thinking 
include: 
 
1. All-Or-Nothing-Thinking (also called Black-and-White-Thinking): you view a situation in 
only two categories instead of on a continuum. Example: “If I’m not a total success then I’m 
a failure.” 
 
2. Catastrophizing: You predict the future negatively without considering other more likely 
outcomes. Example: “I’ll be so upset I won’t be able to function at all.” 
 
3. Discounting the Positive: You unreasonably tell yourself that positive experiences, deeds, or 
qualities do not count. Example: “I did that project well but that doesn’t mean I’m 
competent; I just got lucky.” 
 
4. Emotional Reasoning: You think something must be true because you “feel” (actually 
believe) it so strongly, ignoring or discounting evidence to the contrary. Example: “I know I 
do a lot of things okay at work, but I still feel like I’m a failure.” 
 
5. Labelling: You put a fixed, global label on yourself or others without considering that the 
evidence might more reasonably lead to a less disastrous conclusion. Example: “I am 
incapable.” 
 
6. Magnification / Minimization: When you evaluate yourself, another person, or a situation, 
you unreasonably magnify the negative and /or minimize the positive. Example: “Getting a 
mediocre evaluation proves how inadequate I am. Getting high marks doesn’t mean I’m 
smart.” 
 
7. Mental Filter: You pay undue attention to one negative detail instead of seeing the whole 
picture. Example: “Because I got one low rating on my evaluation (which also had several 
high ratings) it means I’m doing a lousy job.” 
 
8. Mind Reading: You believe you know what others are thinking, failing to consider other 
more likely possibilities. Example: “He’s thinking that I don’t know the first thing about this 
project.” 
 
9. Overgeneralization: You make a sweeping negative conclusion that goes far beyond the 
current situation. Example: “Because I felt uncomfortable at the meeting I don’t have what it 
takes to make friends”.  
 
10. Personalization: You believe others are behaving negatively because of you, without 
considering more plausible explanations for their behavior. Example: “The repairman was 
curt to me because I did something wrong.” 
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11. ‘Should’ and ‘Must’ Statements: You have a precise, fixed idea of how you or others should 
behave and you overestimate how bad it is that these expectations are not met. Example: “It’s 
terrible that I made a mistake. I should always do my best.” 
 
12. Tunnel Vision: You only see the negative aspects of a situation. Example: “My son’s teacher 




Identifying Negative Automatic Thoughts 
F. Keefe 
 
These are some of the thoughts that people with chronic pain sometimes report having when they 
have a pain episode. Examine whether you have had any of these thoughts. Write down other 
thoughts that you have had. It helps to identify these thoughts so that you can try to change them.  
 
Negative Thoughts:  
If this keeps up I’ll be crippled and unable to walk.  
I can’t go on like this. 
I am a weak person. 
I can’t do anything I used to do. 
I am useless. 
I can’t deal with this pain. 
No one understands my problem. 
I am a burden on my family and friends. 
Why me? I didn’t do anything to deserve this. 
If things go on this way, I won’t be able to cope. 
I am worthless when I’m like this. 
 
Identify some of your own negative thoughts: 
______________________________________________________________________________
__________________________________________________________________ 
These thoughts can lead to emotions such as: depression, frustration, resentment, alienation, 
isolation, anger, guilt, jealousy, and fear. Write down the feelings that you have experienced as 
well as others that are not listed.  
______________________________________________________________________________
__________________________________________________________________ 
A way to deal with these automatic negative thoughts is to try to replace them with more 
adaptive thoughts, or coping thoughts. These new coping thoughts do not have to be overly 
positive or optimistic, but they should be more realistic so that you believe them.  
For example: 
Negative Thought:    Coping Thought: 
I can’t do anything I used to do.  I may not be able to do everything I used to do, but 
there are things I can do well. 
 
Negative Thought: Coping Thought: 
I can’t deal with this pain.  There are things I can do to control and decrease my 
pain. 
 
Negative Thought: Coping Thought: 




Identifying and Replacing the Most Troublesome Negative Thought 
 
This week, during some episodes of intense pain or interference due to pain, note the thoughts 
that automatically pass through your mind, such as “here we go again.” 
 
Try to notice one negative automatic thought each day and list them below. Identify the most 









* Most troublesome thought: ________________________________________________ 
* Replacement ‘coping thought’: _____________________________________________ 
 
Cognitive Strategies for Reappraising Pain 
 
1. Transforming the body: Imagine the body to be numb or made of something else, such as 
rubber, electrical parts, or water.  
 
2. Transforming context in which pain is felt: Imagine the pain is a result of a particular 
experience. For example, pain in the knee is due to pressing the knee against a wall, pain in 
the head is from a tight hat, etc.  
 
3. Denial and redefinition: Tell yourself that you are not in pain and think of the sensation as 
due to stretching or scar tissue, pulling of muscles, pulsing of the arteries, etc.  
 
4. Limiting the scope of pain: Focus only on the area in which you feel pain, noting its depth 
and area over which it spreads.  
 
5. Relocation of pain: Move the pain to another site on your body. Note: this technique requires 
a lot of concentration and practice with relaxation and imagery will help to develop this skill.  
 
6. Relocating thoughts: Concentrate on a pain-free site on your body. Try to “think” from that 




Home Practice Sheet 
F. Keefe 
 
1. How many times in the past week did you practice with your relaxation CD? 
    ________________________________________________________________________ 
 
2. How many times did you do mini-practices this week? _________________________ 
    How many times did you use imagery? ______________________________________ 
 












5. Were there any examples of times when you were able to decrease pain or tension using 
relaxation, mini-practices, imagery, etc.? 












Individuals with pain have a tendency to overdo it or push themselves when they are feeling 
better, but this often results in being caught in a negative cycle. This negative cycle is 
characterized by overdoing activities, which leads to severe pain, which results in being forced to 
rest. The need for rest may last several days and may cause you to miss work, activities, or social 
gatherings. This cycle usually repeats itself time and time again. There are many negative 
consequences of this cycle, including: anticipating pain, periods of increased pain and fatigue, 
tension, worry and anxiety, and a tendency to avoid activities that you are capable of doing. 
 
The activity-rest cycle is a better way to pace your activities. To follow the activity-rest cycle 
you need to:  
1) identify activities you tend to overdo  
2) set a time limit for these activities 
3) when you reach the time limit stop, rest, and relax 
4) keep count of how many times you stop yourself and then rest and relax 
 
To set up an activity-rest cycle that will work for you, follow these steps: 
 




Step 2. Set a time limit for this activity. 
 My time limit is: ___________________________________________________ 
   
Step 3. When you reach the time limit STOP, then REST and RELAX. 
When I reach my time limit I will stop. Then I will rest and relax for the following length 
of time: _____________________________________________________   
 
Step 4. Keep count this week of how many times you stop yourself from overdoing it and then 
rest and relax instead. 








Your pain coping skills menu now includes a number of different skills. As you practice with 
these skills you will notice many positive benefits.  
 
Menu of Coping Skills 
 
a. deep diaphragmatic breathing 
b. progressive muscle relaxation 
c. mini-practices 
d. pleasant activity scheduling 
e. pleasant imagery 
f. cognitive strategies (coping thoughts) 
g. distraction methods (focal/auditory) 
h. problem solving 




Problem Solving  
There are some situations in which it seems very difficult to cope with pain using only one of 
your coping skills (e.g. a mini-practice). These problem situations can often be managed 
successfully by using a combination of different pain coping skills (e.g. mini- practice plus 
calming self-statements plus an activity-rest cycle). 
 
The following three steps can help you arrive at solutions for dealing with problem situations. 
Follow these steps when you think that a future situation may be problematic.  
  
 Step 1. Describe the situation in detail. 
 
 Step 2. Describe the difficulties you are likely to have in the situation.  
 
 Step 3. List the coping skills that you can apply in that situation.  
 
Note: when working on Step 3 it is important to be very specific. For example, write down which 
coping skills you will use, when, and how. By planning ahead, you will be prepared in that 
situation and better able to put your skills to work. Also, when other problem situations arise you 
will be more successful because you have been specific in the past about how to use your skills 




Home Practice Sheet for Week 7 
F. Keefe 
 
1. How many times in the past week did you practice with your relaxation CD? ________ 
    How many times did you use imagery after a relaxation exercise? _________________ 
 
2. How many times did you do mini-practices this week? _________________________ 
    How many times did you use focal point distraction? ______Auditory stimuli? ______ 
 
3. List any negative automatic thoughts (‘hot thoughts’) that you identified and list the 













5. How many times were you able to stop yourself from ‘overdoing it’ this week using 
    the Activity-Rest Cycle? _________________________________________________ 
 
6.  Were there any examples of times when you were able to decrease pain or tension using 
relaxation, mini-practices, imagery, etc.? Describe… 
    ______________________________________________________________________ 




Recommended Home Practice Schedule 
(F. Keefe) 
 
1. Progressive relaxation training (with diaphragmatic deep breathing) 
 Listen to the relaxation CD one time each day 
 
2. Pleasant Imagery 
 Practice using pleasant imagery each time you listen to the relaxation CD 
 
3. Mini-practices 
 Do 15 a day (it only takes less than 1 minute) 
 Do one with imagery, one with focal point distraction, one with auditory stimuli 
 
4. Activity scheduling 
 Use log sheets to schedule 5 pleasant activities each week 
 
5. Pacing 
Keep track of the number of times you stop yourself from overdoing and use rest and 
relaxation 
 
6. Cognitive strategies 
Always be aware of negative automatic thoughts and use handouts to help you to identify 
‘hot thoughts’ and replace them with ‘coping thoughts’ 
 
7. Problem Solving 
Review the handout on problem solving every time you have a major problem coping 




Plan for Maintaining Progress 
 






2. Schedule a regular time for your weekly practice. 
a. identify a specific time each day of the week 










3. Identify short-term and long-term goals that you can attain if you continue to work on the pain 
coping skills that you have learned. You may find it helpful to consider various types of goals, 































Treatment for Fibromyalgia 
Consent Form I 
Title 
Treatment for Fibromyalgia. 
 
Name of principal investigators 
Melanie Langford, BA 
Michael Wm. MacGregor, Ph.D.  
Department of Psychology 






The purpose of this investigation is to assess an educational-interpersonal  treatment for 
women with fibromyalgia.  
 
Benefits 
Your participation in this investigation will contribute to a better understanding of how 
educational-interpersonal approaches can affect the symptoms of fibromyalgia and the ways in 
which people manage the syndrome. In the future this information may provide a better 
understanding of how these approaches relate to managing illness. Also, this information may 
contribute to the construction of future psychological interventions designed specifically for 
fibromyalgia.   
 
Procedures 
 We would like to conduct an assessment in order to determine whether people are eligible 
to participate in this study. Eligibility requires a diagnosis of fibromyalgia by a rheumatologist 
and the absence of certain psychiatric diagnoses as determined by a psychologist.  
This is a randomized controlled study; therefore, eligible participants will be randomly 
assigned to either Group A or Group B.  
Participants in group A will receive phone calls by the principal investigator, once a week 
for 8-weeks, for discussions of approximately 10 minutes in duration. The discussions will relate 
to symptoms of fibromyalgia and ways in which participants attempt to manage their symptoms. 
The discussions will be supportive in nature but will not provide information on strategies or 
treatments for fibromyalgia. If desired, participants in Group A will have the opportunity to 
receive the exact same treatment that the participants in Group B receive upon completion of the 
investigation. 
Participants in Group B will attend 8, 90-minute group sessions once a week for 8 weeks. 
The sessions provide educational information on fibromyalgia, coping strategies, and methods 
for managing the disorder. The sessions will also involve discussion of interpersonal issues that 
are related to living with fibromyalgia. Upon completion of the treatment, we may request your 
feedback regarding the Group B sessions.   
   
 172 
 
 We will ask you to complete 6 questionnaires on 4 different occasions: prior to the 
treatment period, following the treatment period, and at 1 month and 3 month follow-up. We 
may also ask you to complete these questionnaires at 6-month or 1-year follow-up if you are 
interested. The questionnaires address the following areas: satisfaction with physical and mental 
well-being, self-efficacy for physical function, fibromyalgia symptoms, pain management, 
coping strategies, mood, health status, functional ability, and pain intensity. We would like to ask 
you about the number of appointments you have with a physician during the duration of the 
investigation, related to fibromyalgia symptoms/concerns. Also, we would like to ask about any 
other ongoing physical or psychological treatments that you are involved in related to 
fibromyalgia. All information provided during the assessment and on the questionnaires will be 
kept strictly confidential. It is expected that Group A will spend approximately 8 hours to 
complete this investigation, which includes time required for assessment and questionnaires. It is 
expected that Group B will spend approximately 20 hours to complete this investigation, which 
includes time required for assessment and questionnaires.   
 
Risks and ability to withdraw 
This investigation will involve some discussion of personal issues. This discussion is held 
in a safe and confidential environment in a supportive manner. Negative emotion may 
accompany such discussion, however, this is typical of psycho-educational or psychotherapy 
groups. There are no known risks or discomforts associated with this investigation beyond this. 
However, if for any reason you wish to stop taking part in the study you may do so at any time, 
without any negative effects. If you choose to withdraw, your data will be deleted from the study 
and destroyed. If you have any questions or are experiencing any difficulties associated with this 
study, we can arrange for you to speak with the principal investigator or research supervisor. We 
can also provide a list of names of psychologists in the community if you would like.    
 
Confidentiality 
Data collected by questionnaire will be kept on computer and participants will only be 
identified by research identification numbers. Paper copies of assessment information or 
questionnaires will be kept in boxes in a secure and locked room. Only the principal investigator, 
research assistants, and the research supervisor will have access to the collected data. All data 
will be stored for a minimum of 5 years. Every effort will be made to ensure that participants are 
not individually identifiable (e.g. by name, etc.). Please do not put any identifying marks on the 
questionnaires. 
There will be one master list identifying each participant by his or her identification 
number in order to collate data for each participant; however, this list will be kept separate from 
all other data collected. It will be kept in a secure and locked area separate from the data and will 
only be used for the purposes of collating data. Once all the data has been collated the list will be 
destroyed.   
 
Use of data and dissemination of results 
Data collected will be disseminated in a Ph.D. thesis, journal articles, conference 
presentations, and posters. Data will be presented in such a way that individual participants are 





 If any new information comes to light during this investigation that might influence your 
decision to continue in this investigation, you will be informed of the information and asked 
whether or not you want to continue with the investigation. 
 
Debriefing 
Following participation, the purpose of the investigation and how the results will be 
disseminated will be reviewed with you. You will also again be informed that the data will not be 
used in a way that you can be personally identified and that all data will be kept in a secure 
environment only available to the principal investigator and research supervisor. Any questions 
you might have will be answered at this time. If you are interested, your name will be taken and 
a copy of the results will be mailed to you when the study is complete.   
 
Contact person 
If you have any questions about this study you may contact Melanie Langford at (306) 
270-9224 in the department of psychology at the University of Saskatchewan.  As well, you may 
contact the Office of Research Services at (306) 966-4053 if you have any questions regarding 
your rights as a participant. 
 174 
 
Treatment for Fibromyalgia 
Signature and Consent Form I 
 
I have read and understood the description of this investigation and I agree to participate. I 
have had the investigation explained to me and I have had any questions I had about the 
investigation answered. By signing below I acknowledge that I am willing to participate in 
this investigation on treatment for fibromyalgia and that I have received a copy of the 
consent form for my records. 
 
 
This research was approved by the University of Saskatchewan Behavioral Research Ethics 





































Treatment for Fibromyalgia 
Consent Form II (Assessment) 
 
Title 
Treatment for Fibromyalgia. 
 
Name of principal investigators 
Melanie Langford, BA. 
Michael Wm. MacGregor, Ph.D. 
Department of Psychology 






The purpose of this investigation is to assess an educational-interpersonal  treatment for 
women with fibromyalgia.  
 
Procedures 
In order to participate in this study you need to meet certain eligibility criteria. You need 
to have a diagnosis of fibromyalgia as diagnosed by a rheumatologist. We will ask you to 
provide consent to be assessed by a psychologist to determine whether you have certain 
psychiatric or psychological disorders, for example, psychosis. We would like to audio and video 
tape the assessment. The information from these tapes will be kept strictly confidential, only the 
principal investigator, research assistants, and the research supervisor have access to the tapes. 
The information on the tapes will not be used in the dissemination of results. The purpose of the 
taping is to ensure that the standard questions involved in the assessment have been asked. By 
signing this form I am indicating that I agree to participate in the assessment and I am aware that 
the assessment is taped.  
If you do not have a diagnosis of fibromyalgia from a rheumatologist you will not be 
eligible to participate in this study. If you do not meet eligibility criteria based on the 
psychological assessment you will not be eligible to participate in this study. If you do meet 
eligibility criteria you will be able to participate in the study.  
If you cannot participate in the study all information that you have provided will be kept 
strictly confidential and will be destroyed. If you are interested in receiving a copy of the results 
of this study the principal investigator will make arrangements to provide you with this 
information. If you have any questions or concerns we can make arrangements for you to speak 
with the principal investigator or the research supervisor. If you would like, we can also provide 
a list of names of psychologists in the community.  
 
Contact person 
If you have any questions about this study you may contact Melanie Langford at (306) 
270-9224 in the department of psychology at the University of Saskatchewan. As well, you may 
contact the Office of Research Services at (306) 966-4053 if you have any questions regarding 
your rights as a participant. 
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Treatment for Fibromyalgia 
Signature and Consent Form II 
 
I have read and understood the description of this investigation and all information provided 
in the consent form. By signing this consent form I am agreeing to participate and agree to 
the terms outlined in the consent form. I have had the investigation explained to me and I 
have had my questions about the investigation answered. By signing below I acknowledge 
that I am willing to participate in this investigation on treatment for fibromyalgia and that I 
have received a copy of the consent form for my records. 
 
 
This research was approved by the University of Saskatchewan Behavioral Research Ethics 




































Treatment for Fibromyalgia 
Consent Form III (Group) 
 
Title 
Treatment for Fibromyalgia. 
 
Name of principal investigators 
Melanie Langford, BA. 
Michael Wm. MacGregor, Ph.D. 
Department of Psychology 






The purpose of this investigation is to assess an educational-interpersonal  treatment for 
women with fibromyalgia. 
 
Procedures 
 All information discussed in the group sessions is confidential. Any information shared 
within the group will not be discussed outside the group, including the names of other group 
members. Personal issues will be discussed in the context of a safe and confidential group 
therapy setting. The privacy and dignity of all members of the group will be respected. By 
reading and signing this consent form I am indicating that I understand that the information 
discussed in the group sessions is confidential and I will not discuss it with anyone outside the 
group.  
 The group sessions will be audio and/or video taped. The information from these tapes 
will be kept strictly confidential, only the principal investigator, research assistants, and the 
research supervisor have access to the tapes. The information on the tapes will not be used in the 
dissemination of results. The purpose of the taping is to ensure that the treatment is delivered in 
accordance with the treatment manual, and to ensure that each Group B group receives the same 
treatment. As such, the sessions may be observed by the supervisor, future therapists, and/or 
research assistants. By signing this form I am indicating that I agree to participate in the group 
treatment and I am aware that the sessions are taped.  
 
Contact person 
If you have any questions about this study you may contact Melanie Langford at (306) 
270-9224 in the department of psychology at the University of Saskatchewan. As well, you may 
contact the Office of Research Services at (306) 966-4053 if you have any questions regarding 
your rights as a participant. 
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Treatment for Fibromyalgia 
Signature and Consent Form III 
 
I have read and understood the description of this investigation and all information provided 
in the consent form. By signing this consent form I am agreeing to participate and agree to 
the terms outlined in the consent form. I have had the investigation explained to me and I 
have had my questions about the investigation answered. By signing below I acknowledge 
that I am willing to participate in this investigation on treatment for fibromyalgia and that I 
have received a copy of the consent form for my records. 
 
 
This research was approved by the University of Saskatchewan Behavioral Research Ethics 





































Treatment for Fibromyalgia 
 
Name of principal investigators 
Melanie Langford, B.A. 
Michael Wm. MacGregor, Ph.D. 
Department of Psychology 





The purpose of this investigation is to better understand the effectiveness of an educational-
interpersonal treatment for women with fibromyalgia. This study compares a treatment group to 
a control group. The treatment group involves cognitive-behavioural and interpersonal therapy 
components in order to address the needs of fibromyalgia patients. For example, coping 
strategies and pain management techniques may reduce symptoms, improve quality of life, or 
increase sense of efficacy. The control group involves weekly phone contact with the researcher. 
The data that you have provided will allow us to better understand how psychotherapeutic 
treatments can help people with fibromyalgia, and how these treatments can be tailored to more 
specifically meet the needs of fibromyalgia patients.   
 
Confidentiality 
Data collected by questionnaire will be kept on computer and participants will be identified by 
research identification numbers. Paper copies of questionnaires will be kept in boxes in a secure 
and locked room. Only the principle investigators will have access to the collected data. All data 
will be stored for a minimum of 5 years. Every effort will be made to ensure that participants are 
not individually identifiable (e.g. by number, name, etc.). 
 
Use of data and dissemination of results 
Data collected will be disseminated in a Ph.D. thesis, journal articles, conference presentations 
and posters. Data will be presented in such a way that individual participants are not identifiable. 
 
Contact person 
If you have any questions about this study you may contact Melanie Langford at (306) 270-9224 
or (306) 966-6665 in the department of psychology at the University of Saskatchewan. As well, 
you may contact the Office of Research Services at (306) 966-4053 if you have any questions 
regarding your rights as a participant.  
Thank you for your participation.  
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Consent to be contacted in the future 
Fibromyalgia Treatment Study 
  
I agree to be contacted in the future for a follow-up on the Fibromyalgia Treatment Study. I 
understand that by agreeing to be contacted I am not obligated to participate if I have changed 
my mind. 
  
By signing below I agree to be contacted in the future regarding participation in the follow-up 
study. I also understand that when contacted any additional risks or benefits will be explained at 
the time. 
   
Yes I agree to be contacted in the future.     
______ 












Phone number        _________________________________ 
E-mail address       _________________________________ 
  
  
If I have any questions about the investigation I just participated in I can contact Melanie 
Langford or Michael MacGregor at (306) 270-9224 in the Department of Psychology, University 
of Saskatchewan. If I have any questions about my rights as a participant in this investigation I 
can contact the Office of Research Services at (306) 966-4053 at the University of 
Saskatchewan. 
  




Protocol for the Attention-Control Condition 
The researcher will telephone participants in the attention-control condition once each 
week for a period of 8 weeks. The days of the week and time of day/evening of the phone calls 
will be arranged with each participant in order to: maximize convenience for the participant, 
allow the participant to be prepared for the call, and increase the likelihood of making contact. 
Each phone call will be of approximately 10-15 minutes in duration.  
The researcher will ask each participant the following questions. These specific questions 
are to be asked, without adding or deleting content. Question 1 should be the first question asked 
each week and should be asked every week. Apart from question 1, different combinations of 
questions are to be asked each week, depending on the time the participant requires to answer the 
questions. For example, if 10-15 minutes have passed after asking only three questions, it is not 
necessary to ask additional questions. However, each question must be asked at least once during 
the course of the 8 weeks. It may be necessary to repeat some or all of the questions during the 8-
week period. Questions will be asked one at a time, allowing time for the participant to answer 
after each question. Cues can be given if the participant provides a vague answer or a brief 
answer. The following cues are permissible: a) ‘can you please tell me more about that?’ or b) 
‘can you please provide a specific example?’  
Question 1. Please describe your last week, in terms of what you did day by day. 
Question 2. Please describe your most stressful day during the past week.  
Question 3. Please describe your most pleasant day during the past week.  
Question 4. Have you had any thoughts directly related to your fibromyalgia diagnosis in 
the past week? If so, what was (were) the thought(s)? 
Question 5. What was the most effective strategy that you used to cope with or manage 
symptoms of fibromyalgia this week?  
Question 6. Was there a specific interpersonal issue/incident that was 
upsetting/frustrating for you in the past week? 
Question 7. Was there a specific interpersonal issue/incident that was fun/enjoyable for 
you in the past week?  
Question 8. What are your goals for the following week? You may have goals of a work, 
social, exercise, or recreational nature (or other).  
 If a participant asks for information or advice related to fibromyalgia, coping, or personal 
issues, the researcher should respond in a professional and supportive manner. However, the 
researcher should make every effort not to provide direct answers, as this may jeopardize the 
attention-control condition. For example, if information is provided regarding fibromyalgia, this 











 The differences between the results of the original data and the intention-to-treat data are 
as follows:  
• The ANCOVA for FIQ total at post-treatment was significant at p < .05 for the 
intention-to-treat data but not for the original data. 
• The results for the relaxation strategy for the CPCI were the same at post-
treatment.  However, at follow-up, the ANCOVA was significant for the 
intention-to-treat data but not for the original data.  Similarly, the ANCOVA for 
relaxation, as measured by the self-efficacy scale, was significant at follow-up for 
the intention-to-treat data but not for the original data.  
ANCOVA Results Based on the Original Data 
Primary Outcome Variable 
H1) Fibromyalgia impact.  To test the hypothesis that the treatment condition’s 
fibromyalgia impact scores would significantly improve (decrease) from time 1 to time 2 while 
the control condition’s scores would not significantly change, an ANCOVA was conducted.  The 
dependent variable for the analysis was fibromyalgia impact time 2, that is, the impact that 
fibromyalgia symptoms have on various aspects of life, measured by the FIQ total score. The 
independent variable was condition (treatment condition or attention-control condition). The 
fibromyalgia impact total score at time 1 served as the covariate.   
The covariate, fibromyalgia impact time 1, was significantly related to the fibromyalgia 
impact time 2 score, F (1, 71) = 29.49, p < .001. There was not a significant effect of condition 
on fibromyalgia impact time 2 after controlling for the effect of fibromyalgia impact time 1.  A 
higher score on the FIQ indicates greater impairment due to fibromyalgia symptoms.  
Although there was not a significant treatment effect, to test the hypothesis that the 
treatment condition and control condition differed at follow-up (time 4) an ANCOVA was 
conducted. There was not a significant effect of condition.  
Secondary Outcome Variables 
H2) Pain (intensity, frequency, duration).  To test the hypothesis that the treatment 
condition’s pain intensity scores would significantly improve (decrease) from time 1 to time 2, 
while the control condition’s scores would not significantly change, an Analysis of Covariance 
(ANCOVA) was conducted. The dependent variable for the analysis was pain intensity at time 2, 
which is a composite of current, worst, least, and average pain ratings measured by the NPRS. 
The independent variable was condition (treatment condition or attention-control condition). The 
pain intensity score at time 1 served as the covariate.   
The covariate, pain intensity time 1, was significantly related to pain intensity time 2, F 
(1, 70) = 28.28, p < .001. There was not a significant effect of condition on pain intensity time 2 
after controlling for the effect of pain intensity time 1.  
Since a treatment effect was not observed at time 2 there will not be maintenance of a 
treatment effect at follow-up. However, to test the hypothesis that the treatment condition and 
control condition would differ on pain intensity at time 4, an ANCOVA was conducted. The 
dependent variable for the analysis was pain intensity time 4. The covariate, pain intensity time 
1, was significantly related to pain intensity time 4, F (1, 46) = 23.08, p < .001. There was not a 
significant effect of condition observed at follow-up.   
To test the hypotheses for the frequency of pain and the duration of pain ANCOVA’s 
were also conducted. Frequency of pain refers to the number of days in a week that a person 
experienced pain. Duration refers to the longest length of time that a person experienced 
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continuous pain during a week. Frequency and duration of pain were also measured by the 
NPRS. The effect of condition was not significant for either frequency of pain or duration of pain 
after controlling for the effect of frequency at time 1 and duration at time 1. Nor was an effect 
observed at follow-up (time 4). At time 2 and time 4 respectively, the covariates were 
significantly related to the independent variables: frequency, F (1, 70) = 22.36, p < .001, F (1, 
45) = 15.61, p < .001; duration, F (1, 70) = 21.59, p < .001, F (1, 45) = 27.51, p < .001. 
H3) Functional disability.  To test the hypothesis that the treatment condition’s level of 
functional disability would significantly improve (decrease) from time 1 to time 2 while the 
control condition’s scores would not significantly change, an ANCOVA was conducted. The 
dependent variable for the analysis was functional disability at time 2 as measured by the HAQ.  
The independent variable was condition (treatment condition or attention-control condition). The 
functional disability score at time 1 served as the covariate.  
The covariate was significantly related to functional disability time 2, F (1, 71) = 74.15, p 
< .001. The effect of condition was not significant. Nor was there an effect of condition at time 4, 
although the covariate was significantly related with the time 4 scores, F (1, 46) = 72.68, p < 
.001. 
H4) Workdays missed.  To test the hypothesis that the treatment condition’s number of 
workdays missed would significantly improve (decrease) from time 1 to time 2 while the control 
condition’s scores would not significantly change, an ANCOVA was conducted. The dependent 
variable for the analysis was the number of workdays missed at time 2. The independent variable 
was condition (treatment condition or attention-control condition). The number of workdays 
missed at time 1 served as the covariate.  
The covariate was significantly related to workdays missed time 2, F (1, 71) = 29.70, p < 
.001.  The effect of condition was not significant.  
Since a treatment effect was not observed at time 2 there will not be maintenance of a 
treatment effect at follow-up. However, to test the hypothesis that the treatment condition and 
control condition would differ on number of workdays missed at time 4, an ANCOVA was 
conducted. The dependent variable for the analysis was workdays missed time 4. The covariate, 
workdays missed time 1, was significantly related to workdays missed time 4, F (1, 46) = 17.86, 
p < .001.  There was not a significant effect of condition observed at follow-up.   
H5) Health care utilization.  To test the hypothesis that the treatment condition’s use of 
health care would significantly improve (decrease) from time 1 to time 2 while the control 
condition’s scores would not significantly change, an ANCOVA was conducted. The dependent 
variable for the analysis was the number of appointments with their physician related to 
fibromyalgia symptoms at time 2. The independent variable was condition (treatment condition 
or attention-control condition). The number of visits to their family physician at time 1 served as 
the covariate.   
The covariate was significantly related to appointments with physician time 2, F (1,) = 
53.36, p < .001. The effect of condition was not significant.  
Since a treatment effect was not observed at time 2 there will not be maintenance of a 
treatment effect at follow-up. However, to test the hypothesis that the treatment condition and 
control condition would differ on health care utilization at time 4, an ANCOVA was conducted. 
The dependent variable for the analysis was visits to physician time 4. The covariate, visits to 
physician time 1, was significantly related to visits to physician time 4, F (1,101) = 61.88, p < 
.001.  There was not a significant effect of condition observed at follow-up, time 4.   
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H6) Depression.  To test the hypothesis that the treatment condition’s depression scores 
would significantly improve (decrease) from time 1 to time 2 while the control condition’s scores 
would not significantly change, ANCOVAs were conducted.  Depression was measured by the 
FIQ and the SCL90-R and an ANCOVA was conducted for each variable.  In each case the 
independent variable was condition (treatment condition or attention-control condition) and the 
covariate was the time 1 score.  
The covariate, FIQ depression time 1, was significantly related to FIQ depression time 2, 
F (1, 71) = 68.27, p < .001.  There was also a significant effect of condition on FIQ depression 
time 2 after controlling for the effect of FIQ depression time 1, F (1, 71) = 7.37, p = < .01.  A 
higher score indicates greater impairment. T4 covariate F (1, 46) = 38.64, p < .001. 
The covariate, SCL90 depression time 1, was significantly related to SCL90 depression 
time 2, F (1, 66) = 85.61, p < .001.  The effect of condition was not significant. To examine 
follow-up effects, the covariate for SCL90 depression was significantly related to the SCL90 
depression time 4 score, F (1, 40) = 111.72, p < .001. However, the effect of condition was not 
significant.  
H7) Anxiety.  To test the hypothesis that the treatment condition’s level of anxiety would 
significantly improve (decrease) from time 1 to time 2 while the control condition’s scores would 
not significantly change, ANCOVAs were conducted.  Anxiety was measured by the FIQ and the 
SCL90-R and an ANCOVA was conducted for each variable.  In each case the independent 
variable was condition (treatment condition or attention-control condition) and the covariate was 
the time 1 score.  
The covariate, anxiety FIQ time 1, was significantly related to anxiety FIQ time 2, F (1, 
71) = 54.14, p < .001.  The effect of condition was not significant. The covariate, anxiety SCL90 
time 1, was significantly related to anxiety SCL90 time 2, F (1, 66) = 43.92, p < .001.  The effect 
of condition was not significant.  
Since a treatment effect was not observed at time 2 there will not be maintenance of a 
treatment effect at follow-up. However, to test the hypothesis that the treatment condition and 
control condition would differ on anxiety at time 4, ANCOVAs were conducted. The covariate, 
anxiety FIQ time 1, was significantly related to anxiety FIQ time 4, F (1, 46) = 54.55, p < .001.  
There was not a significant effect of condition. The covariate, anxiety SCL90 time 1, was 
significantly related to the anxiety SCL90 time 4 score, F (1, 40) = 110.53, p < .001.  The effect 
of condition was not significant.  
H8) Coping. To test the hypothesis that the treatment condition’s wellness focused 
coping strategies would significantly improve (increase) from time 1 to time 2 while the control 
condition’s scores would not significantly change, ANCOVAs were conducted. The dependent 
variable for each analysis was the strategy (relaxation, task persistence, self-statements) at time 2 
as measured by the CPCI. The independent variable was condition (treatment condition or 
attention-control condition). The strategy at time 1 served as the covariate.  
Each covariate (relaxation, task persistence, self-statements) was significantly related to 
the strategy at time 2, F (1, 59) = 37.86, p < .001; F (1, 59) = 37.99, p < .001; F (1, 59) = 27.45, p 
< .001 (respectively). The effect of condition was significant for relaxation F (1, 59) = 22.84, p < 
.001 and task persistence F (1, 59) = 4.48, p < .05 but not for self-statements. A higher score 
indicates greater endorsement of the coping strategy. At time 2, the treatment condition endorsed 
the use of task persistence less than the control condition. 
To test the hypothesis that the treatment condition’s improvement in coping strategies 
would be maintained at follow-up (time 4) and the control condition’s scores would not 
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significantly change, ANCOVAs were conducted. There was not a significant effect of condition 
for relaxation or task persistence; therefore, the treatment effects were not maintained at time 4. 
Nor was the effect of condition significant for self-statements at time 4.  
To test the hypothesis that the treatment condition’s illness focused coping strategies 
would significantly decrease from time 1 to time 2 while the control condition’s scores would 
not significantly change, ANCOVAs were conducted. The dependent variable for each analysis 
was the strategy (guarding, resting, asking for assistance) at time 2 as measured by the CPCI. 
The independent variable was condition (treatment condition or attention-control condition). The 
strategy at time 1 served as the covariate.  
Each covariate (guarding, resting, asking for assistance) was significantly related to the 
strategy at time 2, F (1, 59) = 36.62, p < .001; F (1, 59) = 39.69, p < .001; F (1, 59) = 73.70, p < 
.001 (respectively). The effect of condition was significant for resting after controlling for the 
effect of resting time 1, F (1, 59) = 10.02, p < .01. The effect was not maintained at follow-up 
(time 4).  The effect of condition was not significant for guarding or asking for assistance. 
However, for guarding there was a significant effect at follow-up. The covariate, guarding time 
1, was significantly related to the guarding time 4 score, F (1, 40) = 113.17, p < .001. There was 
a significant effect of condition on guarding time 4 after controlling for the effect of guarding 
time 1, F (1, 40) = 9.53, p < .01.   
Seeking social support is another coping strategy but it is considered neither wellness 
focused nor illness focused. To test the hypothesis that the treatment condition’s seeking social 
support coping strategy would significantly improve from time 1 to time 2 while the control 
conditions scores would not significantly change, an ANCOVA was conducted. The dependent 
variable for the analysis was seeking social support time 2, as measured by the CPCI.  
The independent variable was condition (treatment condition or attention-control 
condition). Seeking social support at time 1 served as the covariate. The covariate was 
significantly related to seeking support time 1, F (1, 59) = 87.03, p < .001. There was no effect of 
condition at time 2 or at follow-up (time 4). 
H9) Relaxation.  In addition to relaxation as a coping strategy, relaxation was also 
measured by the CDQ.  To test the hypothesis that the treatment condition’s relaxation scores 
would significantly improve (increase) from time 1 to time 2 while the control condition’s scores 
would not significantly change, an ANCOVA was conducted.  The dependent variable for the 
analysis was relaxation time 2, measured by the CDQ. The independent variable was condition 
(treatment condition or attention-control condition). The relaxation score at time 1 served as the 
covariate.   
The covariate, relaxation time 1, was significantly related to the relaxation time 2 score, F 
(1, 71) = 42.77, p < .001.  There was also a significant effect of condition on relaxation time 2 
after controlling for the effect of relaxation time 1, F (1, 71) = 11.94, p = .001.  A higher score 
indicates greater use of mental relaxation techniques.  Therefore, at time 2 the treatment 
condition utilized mental relaxation techniques to a greater extent compared to the control 
condition.  
To test the hypothesis that the treatment condition’s improvement in relaxation scores 
would be maintained at follow-up (time 4) and the control condition’s scores would not 
significantly change, an ANCOVA was conducted. The covariate was significantly related to the 
relaxation score at time 4, F (1, 46) = 457.81, p < .001. There was not a significant effect of 
condition at time 4.  Therefore, the treatment effect was not maintained at time. 
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H10) Self-efficacy.  To test the hypothesis that the treatment condition’s self-efficacy 
scores would significantly improve (increase) from Time 1 to Time 2, while the control 
condition’s scores would not significantly change, an ANCOVA was conducted.  The dependent 
variable for the analysis was self-efficacy time 2 as measured by the ASES.  The independent 
variable was condition (treatment or attention-control). Self-efficacy at time 1 served as the 
covariate.   
The covariate, self-efficacy time 1, was significantly related to self-efficacy time 2 score, 
F (1, 71) = 56.75, p < .001. There was also a significant effect of condition on self-efficacy time 
2 after controlling for the effect of self-efficacy time 1, F (1, 71) = 8.27, p < .01.  A higher score 
indicates greater self-efficacy or greater confidence in ability to do various tasks. Therefore, at 
time 2, the treatment condition experienced greater self-efficacy compared to the control 
condition. 
To test the hypothesis that the treatment condition’s improvement in self-efficacy would 
be maintained at follow-up (time 4) and the control condition’s scores would not significantly 
change, an ANCOVA was conducted. There was not a significant effect of condition; therefore, 
the treatment effect was not maintained at time 4. 
H11) Quality of life. To test the hypothesis that the treatment condition’s quality of life 
would significantly improve (increase) from time 1 to time 2 while the control condition’s scores 
would not significantly change, an ANCOVA was conducted. The dependent variable for the 
analysis was quality of life as measured by the QOLS at time 2. The independent variable was 
condition (treatment or attention-control). Quality of life at time 1 served as the covariate. 
The covariate was significantly related to quality of life time 2, F (1, 62) = 34.24, p < 
.001. There was no significant effect of condition after controlling for time 1 scores. Nor was 





Means and Standard Deviations for the Primary and Secondary Variables based on the Original 
Data for the Treatment and Control Condition at Four Time Periods   
 
Variable Group        Time 1         Time 2 
      
Time 3          Time 4 
    M SD M SD M SD M SD 
Primary Variable          
     FIQ total Treatment 57.37 15.38 48.15 19.47 52.22 16.50 53.65 16.79
 Control 53.23 15.36 53.08 17.19 64.37 9.86 55.59 13.61
Secondary Variables                   
     Pain          
          intensity Treatment 213.42 63.20 200.17 70.70 190.71 67.68 198.66 67.31
 Control 199.21 56.63 205.09 76.09 238.33 46.17 195.48 67.67
          
           frequency* Treatment 5.69 1.99 5.04 2.19 5.29 1.97 5.39 2.29
 Control 6.34 1.48 5.91 1.68 6.50 1.00 5.95 1.88
          
          duration* Treatment 71.80 65.07 64.33 69.29 69.60 74.09 71.46 70.25
 Control 97.93 68.53 102.07 76.55 120.81 74.43 85.92 78.08
          
     Functional disability Treatment 0.61 0.48 0.54 0.42 0.54 0.44 0.53 0.44
 Control 0.59 0.46 0.57 0.45 0.81 0.53 0.71 0.71
          
     Work missed* Treatment 2.94 3.56 2.02 2.80 2.72 3.13 2.45 3.37
 Control 2.55 3.08 2.91 2.71 4.29 2.58 3.30 3.51
          
     Health care utilization* Treatment 3.65 2.68 3.47 3.01 2.65 1.95 3.52 3.75
 Control 3.63 2.65 3.93 4.20 4.44 4.33 3.26 3.48
          
     Depression          
           FIQ* Treatment 4.44 2.95 3.28 2.70 3.81 2.66 4.02 2.84
 Control 3.64 2.52 4.28 2.48 5.39 2.15 3.83 2.83
          
           SCL90 Treatment 1.68 0.89 1.38 1.02 1.23 0.88 1.47 1.10
 Control 1.41 0.76 1.49 0.85 1.66 0.65 1.56 0.78
          
     Anxiety          
          FIQ* Treatment 5.27 2.81 4.39 2.73 4.31 2.76 4.95 2.82
 Control 4.06 2.70 4.05 2.79 5.39 2.06 4.60 2.55
          
          SCL90-R Treatment 1.14 0.80 0.91 0.78 0.73 0.78 0.87 0.81






Table M1 (continued) 
 
Means and Standard Deviations for the Primary and Secondary Variables based on the Original 
Data for the Treatment and Control Condition at Four Time Periods   
 
Variable Group        Time 1         Time 2 
      
Time 3          Time 4 
    M SD M SD M SD M SD 
Secondary Variables          
     Coping          
           self-statements Treatment 3.08 1.84 3.38 1.48 3.08 2.01 3.04 1.89
 Control 2.94 1.64 3.08 1.95 2.72 1.62 2.94 1.94
          
           task persistence Treatment 4.46 1.92 4.07 1.74 3.92 1.98 4.36 2.11
 Control 5.04 1.32 5.03 1.44 5.07 2.05 5.16 1.46
          
           relaxation Treatment 1.96 1.37 3.53 1.27 2.44 1.54 2.30 1.43
 Control 2.01 1.51 2.25 1.92 1.78 1.81 2.09 1.49
          
           guarding Treatment 3.22 2.13 2.94 1.79 3.04 1.88 2.81 1.73
 Control 2.76 1.51 2.86 1.74 3.79 1.72 3.27 1.94
          
           asking for help Treatment 2.16 1.92 2.88 2.64 2.67 1.96 2.38 2.08
 Control 1.65 1.52 2.22 2.05 2.18 2.09 1.75 1.43
          
           resting Treatment 3.89 1.64 3.91 1.40 3.80 1.82 3.84 1.80
 Control 3.03 1.42 2.97 1.86 3.35 1.31 2.74 1.54
          
           seeking support Treatment 2.36 1.46 2.73 1.68 2.33 1.74 2.58 1.75
 Control 2.15 1.46 2.50 1.56 2.18 1.30 2.30 1.25
          
     Relaxation (CDQ) Treatment 3.39 4.33 10.30 10.69 5.98 6.86 4.00 5.21
 Control 5.10 13.43 5.28 10.28 4.56 6.15 7.86 20.63
          
     Self-efficacy Treatment 4.40 1.63 6.31 2.01 6.11 2.16 5.14 1.98
 Control 5.14 1.66 5.53 1.75 4.20 1.24 5.02 1.76
          
     Quality of life Treatment 73.32 12.11 75.14 14.83 77.60 10.94 72.32 16.62
  Control 71.42 14.88 69.19 11.42 64.43 13.96 70.21 11.38
Note. The means and standard deviations for time 2 and time 4 are based on the ANCOVA results. 
* indicates a single item. FIQ = Fibromyalgia Impact Questionnaire, SCL90-R = Symptom Checklist 
90-Revised, CDQ = Chronic Disease Questionnaire.       
 
 
 
